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Cardiovascular disease (CVD) is the leading cause of mortality among American women, 
and event rates are particularly high among African Americans.  Recent technologies have 
facilitated early detection of subclinical vascular changes that precede clinical events.  This 
research project examined the interrelationships of ethnicity, CVD risk factors, socioeconomic 
status (SES), and psychosocial health with these subclinical CVD changes among women.  
 
We examined data from the Study of Women’s Health Across the Nation (SWAN) Heart 
Study (n’s=303-536), a prospective epidemiological study of middle-aged African Americans 
and Caucasians.  Coronary artery calcification (CAC), aortic calcification (AC), carotid artery 
intima-media thickness (IMT), and aortic pulse-wave velocity (PWV) were assessed at two 
visits, an average of 2.3 years apart.    
 
We examined ethnic differences in the associations of traditional CVD risk factors on 
PWV progression, or arterial stiffening.  Systolic blood pressure (SBP) and waist circumference 
were associated with accelerated PWV progression.  The effect of SBP was stronger among 
African Americans than among Caucasians, and LDL-C, diastolic blood pressure (DBP) and 
glucose levels were associated with PWV progression only among African Americans.   
 
African American women have poorer CVD outcomes but do not consistently have 
higher subclinical CVD in the literature.  We speculated that SES partly explains relationships 
between ethnicity and subclinical CVD.  Our findings indicated that low education was related to 
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AC, after adjustment for ethnicity.  African American ethnicity was associated with IMT and 
PWV after adjustment for education, but not income.  A significant interaction between ethnicity 
and income suggested that low-income African American women were at greatest risk of 
presenting with high PWV. 
 
Finally, we observed that low educational attainment was associated with greater CAC 
progression among Caucasians but not African Americans.  Financial strain partly mediated this 
relationship. 
 
Our findings suggest that certain CVD risk factors are more strongly related to 
progression among African Americans than among Caucasians.  Furthermore, SES may explain 
some ethnic differences in the extent of subclinical CVD.  Lastly, psychosocial indicators 
explain higher CAC progression among low-SES Caucasian women.   
 
This project has public health significance.  Clarifying how biological and psychosocial 
factors contribute to subclinical CVD may reveal targets for prevention of clinical disease. 
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1.0   DISSERTATION OVERVIEW AND OBJECTIVES 
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among 
women in the United States.  While African American women have greater prevalence of clinical 
events, including coronary heart disease (CHD) and stroke, autopsy and angiography studies 
reveal that they are unexpectedly less likely than are Caucasian women to show lesions or 
stenoses in their coronary vessels.   
 
This paradox also extends to subclinical measures of cardiovascular disease, which 
represent early stages of adverse vascular change and may precede clinical outcomes and 
symptoms.  African American women have less coronary artery calcification (CAC) than do 
Caucasian women, but greater prevalence or extent of aortic calcification (AC), carotid artery 
intima-media thickness (IMT) and aortic pulse wave velocity (PWV).  Ethnic discrepancies 
between subclinical CVD and clinical outcomes underscore the fact that relatively little is known 
about why certain women develop subclinical disease or what risk factors contribute to the 
progression of these early stages of disease.   
 
The objective of this dissertation was to examine the interrelationships of ethnicity and 
biologic, physiologic, and psychosocial risk factors with regard to subclinical CVD changes 
among women.  Research questions were investigated in the Study of Women’s Health Across 
the Nation (SWAN) Heart study, a prospective study of CHD-free, middle-aged African 
American and Caucasian women. 
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Research questions were addressed in a series of three research articles:  
 
1. What are the associations of traditional CVD risk factors with the progression of 
arterial stiffness?  Do these relationships vary by ethnicity? 
2. What are the independent and combined associations of ethnicity and 
socioeconomic status (SES) with cross-sectional measures of CAC, AC, IMT, and PWV? 
3. What are the combined relationships of ethnicity and SES with respect to 
progression of CAC?  Are these relationships explained by psychosocial factors? 
 
In order to prevent these early cardiovascular changes from progressing into clinical 
events among women, it is important to identify and understand the effects of pertinent risk 
factors that promote subclinical CVD onset and progression.   
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2.0  BACKGROUND 
2.1 CARDIOVASCULAR DISEASE BURDEN IN WOMEN 
Cardiovascular disease (CVD) is the leading cause of death and disability in the United 
States.  In 2007, the American Heart Association reported that cardiovascular diseases were 
responsible for 869,700 deaths, or approximately 1 of every 2.8 deaths in the United States.  An 
estimated 80,000,000 living Americans are burdened with at least one form of CVD, including 
hypertension, coronary heart disease (CHD), stroke, or heart failure.1  
 
CVD was traditionally considered to be a disease of men, since CVD symptoms and 
events present approximately ten years earlier in men than in women.2   Estrogen is a 
cardioprotective hormone and is postulated to ameliorate the inflammatory cascade that 
contributes to vascular disease.3  After estrogen levels decline during the menopause transition, 
CVD mortality rates in women rapidly equalize to those of men—indeed, 52.8% of total CVD 
deaths in 2004 occurred among women.  The most recent statistics from the American Heart 
Association indicate that between 2004 and 2005, 217,800 women died from CHD, 7.3 million 
women developed clinical CHD, 4.6 million women developed angina pectoris, and 3.0 million 
women endured myocardial infarctions.1   
 
Despite these sobering statistics, the earlier-mentioned gender bias in CVD assessment 
has contributed to a deficiency of studies that focus on CVD in women.  Findings from studies of 
men are typically generalized to women-- an approach that may be inappropriate due to 
differences in hormones, distributions of adipose tissue, CVD risk factor profiles, lifestyle and 
psychosocial factors between the genders.4  This underscores the need to better understand risk 
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factors that contribute to CVD in women, particularly at the earliest and potentially reversible 
stages of adverse vascular change. 
 
Indeed, there is still much to learn about why certain women are at higher risk of 
developing CVD.  Notably, CVD incidence and prevalence are particularly burdensome for 
African American women.  Compared to Caucasian women, African American women have 
higher estimated rates of CVD mortality (333.8/100,000 versus 238.0/100,000), and prevalence 
of myocardial infarction (3.3% versus 2.5%), CHD (7.8% versus 6.0%) and stroke (4.1% versus 
2.7%).  This disproportionate burden in part reflects a higher proportion of adverse CVD risk 
factors among African American women: compared to Caucasian women, African American 
women are more likely to be overweight or obese (79.6% versus 57.6%), hypertensive (44.6% 
versus 33.6%), and diabetic (13.2% versus 5.6%).1   
 
Paradoxically, while the CVD risk factor burden, prevalence and incidence of CVD 
events are higher among African American women, the extent of clinically-detectable vascular 
disease appears to be greater among Caucasians.  Two angiography studies found that Caucasian 
women had more extensive coronary artery disease than did African American women, and were 
also more likely to present with coronary obstructions or stenoses. 5, 6  These results are 
consistent with studies of men, which are more numerous; autopsy or angiography studies of 
individuals with MI/unstable angina indicate that African American men are less likely to have 
coronary obstructions, and more likely to have normal angiography findings than are Caucasian 
men.7-9  This paradox is still largely unexplained.  
4 
 2.2 SUBCLINICAL CARDIOVASCULAR DISEASE 
The paradoxical finding that higher detectable vascular disease among Caucasians is not 
associated with higher clinical outcomes has also been observed in a variety of subclinical CVD 
measures.  Subclinical CVD measures represent aspects of arteriosclerosis and atherosclerosis-- 
two distinct yet related processes that may culminate in clinical outcomes.  Both processes share 
common mechanistic progenitors, including inflammation and dyslipidemia; they also share 
common clinical risk factors.  According to the American Society of Hematology, “proven risk 
factors…are hypercholesterolemia, hypertension, cigarette smoking, obesity, physical inactivity, 
age, family history, diabetes and male sex.”10  However, these known risk factors explain only 
part of the variation in clinical CVD outcomes.11  Identification and modification of reversible 
risk factors among women may help to prevent the progression of atherosclerosis and 
arteriosclerosis into clinical CVD events.   
 
The following sections will describe the overall pathogenesis of atherosclerosis and 
arteriosclerosis, and then describe the subclinical CVD measures that represent various aspects 
of these processes.  
 
2.2.1 Pathogenesis of Atherosclerosis  
Atherosclerosis is characterized by fatty degeneration of the vasculature, plaque 
formation and localized arterial stiffening.  Vascular endothelial cells may over-express adhesion 
molecules when injured or exposed to an inflammatory milieu.  VCAM-1, a well-characterized 
adhesion molecule, attracts immune cells and lipids to a weakened or damaged vessel.  
Circulating lipids begin to accumulate underneath the damaged endothelium.  Macrophages 
engulf the lipids, developing into large foam cells that are trapped in the intima layer.  
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Histologically, this is described as the “fatty streak,” and represents one of the earliest detectable 
lesions of atherosclerosis.  The foam cells are also a major component of the atheroma, or the 
lipid-laden core of the developing plaque.  Foam cells express cytokines that attract 
inflammatory molecules.  As foam cells die, they expel their contents into the sub-intimal space; 
this attracts additional macrophages and inflammatory cytokines.  Smooth muscle cells from the 
neighboring media layer also migrate into the area of vascular injury, contributing to arterial 
stiffening around the damaged area.  Advanced lesions may become calcified.  A fibrous cap, or 
connective tissue scar, forms as a result of the inflammatory process and may initially stabilize 
the plaque.   
 
Atherosclerotic plaque formation results in vessel narrowing, which reduces blood flow 
and oxygenation of tissues distal to the stenosis.  This general process is observed in myocardial 
infarction, peripheral arterial disease, and/or cerebrovascular disease; consequences may be fatal.  
Plaque rupture or thrombosis may lead to complete or partial vessel occlusion further along the 
cardiac artery.  High shear stress at areas of stenosis may cause subsequent plaque instability and 
rupture.  Thrombi may also form on the surface of the tethered plaque due to variations in shear 
stress across the lesion.  If a ruptured clot or plaque fragment partially obstructs a coronary 
vessel distal to the original lesion, it may cause angina pectoris; if it completely occludes the 
vessel, it may cause myocardial infarction and tissue death. 12 
 
2.2.2 Pathogenesis of Arteriosclerosis 
Arteriosclerosis is marked by generalized vascular stiffening, resulting from reduced 
elasticity of large- and medium-sized arteries, including the aorta.  A normal, healthy artery must 
be sufficiently compliant, durable, and stable to withstand a range of hemodynamic forces.  The 
extracellular matrix of the vascular wall is composed primarily of four proteins: collagen, elastin, 
glycoprotein and proteoglycan.  Collagen is needed for structural integrity and tensile strength, 
while elastin provides flexibility needed for the normal dilation and constriction of the vessel.  
Reduction of elasticity in the large arteries commonly occurs with age, and is coupled with 
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increases in collagen content and accumulation of vascular smooth muscle cells.  These 
processes are often evidenced by systolic hypertension and widened pulse pressures in the 
elderly.  Natural, age-related processes in women, such as estrogen decline through menopause, 
may also be accompanied by decreases in aortic compliance. 13, 14 
 
Stiffening may be abnormally accelerated in response to certain disease processes.  
Diabetes mellitus, the metabolic syndrome, excess adiposity, and hypertension are each 
associated with measurable increases in inflammatory molecules.  Inflammatory molecules may 
initiate a cascade of additional abnormal processes, culminating in overproduction of 
dysfunctional collagen, disordered endothelial cells, broken elastin molecules, leukocyte 
infiltration into the arterial wall, vascular smooth muscle cell accumulation, and a thicker arterial 
wall.15, 16  Endothelial dysfunction may be a secondary effect of hypertension or inflammation, 
and result in reduced synthesis and/or release of nitric oxide, a potent vasodilator.16, 17   
Hyperglycemia, in addition to its association with inflammation, may further stimulate 
collagenation in the vascular wall.18  In relation, hyperinsulinemia has been shown to activate an 
adrenergic response, leading to vascular wall hypertrophy.19   Tachycardia, a physiologic 
response to sympathetic nervous system activation, has been associated with increased vascular 
smooth muscle tone.20  These processes independently or cumulatively may result in a stiffer 
artery.  
 
A stiffer artery has a lower reserve for injury, and is more susceptible to damage from 
factors such as hypertension, tobacco use, and elevated plasma homocysteine.13  Once an artery 
is damaged, the process of atherosclerosis may commence as described in the preceding section 
(2.2.1.).  In addition, arterial stiffening results in increased blood pressure, which leads to greater 
arterial damage and stiffening; this reinforcing feedback cycle is linked to clinical events such as 
stroke and cerebrovascular incidents.21 
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2.2.3 Measures of Subclinical Cardiovascular Disease (CVD) 
Clinical cardiovascular event and mortality rates are higher among African American 
than among Caucasian women.  However, among women with clinical symptoms, African 
American women may have similar levels or less angiographically-detectable CHD than do 
Caucasian women. As noted earlier, the apparent contradiction of these observations can be 
observed even in the subclinical phase of disease, prior to the advent of clinical symptoms and 
events. 
 
Subclinical CVD measures are surrogate indicators of atherosclerosis or arteriosclerosis.  
These measures have been developed in order to detect adverse vascular changes prior to clinical 
symptoms or events.  Unlike angiography, these measures may be used prior to the onset of 
clinical symptoms and are noninvasive.  The measures that will be assessed in this project 
include: coronary artery calcification (CAC) and aortic calcification (AC), carotid artery intima-
media thickness (IMT), and carotid-femoral (aortic) pulse wave velocity (PWV).  Although no 
studies have examined the associations of all of these measures within a single cohort, various 
studies have found correlations between CAC, AC, IMT, and PWV. 22-27   
 
It is important to understand what factors contribute to subclinical CVD in order to 
appreciate how and why some women develop adverse clinical cardiovascular outcomes.  
Among women who have already developed clinical disease, clarifying the cardiovascular risk 
factors that contributed to their CVD may be difficult, given possible confounding by current 
medication usage or alterations in lifestyle or behaviors—therefore, it is advantageous to 
examine risk factors before the onset of clinical disease.  In addition, much work has already 
been dedicated to understanding how traditional CVD risk factors, such as excess body weight, 
hyperglycemia, and hypertension, relate to clinical events.  However, there is incremental value 
in examining subclinical CVD measures rather than CVD risk factors alone in studies of 
ethnicity, atherosclerosis or clinical outcomes.  Many middle-aged or older women present with 
more than one CVD risk factor,28, 29 and the complex interactions between multiple risk factors 
may obscure their independent contributions to atherosclerosis, arteriosclerosis, or to CVD 
events.  Subclinical CVD measures are a reflection of the vascular changes that are promoted by 
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the presence and extent of adverse CVD risk factors.  Therefore, it may be optimal to directly 
assess representative measures of the atherosclerotic or arteriosclerotic processes—i.e, 
subclinical CVD-- rather than to examine CVD risk factors alone or the vasculature after clinical 
outcomes have occurred.    
 
A woman’s genetic background, environment and behaviors over the life course—from 
infancy to adulthood-- may be reflected in a cross-sectional measure of subclinical CVD.  
Assessments of subclinical CVD progression over a specified period of time may provide 
additional insight, by revealing risk factors that are most important in promoting short-term 
increases in subclinical disease.  This project will present findings from cross-sectional and 
longitudinal assessments of subclinical CVD among women.  
 
The subsequent sections will describe CAC, AC, IMT, and PWV in greater detail.  
Sections will include for each subclinical CVD measure: 1) descriptions and measurement, 2) 
associations with known CVD risk factors, 3) predictive value of future clinical events, and 4) 
variations in extent or prevalence by ethnicity.   Studies of women will be highlighted in the 
following review. 
 
2.2.3.1 Coronary Artery and Aortic Calcification (CAC, AC) 
 
Coronary artery calcification (CAC) and aortic calcification (AC) represent calcified 
atherosclerotic plaque in the coronary arteries and aorta.  Circulating calcium phosphate particles 
precipitate onto debris from dead immune cells and smooth muscle cells that were involved with 
formation of the atherosclerotic lesion.  Greater extent of calcification is directly correlated with 
a greater burden of atherosclerotic vessel disease, and worse prognosis for future clinical 
events.30  For undetermined reasons, AC presents earlier than does CAC among women, and 
women tend to have more AC than do men at the same age.31   
 
Electron-beam computed tomography (EBCT) is the gold-standard method of detecting 
calcified atherosclerotic plaque.  The amount of detectable calcification in all of the coronary 
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vessels or aorta can be summed and scored, with higher scores representing a larger burden of 
calcified plaque.  Most calcium scores are calculated using the gold-standard Agatston method, 
in which a lesion is defined as 2 to 4 adjacent pixels (area greater than 0.51mm2) with a signal 
density greater than 130 Houndsfield Units (HU).  The lesion area is multiplied by a constant 
representing the signal density.  This calculation generates a score that corresponds to the size, 
density and quantity of calcium in the lesion.  If multiple calcified lesions are detected, the 
calcium scores from each lesion are summed to yield a total calcium score.  Calcium scores from 
the coronary arteries are summed separately from those of the aorta.   
 
The most important risk factors for cross-sectional and longitudinal CAC measures 
include age and male gender.32  Hypercholesterolemia, higher body mass index (BMI), systolic 
blood pressure (SBP), and triglycerides, current smoking status, and diabetes mellitus have also 
been identified as risk factors for cross-sectional and longitudinal measures of CAC.32-34   The 
Multi-Ethnic Study of Atherosclerosis (MESA) reported that AC is associated with most 
traditional CVD risk factors, and most strongly associated with hypertension and current 
smoking status.31  Consistent with these findings, the Healthy Women Study (HWS) reported 
that among  postmenopausal women, high AC scores were associated with higher low-density 
lipoprotein cholesterol (LDL-C) levels, current smoking status, and SBP.35    
 
Higher CAC scores are associated with greater incidence of CVD events and mortality in 
studies of men and women. 36-40  MESA also reported that among women who were at low risk 
for clinical CVD based on the Framingham score 10-year CHD risk score, those who had 
detectable CAC as compared to women with no CAC were over 5 times more likely to have 
CHD or CVD events over a 4-year follow-up period.38   AC, although less studied than CAC, has 
also been associated with CVD events and mortality.  41-43  In the Framingham study, middle-
aged women with detectable AC were at approximately twice the risk of developing CVD than 
were women with no AC during a 12-year follow-up, and after adjustments for multiple CVD 
risk factors.42  
 
Healthy African American women have similar or less CAC than do Caucasian women in 
a majority of studies.  Four large prospective studies—the Prospective Army Coronary Calcium 
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study (PACC), MESA, a study by UCLA investigators, and the Cardiovascular Health Study 
(CHS)—found that African American women had less extensive CAC than did Caucasian 
women.36, 44-47  Three studies—the Coronary Artery Risk Development in Young Adults 
(CARDIA), Women’s Health Initiative Observational Study (WHI-OS), and Dallas Heart Study 
(DHS)—found that African American and Caucasian women had similar levels of CAC.48-50  
One study conducted by a separate group of UCLA investigators, found that African American 
women had higher CAC levels than did Caucasians, although participants had an excess of CVD 
risk factors as compared to Caucasians.51  Only one study has examined CAC progression in a 
multi-ethnic cohort, and reported that while Caucasian women on average had higher cross-
sectional CAC scores, levels of CAC progression were similar between African American and 
Caucasian women.33   These findings cumulatively suggest that African American women have 
less calcified atherosclerotic plaque in the coronary arteries than do Caucasians despite having a 
larger burden of clinical cardiovascular disease. 
 
The Study of Women’s Health Across the Nation (SWAN) Heart Study observed that AC 
was significantly more prevalent among middle-aged African American women than Caucasian 
women (76.8% vs. 64.0%).  The extent of AC was not reported in this sample.  To our 
knowledge, this is the only study with sufficient enrollment of African Americans to examine 
biracial differences in AC.52  
 
It is important to note that the findings of each of these studies were statistically adjusted 
for a number of CVD risk factors, including age.  In addition, these data are also consistent with 
observations in African American and Caucasian men.  In fact, because men tend to have greater 
CAC than women at the same ages, the higher CAC gradient among Caucasian men as compared 
to African American men is even more pronounced than that observed among women.44     
 
2.2.3.2.  Carotid Artery Intima-Media Thickness (IMT) 
 
Abnormal thickening of the intima and media layers of the carotid wall occurs due to 
atherosclerotic plaque and/or in response to hypertension or other physiologic stressors.  
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Increased IMT may thereby reflect a combination of arteriosclerotic and atherosclerotic 
processes.  First, the arterial wall may thicken in response to changing tensile and shear stresses 
related to hypertension.53   In addition, sub-intimal atherosclerotic plaque in segments of the 
carotid artery may increase the apparent thickness of the intima and media layers.  Therefore, an 
abnormally thickened carotid artery may reflect compensatory arterial remodeling and/or 
detectable atherosclerotic plaque.  
 
Thickening of the vascular wall may be detected by B-mode ultrasound.  In carotid artery 
IMT protocols, an ultrasound probe is placed on an individual’s skin surface perpendicular to the 
carotid artery.  This yields a series of images of the intima, media, and adventitial layers of the 
artery.  A trained reader digitally traces the thickness of the combined intima and media layers, 
which are quantified via computer software.  The clearest images are typically obtained from the 
common carotid artery due to its linear anatomy, although the carotid bifurcation, internal and 
external carotid segments are other common imaging sites.  Normal mean IMT levels range from 
0.36 mm to 0.90 mm.54    
 
Carotid artery IMT is associated with most traditional CVD risk factors.  The HWS 
reported that pre-menopausal levels of triglycerides, pulse rate, and a history of smoking were 
related to mean IMT after controlling for participant age.55   Age, pulse pressure, LDL-C levels, 
SBP, BMI, triglycerides, smoking status, and the metabolic syndrome have also been associated 
with higher IMT.56-59    
 
Higher IMT is an independent risk factor for CHD and stroke.30, 60   The Atherosclerosis 
Risk in Communities (ARIC) study observed that women with mean IMT levels ≥ 1 mm were 
over 5 times more likely to have CHD than women with lower IMT over a 4 to7 year follow-up 
period (95% confidence interval [CI]=3.08-8.36).61   Indeed, each 0.1 mm increase in IMT is 
associated with greater incidence of CVD events and mortality in studies of men and women. 62   
 
African Americans appear to have higher IMT than do Caucasians across a variety of age 
groups.  This is particularly noted in the common carotid segment (CCA-IMT) or using a mean 
thickness score averaged across multiple carotid sites (Mean Average IMT).63-67  Several studies 
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also indicate that African American women have greater IMT progression than do Caucasian 
women.  The Bogalusa study of young adults reported that African American women as 
compared to Caucasian women had significantly greater mean average IMT progression and 
CCA-IMT progression; these results mirror those from the ARIC study, which found that of 
6797 middle-aged and older adults, African American women had greater CCA-IMT progression 
than did Caucasian women.68  
 
2.2.3.3.  Carotid-Femoral (Aortic) Pulse Wave Velocity (PWV) 
 
Arterial stiffness reflects arteriosclerosis, atherosclerosis and aberrant vascular 
remodeling.  As described in sections 2.2.1. and 2.2.2., inflammation, endothelial damage, 
adrenergic activation, and hyperglycemia may contribute to arterial stiffening and vascular 
damage. 
 
Aortic stiffness is assessed by the gold standard method, carotid-to-femoral PWV. In 
PWV protocols, arterial flow waves are simultaneously and non-invasively recorded at the 
carotid and femoral arteries of supine participants, using unidirectional transcutaneous Doppler 
flow probes.  Aortic PWV is calculated as distance between the probes divided by the transit 
time of the pulse wave (cm/seconds).  The transit time of the pulse wave is calculated as the foot-
to-foot delay between the averaged carotid and femoral waveforms.  The distance traveled by the 
pulse waveform is estimated by measurement over the participant’s torso.  The distance from the 
carotid to aortic site is subtracted from the sum of the aortic to umbilicus and umbilicus to 
femoral site to adjust for the opposite direction of the blood flow in that arterial branch.  A 
higher PWV indicates a stiffer vessel.  This measure has been demonstrated to have good 
reproducibility, with an overall laboratory intraclass correlation of 0.77. 69  
 
Traditional CVD risk factors, including SBP, pulse rate, elevated leukocytes, elevated 
blood glucose, and family history of diabetes, have been associated with higher PWV in studies 
of women.20, 70  Indicators of obesity and hyperglycemia, including higher BMI, type 2 diabetes 
and/or poor glucose control, have also been associated with higher PWV in a study of older and 
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younger adults by Wildman and colleagues71, in addition to two studies of older Americans.72, 73  
Increased PWV progression over time has been associated with higher BMI, hypertension, and 
the metabolic syndrome. 74-76   
 
Higher PWV is associated with increased risk of CVD events.77-80  In a study of middle-
aged and older women, participants with high PWV were 2.45 times more likely to develop 
CVD during the four-year follow-up period.81  Among postmenopausal Dutch women, increase 
in PWV of 1 m/s was associated with a 2.2% increased risk of death over an 10-12 year follow-
up, a 1.4% increased risk of CHD, and a 0.9% elevated risk of stroke.20   
 
Only two studies have examined carotid-femoral PWV differences between healthy 
African American and Caucasian women—this represents a substantial gap in the literature.  One 
study reported that young African Americans had higher PWV increases over 2 years than did 
Caucasians; this finding persisted after adjustments for BMI and BMI change,74 and the second 
study reported that African American adolescents had higher PWV than did Caucasian 
adolescents;82 neither study reported findings by gender, and no studies have yet examined ethnic 
differences in PWV among middle-aged women.  Several additional studies suggest that people 
of African heritage may alsop have higher PWV than do Caucasians.  One study reported that 
Afro-Brazilians had higher PWV than did Caucasians; after adjusting for hypertension, Afro-
Brazilians had lower PWV than did Caucasians.83  Two European studies reported that Afro-
Caribbeans had higher PWV than did Caucasians.84, 85  
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2.3 ETHNICITY IS INCONSISTENTLY ASSOCIATED WITH SUBCLINICAL 
CARDIOVASCULAR DISEASE 
 
To summarize briefly, African American women experience a disproportionate burden of 
clinical cardiovascular events as compared to Caucasian women.  However, African American 
women do not consistently present with greater extent of all subclinical CVD measures.  African 
American ethnicity appears to be most strongly associated with higher IMT, while Caucasians 
have higher or similar levels of CAC as compared to African Americans.  African and African 
American ethnicities may be related to higher PWV levels, although the scope of the literature is 
limited.  Ethnic differences in AC are also understudied, although African American women 
appear to have more prevalent AC as compared to Caucasians.  The origins of ethnic differences 
in clinical outcomes and subclinical disease are unclear. 
 
Ethnic differences in subclinical CVD may partly reflect genetic variations.86  For 
example, while high CAC represents a greater extent of atherosclerotic plaque, a higher amount 
of calcium in a particular coronary lesion may stabilize the plaque, preventing rupture and 
subsequent myocardial infarction.  Several studies indicate that Caucasians have higher levels of 
calcium in their individual plaques, which may reflect genetic polymorphisms in calcium 
metabolism,87 and may protect Caucasians against myocardial infarction.  Caucasian women also 
have been observed to have a greater propensity for developing osteoporosis than do African 
American women.  Bone density appears to be inversely associated with vascular calcification, 
which has led some researchers to hypothesize that bone remodeling among Caucasians may 
lead to more deposition of calcium in the coronary arteries.30, 86   
 
Ethnic differences may also originate from different cardiovascular risk factor 
distributions.  For example, African American women have a higher prevalence of hypertension 
and diabetes than do Caucasian women1, which are independently associated with arterial 
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stiffening and atherosclerosis.  While many of the studies of subclinical CVD make statistical 
adjustments for known CVD risk factors, it is also possible that not all pertinent risk factors have 
been identified or tested.   
 
In addition, the consequences of certain CVD risk factors in subclinical CVD 
development may differ by ethnicity.  For example, hypertension or hyperglycemia may play a 
larger role in the adverse remodeling of arteries in African Americans than among Caucasians.  
This hypothesis is understudied, and greater emphasis on identifying CVD risk factors related to 
ethnicity may better clarify the pathogenesis of cardiovascular disease in certain groups.   Indeed, 
certain CVD risk factors may require more aggressive management among African American 
women or Caucasian women in order to prevent adverse clinical sequelae.  This project 
examined the independent and combined associations of traditional CVD risk factors with 
progression of arterial stiffening, as measured by PWV, and examined whether these associations 
vary by ethnicity [Research Article 1 (Chapter 3)].   
 
Socioeconomic status (SES) is another important risk factor that may help to further 
explain the inconsistent associations between ethnicity and subclinical CVD measures.  In a 2003 
U.S. telephone survey of 256,155 Americans, nearly half of all African Americans reported 
having at least two CVD risk factors; African Americans had the highest prevalence of CVD risk 
factors as compared to all other ethnic groups.  Low educational attainment and low household 
income were also associated with higher prevalence of multiple CVD risk factors among 
respondents.88  The study did not assess the combined associations of SES and ethnicity with 
respect to CVD risk factor prevalence in this sample.  However, from childhood through 
adulthood, African Americans are more likely to be poor, less-educated, and more 
disenfranchised from the health care system than are Caucasians.89, 90  Given that low SES is 
independently associated with higher prevalence of CVD risk factors, and that African 
Americans disproportionately report indicators of low SES, it is conceivable that low SES may 
explain some of the associations between African American ethnicity and subclinical CVD.  
Differences in SES distributions by ethnicity across different study samples may also contribute 
to varying associations between ethnicity and subclinical CVD measures.  Understanding the 
role of SES may better clarify the associations between African American ethnicity and the 
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extent of subclinical CVD.  This project examined the combined associations of ethnicity and 
SES with regard to cross-sectional and longitudinal measures of subclinical CVD [Research 
Articles 2 and 3 (Chapters 4, 5)]. 
 
The relationships between ethnicity and CVD risk factors with respect to PWV 
progression, and the relationships between socioeconomic status, ethnicity, and subclinical CVD 
measures, will be discussed further in the following sections. 
 
2.3.1 Relationships Between Ethnicity and Cardiovascular Risk Factors May Explain 
Differences in Progression of Arterial Stiffness 
Accelerated arterial stiffening is associated with adverse clinical cardiovascular 
outcomes. 77-80  As an artery stiffens, it becomes more vulnerable to endothelial injury, 
hypertension and atherosclerosis.91  These changes increase the risk of stroke and CHD.   
Carotid-femoral, or aortic, PWV is a measure of aortic stiffening that has been associated with 
higher BMI, SBP, type 2 diabetes mellitus, and the metabolic syndrome. 70, 75, 92, 93   An 
individual with multiple CVD risk factors has a greater risk of developing aggressive PWV 
progression; in one study, people with three or more CVD risk factors had significantly higher 
PWV progression than did people with fewer risk factors.92   
 
As noted earlier, African Americans appear to have higher PWV than do Caucasians. 74  
African American women also have a greater prevalence of traditional CVD risk factors than do 
Caucasian women, particularly with respect to excess body weight and waist circumference, the 
metabolic syndrome, hypertension, and diabetes mellitus.1  Furthermore, at younger ages, the 
risk of developing hypertension is higher among African Americans than among other ethnic 
groups.94  The preponderance of risk factors in addition to cumulative lifetime exposure to risk 
factors among African American women may culminate in premature or accelerated arterial 
stiffening in this group.  This pathway may also help to explain the excess burden of CHD and 
stroke among African American women.  
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 A related but understudied question is whether the magnitude of the influence of certain 
CVD risk factors on arterial stiffness also varies by ethnicity.  For example, hypertension among 
African Americans is associated with a CVD mortality rate that is 3 to 5 times that of 
Caucasians.95   In the ARIC study, hypertension was an especially robust predictor of CHD 
among African American women as compared to Caucasian women.96  Therefore, it is possible 
that African American women who have certain CVD risk factors such as hypertension are at 
greater risk of developing clinical or subclinical CVD than are Caucasian women.   
 
Several proposed pathways support the hypothesis that the effects of certain risk factors 
on arterial stiffness may be stronger among African Americans.  A study of adult males observed 
that Afro-Brazilians experienced a greater SBP-dependent increase in cross-sectional PWV 
measurements than did Caucasians, resulting in substantially higher PWV among Afro-
Brazilians with hypertension as compared to Caucasians with hypertension.97   The Bogalusa 
Study of young adults reported that luminal enlargement associated with early atherosclerosis 
was more strongly related to mean arterial pressures and vascular wall thickness among African 
Americans than among Caucasians.  In a milieu of atherosclerotic or pressure-related risk 
factors, the vasculature of African Americans may be more inclined to undergo compensatory 
remodeling processes.98  This protective mechanism initially may preserve perfusion, but the 
reserve capacity of the vessels is limited; after this capacity is exhausted, centralized stiffening of 
the central arteries may ensue.  In a separate pathway, endothelial injury is thought to enhance 
PWV progression by limiting the endogenous nitric oxide supply needed for normal 
vasodilation.  African Americans generally have less of a vasodilatory response to nitric oxide 
than do Caucasians;99 if atherosclerotic or hypertensive damage to the endothelium occurs, even 
less endogenous nitric oxide  is available to facilitate vasodilation and arterial relaxation for 
African Americans.  This may lead to increased blood pressures and additional endothelial 
damage, in a positive, re-enforcing feedback loop.   
 
To summarize, the effects of hypertension, mean arterial pressures, or atherogenic risk 
factors might lead to more extensive arterial remodeling among African Americans as compared 
to Caucasians.  While some studies have examined the associations of CVD risk factors with 
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accelerated PWV progression, no study to our knowledge has examined whether the strength of 
these associations varies by ethnicity.   
 
Because higher PWV is associated with greater risk of clinical cardiovascular disease 
events,1, 77-80 part of the excess burden of clinical disease among African American women may 
be attributed to accelerated arterial stiffening in this group.  Examining the relative importance of 
various CVD risk factors on PWV progression by ethnicity may lead to better understanding of 
why African Americans appear to have stiffer arteries, more accelerated arterial stiffening and 
more clinical outcomes than do Caucasians.  Few studies have examined PWV progression 
among African American women, and this question has clear clinical significance for this group.  
Aggressive management of certain CVD risk factors that promote PWV progression may thereby 
reduce the risk of accelerated arterial stiffening and prevent clinical sequelae.  
 
2.3.2 Socioeconomic Status May Explain Inconsistencies Between Ethnicity and 
Subclinical CVD 
2.3.2.1 Definitions of Socioeconomic Status 
 
As defined by Krieger and colleagues, socioeconomic status (SES) is “an aggregate 
concept that includes both resource-based and prestige-based measures as linked to both 
childhood and adult social class position.  Resource-based measures refer to material and social 
resources and assets, including income, wealth, educational credentials… prestige-based 
measures refer to an individual’s rank or status in a social hierarchy, typically evaluated with 
reference to people’s access to and consumption of goods, services, and knowledge, as linked to 
their occupational prestige, income, and educational level.”100 
 
Strong and inverse associations between SES and health outcomes have been observed in 
a substantial body of literature.  This project will focus primarily on the associations of 
adulthood educational attainment, income, and financial strain with subclinical CVD.    
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Educational attainment is the most frequently-used surrogate measure of SES, and is 
found in approximately 45% of epidemiologic studies on SES.101  Advanced education may 
facilitate higher social status, enhance an individual’s ability to navigate through the health 
system, and provide access to better employment, higher wages, and occupational prestige.  
Education is a widely-used SES indicator in part because of its stability: generally, education is 
maximally attained in early adulthood and remains unchanged through adulthood.  Furthermore, 
there is less variability over time in years of education or educational degrees than is observed 
with other SES indicators, such as income or occupation.  Finally, a majority of adults in the U.S. 
have some educational attainment, and response rates to education questions typically are 
high.102   
 
Income is another widely-used SES indicator, and is typically assessed by total combined 
household income over a designated period.102  Higher incomes may facilitate direct access to 
material resources and access to health-promoting activities, and may contribute to social power 
and prestige.103  Without adequate finances, people may be subject to substandard housing 
conditions, may be unable to afford health care or medications, or may not have access to healthy 
nutrition or opportunities for physical activity.  Interestingly, while income and education are 
related, the associations between income and health outcomes do not fully overlap with those of 
education.104  This suggests that income and education indicators may each provide important 
information with regard to health. 
 
Studies relating SES with health outcomes have traditionally examined those individuals 
who report the lowest levels of education and income.  The assumption has been that poverty and 
inadequate educational attainment—i.e., severe deprivation and social disenfranchisement—are 
the true origins of adverse health outcomes.  In actuality, there is a consistent, graded and inverse 
association between health outcomes and SES across a wide span of SES levels, including higher 
income and educational degree categories.104  This finding was observed in the Whitehall study, 
which examined cardiovascular health outcomes among 17,530 male British civil servants over 
10 years.  Among skilled, professional levels in the cohort, top administrators had lower CHD 
mortality risk than did executives who were ranked slightly lower; both grades also had lower 
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CHD mortality than did unskilled grades in the cohort.105   As reported by Gallo and Matthews, 
“the impact of SES is not only at the poverty line.  Rather, health discrepancies have a 
monotonic relationship with SES, so that even relatively affluent groups exhibit worse health 
than their higher SES counterparts.”106  In certain social groupings, the association between low 
SES and health may be better conceptualized as an association between relatively low versus 
relatively high levels of SES.  Studies of these groups may help to clarify the effects of 
comparative social status and prestige on health.107  
 
SES is a multifaceted construct, and education and income indicators merely approximate 
an individual’s true economic and social position.  Indeed, prior research findings have 
suggested that the social and financial returns of higher education differ by gender, age, and 
ethnicity.108   Furthermore, the quality of the institution granting the educational degree, or the 
social connections that may be gained through attendance at a particular institution, are difficult 
to quantify, but may have substantial effects on power, social status, and material resources.102    
 
Income must be also considered with some caution, particularly among women: 1) 
income may be affected by reverse causation, where the effects of poor health may influence 
material resources or employment; 106 2) income may vary considerably over the life course; 3) 
only 59% of all women are in the labor force, and 39% of married women do not earn their own 
salaries, so personal income versus combined household income measurement is not 
recommended; 109 4) non-response to income-related questions is high, averaging between 9 and 
10%;103 5) if combined household income is not adjusted by the number of people in the 
household, it is challenging to approximate economic status; 6) most income measurements do 
not account for regional differences in living costs.  
 
Several studies advocate the usage of financial strain assessment in conjunction with or in 
lieu of income in order to assess an individual’s economic well-being.110, 111   Typically, 
participants are asked either if they have experienced difficulty paying for basic goods and 
services, or if they have been unable to pay their monthly bills more than once over a designated 
period.  Financial strain is a subjective evaluation, and in some cases, may better reflect an 
individual’s true financial status than objective reports of income.  For example, an individual 
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may report a low income but receive financial help from an outside source, or a family may 
report a large combined income, but carry a sizeable burden of debt.  In these cases, the ability to 
pay for basics or pay monthly bills may be influenced by factors that are not directly related to 
income, and would not otherwise be captured if using income as a single indicator of SES.  
However, there are limitations to assessments of financial strain.  Because perceived financial 
strain is subjective and often undefined, definitions of “basic” goods and services may vary 
substantially between respondents.  Furthermore, this measure typically does not differentiate 
between persistent or temporary strain; short-term financial strain associated with purchasing a 
home may convey different information than does long-term financial stress due to chronic 
illness. 
 
By assessing more than one SES indicator in studies of SES, it may be possible to avoid 
some of the limitations that are associated with independent evaluations of education, income, or 
financial strain.  However, despite these shortfalls, education and income in particular have each 
been associated with greater CVD mortality in an exceptionally large body of literature.  This 
attests to the robustness of these measures, and the strength of the relationships between low SES 
and CVD. 
 
2.3.2.2 Associations Between Socioeconomic Status and Subclinical 
Cardiovascular Disease 
 
Research studies over the past fifty years have consistently found inverse relationships 
between SES and CVD events and mortality.4, 112  A component of this excess risk may be that 
low SES women carry an excess burden of CVD risk factors, such as LDL-C, SBP, total 
cholesterol, triglycerides, BMI, and fasting glucose levels.113   
 
Inverse associations have also been observed between SES and certain measures of 
subclinical CVD.  Lower educational attainment was associated with higher CAC and AC in the 
Healthy Women Study, 114  and low education was associated with higher CAC prevalence 
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among young African Americans and Caucasians.115  The ARIC study reported that lower 
education and income were associated with higher IMT among both African American and 
Caucasian adults.68  A study of African American and Caucasian adolescents reported that lower 
income categories and low neighborhood SES were associated with higher PWV, and that fewer 
household assets (e.g., number of cars, loans, home ownership) were related to higher IMT.82  
Low job status and educational attainment, 116-118 economically disadvantaged neighborhood 
status,119 and low SES at birth have each been associated with greater degree of carotid stenosis, 
120 higher cross-sectional levels of IMT, or accelerated IMT progression.   
 
This evidence suggests that low SES is a potent predictor of adverse atherosclerotic and 
arteriosclerotic changes.  Currently, it is difficult to assess the relative importance of SES across 
the different subclinical CVD indicators among women because no studies have examined all 
four measures in a single cohort; it is possible that certain measures of subclinical CVD are more 
strongly associated with certain indicators of SES than with others.   
 
 
2.3.2.3 Combined Associations Between Ethnicity and Socioeconomic Status 
Towards Subclinical CVD 
 
Although African American ethnicity and low SES are consistently and independently 
related to certain measures of subclinical disease, it is conceivable that they have a combined 
association.  African American ethnicity and low SES are highly correlated in the United States.  
It is possible that SES effects may actually be misclassified in extant literature as effects of 
African American ethnicity, and vice versa.  
 
In addition to any undefined genetic factors or CVD risk factors that may render African 
Americans particularly vulnerable to subclinical and clinical CVD,86 behavioral and 
environmental risk factors could confer greater risks to this group.  Lifetime effects of low SES, 
including adverse health behaviors and inadequate access to health care, may disproportionately 
23 
impact African Americans.  Furthermore, certain social stressors related both to ethnicity and 
subclinical CVD may affect African Americans specifically;121 for example, African American 
women who experienced recurrent episodes of discrimination had higher levels of CAC in one 
study. 122  In sum, African American women with low SES may be at even greater risk than 
Caucasian women with low SES of developing subclinical CVD—and ultimately, clinical 
outcomes.  Given the preponderance of low SES in the African American community, low SES 
may partly confound the relationship of African American ethnicity towards subclinical and 
clinical CVD outcomes.    
 
2.3.2.4 Epidemiologic Link 
 
Given the substantial overlap between African American ethnicity and low SES, it is 
important to examine both simultaneously in order to clarify their independent roles in 
subclinical CVD development.  This type of analysis may be achieved through basic statistical 
methods.  However, while hundreds of studies have examined ethnicity or SES with respect to 
CVD, only nineteen studies in one literature review had examined ethnicity and SES with 
respect to CVD.123  Even fewer prospective cohort studies—five to our knowledge, from four 
different cohorts-- have examined ethnicity and SES in combination with respect to measures of 
subclinical CVD.68, 82, 115, 124, 125 
 
One study of 214 U.S. adolescents examined the independent and combined associations 
between ethnicity and SES with respect to PWV and IMT.  Among African Americans only, low 
and medium household income categories were related to higher PWV, and lower neighborhood 
SES was associated with higher IMT.  Low education was related to higher PWV among 
Caucasians only.  Results were not reported by gender.82 
 
The CARDIA study of 2913 young adults (ages 33-45) examined associations between 
education, 15-year CVD risk factor progression, and cross-sectional measures of CAC.  While 
the interaction between ethnicity and education was not directly tested, both variables were 
included in logistic regression models predicting CAC.   Individuals who were Caucasian or had 
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less than a high school degree had higher CAC levels, with or without simultaneous adjustment 
for various CVD risk factors.  Indeed, people with less than a high school education had 2.5 to 
4.1 times the risk of having prevalent CAC as compared to postgraduate education; African 
Americans had around half the risk of having prevalent CAC than did Caucasians.  These trends 
were not assessed by gender specifically.115 
 
The MESA study of 6814 middle-aged adults examined associations between ethnicity 
and SES as main effects in an analysis of subclinical disease.124  Caucasians with high as 
compared to low educational attainment had lower prevalence of carotid plaque and lower IMT 
levels in the internal carotid arteries.  Among African Americans, a weak, inverse association 
between household income and carotid plaque was observed.  Across African American and 
Caucasian ethnicities, the strength of the associations between different SES indicators and 
carotid IMT and plaque may vary.  The study did not stratify by gender, so it is not clear how 
robust these associations are for women. 
 
The ARIC study also has examined the combined associations of ethnicity and SES with 
regard to IMT.68  ARIC reported that income, education, neighborhood SES, and a composite 
SES score were all inversely associated with baseline CCA-IMT among both Caucasians and 
African Americans.  CCA-IMT progression was also assessed over 5 years.  For Caucasians, low 
income and low composite SES scores were associated with highest rates of IMT progression.  
However, higher income, education, and neighborhood SES were associated with greater IMT 
progression among African Americans.  These results remained either significant or marginally 
significant after adjustments for baseline CVD risk factors.  The authors noted that these 
unexpected findings probably did not result from selective attrition among African Americans.  
While low SES African Americans presented with higher baseline IMT levels than did high SES 
African Americans, the authors refute that a “ceiling effect” explained the slower progression in 
this group; earlier published studies in the cohort showed that baseline IMT levels were not 
associated with the rate of change IMT.  The ARIC data suggest that assessing ethnicity and SES 
interactions in studies of subclinical CVD progression may give us different insights about risk 
factors than do cross-sectional measures.  However, this study also reveals the limits of our 
knowledge about the origins of ethnicity and SES interactions in subclinical CVD literature.  It is 
25 
unknown why middle-aged, high SES African Americans are at highest risk of adverse IMT 
progression.  Like MESA, ARIC reported aggregate findings of men and women; it is unclear 
whether these results are consistent when stratified by gender. 
 
2.3.2.5 Psychosocial Factors May Explain Associations Between Ethnicity, 
Socioeconomic Status, and Subclinical CVD 
 
The authors of the ARIC study were unable to clarify reasons why they observed that 
among African Americans, 1) low SES predicted greater baseline IMT, and 2) high SES 
participants experienced significantly greater IMT progression than did low SES participants.68  
One explanation may be that emotional and affective factors may mediate some relationships 
between ethnicity, SES and subclinical CVD.   
 
Baron and Kenny proposed that a mediator variable explains how another variable, or a 
“predictor,” affects an outcome; the predictor must be correlated with the candidate mediator, the 
mediator must be associated with the outcome, and the predictor must be associated with the 
outcome variable.126  As was noted earlier, low SES may be associated with subclinical CVD 
progression—specifically measures of AC, CAC, and IMT.  African American ethnicity is 
associated with higher levels of some, but not all, subclinical CVD measures.  The following 
sections will provide evidence linking low SES with negative emotions and attitudes, examine 
the relationships between negative emotions, attitudes and subclinical CVD progression, and 
describe how these relationships may vary by ethnicity.  We propose that negative emotions and 
attitudes should be tested in a mediational framework in order to clarify the associations between 
ethnicity, SES and subclinical CVD progression.   
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2.3.2.6 Emotions, Affect and Subclinical CVD Progression 
 
An emerging body of literature has examined the associations of affect and adverse 
health behaviors with regard to subclinical CVD progression among women.  The majority of 
these associations have been observed in studies of IMT.  Higher IMT progression has been 
observed among women with high versus low trait anger scores, women who reacted angrily to 
adverse situations, and women with sustained anxiety over a 2-year period as compared to 
women without anxiety.127, 128  These studies suggest that negative affect or emotions predict 
accelerated progression of one measure of subclinical CVD.   
 
2.3.2.7 Emotions, Affect, SES and Ethnicity 
 
Low SES is associated with negative affect and emotions in a substantial body of 
literature.  A review by Gallo and Matthews proposed that low-SES individuals may be exposed 
to adverse situations where interpersonal, intrapersonal or tangible resources are required.  
However, their environments may not facilitate maintenance or renewal of these resources, and 
their “reserve capacity” to overcome life challenges may be limited.  Resultant stress may lead to 
negative or fatalistic attitudes and emotions, and potentially, riskier or adverse health 
behaviors.106  For example, compared to women with higher educational attainment, women with 
low education in one U.S. study were more likely to report feelings of anger and depression, and 
indicate low levels of social support.   These women were also more likely to smoke, consume 
alcohol, and were more often physically inactive than were women with higher education.129  As 
Gallo and Matthews summarized, “an association between SES and negative emotions and 
attitudes is likely.  The evidence is particularly strong for an association between low SES and 
depressive, hopeless, anxious, and hostile symptoms… our review points to an a number of areas 
for further research, including additional studies examining the association between SES and 
anxiety symptoms.”106  It is important to underscore that anxiety, hopelessness, and hostility 
have also been independently associated with IMT progression, as noted in Section 2.3.3.1. 
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Only one study has examined whether negative affect mediates the associations between 
low SES and CHD.   Thurston and colleagues reported that the lowest levels of education as 
compared to college education were associated with increased CHD risk among men and women 
in the NHANES cohort.130  Higher versus lower levels of depressive and anxious symptoms were 
also associated with increased CHD risk among men and women.  However, depression and 
anxiety did not appear to explain the relationship between low educational attainment and CHD.   
It is possible that the effects of depression and anxiety are most pronounced during the 
subclinical phase of disease, as they may predispose an individual to incident CHD.  Results 
were not presented by ethnicity or gender to low representation of African Americans in the 
sample, and it is unclear whether the mediational framework was tested in all subgroups.   
 
The inverse associations between SES and negative mood or affect have been examined 
in predominately Caucasian samples, but a limitation of the existing literature is that few studies 
have examined these associations among African American women.  Early evidence in the 
SWAN cohort suggests that middle-aged African American women have better psychological 
coping strategies to financial strain and adversity than do Caucasian  women,110 although these 
preliminary findings have not been replicated in other samples. 
 
2.3.2.8 Additional Considerations 
 
Baron and Kenny infer that a predictor variable precedes the mediator, which then exerts 
its effects on the outcome.126  However, as Kraemer and colleagues have observed in the field of 
mental health research, it is challenging to establish a temporal association between a predictor 
and a mediator in most study designs.131  While negative emotions and attitudes may indeed 
result from the difficulties associated with low SES, the potential for reverse causation should 
also be considered; negative or antagonistic attitudes may predispose individuals to low SES.106  
Therefore, any examination of negative emotions and attitudes as mediators of SES must 
consider results with caution.  
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 2.4 LIMITATIONS OF EXISTING EPIDEMIOLOGIC LITERATURE 
 
African American women have a greater incidence of clinical cardiovascular events than 
do Caucasian women.1   It is likely that this excess CVD risk is partly due to excess CVD risk 
factors among African American women.  However, some evidence suggests that ethnic 
variation in the magnitude of the influence of certain CVD risk factors may result in different 
susceptibilities towards subclinical or clinical outcomes.95, 96  No studies have examined this 
question with respect to PWV progression, a marker of arteriosclerosis.  While it is possible that 
certain CVD risk factors may aggravate adverse PWV progression among African American 
women as compared to Caucasian women, it is unclear which traditional CVD risk factors might 
be particularly detrimental to African Americans.  Most epidemiologic studies of PWV 
progression have involved only European cohorts;92, 132 one study included African Americans, 
but adjusted for ethnicity rather than presenting these data separately.93  Understanding the role 
of CVD risk factors in PWV progression may better help to explain why African Americans 
have more pronounced and accelerated arterial stiffening over time, and may reveal candidate 
areas for intervention.  
 
Furthermore, while African American ethnicity is associated with higher levels of clinical 
outcomes, the associations between African American ethnicity and various measures of 
subclinical CVD are inconsistent across studies.  It is possible that part of this inconsistency is 
explained by the effects of SES.  SES has been examined with respect to certain measures of 
subclinical CVD, and particularly with CAC and IMT measures.  However, most epidemiologic 
studies that examine ethnicity and subclinical CVD do not adjust for SES, or vice versa.  Given 
the strong correlations between low SES and African American ethnicity in the United States, 
SES and ethnicity should be considered jointly in studies of subclinical CVD.   
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 2.5 SPECIFIC AIMS 
 
The three studies presented in this project utilized data from the Study of Women’s 
Health Across the Nation (SWAN) Heart Study, a cohort study examining the cardiovascular 
changes of African American and Caucasian women during middle age. 
 
The aim of Research Article 1 (Chapter 3) was to examine whether the associations 
between CVD risk factors and PWV progression varied by African American or Caucasian 
ethnicity.  Traditional CVD risk factors assessed in this study included age, SBP, DBP, LDL-
cholesterol, HDL-cholesterol, fasting glucose levels, triglyceride levels, and waist circumference.   
 
The aim of Research Article 2 (Chapter 4) was to examine the independent and 
combined associations of ethnicity and SES with respect to four subclinical CVD measures—
CAC, AC, IMT, and PWV.  Also investigated were the effects of blood pressure on these 
relationships.   
 
The aim of Research Article 3 (Chapter 5) was to examine the independent and 
combined associations of ethnicity and SES with respect to CAC progression.  Also assessed was 
whether psychosocial factors—including reported feelings of financial strain, trait anxiety, or 
cynical hostility—explained the hypothesized relationships.   
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 3.1 ABSTRACT 
Accelerated central arterial stiffening as represented by progression of aortic pulse-wave 
velocity (PWV) may be influenced by cardiovascular disease (CVD) risk factors.  Little is 
known about the relationships between CVD risk factors and PWV progression among women 
transitioning through the menopause, or whether these relationships vary by ethnicity.  To 
address this knowledge gap, we conducted a subgroup analysis of 303 African American and 
Caucasian participants in the Study of Women’s Health Across the Nation (SWAN) Heart Study 
received PWV scans at baseline examination and at a follow-up examination an average of 2.3 
years later.  CVD risk factors were also assessed at baseline. 
 
Systolic blood pressure (SBP) and waist circumference were the strongest predictors of 
PWV progression, after adjustment for age, low density lipoprotein cholesterol (LDL-C), high 
density lipoprotein cholesterol (HDL-C), diastolic blood pressure (DBP), glucose, and 
triglyceride levels.  The magnitude of the influence of SBP, DBP, LDL-C, and glucose on PWV 
progression varied by ethnicity (difference in slopes: p=0.03 for SBP, p=0.001 for DBP, p=0.01 
for LDL-C, and p=0.06 for glucose).  The positive relationship between SBP and PWV 
progression was significant among women of both ethnicities, but stronger among African 
Americans.  LDL-C, DBP, and, to a lesser extent, glucose levels were positively associated with 
PWV progression only among African Americans. 
 
Arterial stiffening is associated with clinical cardiovascular events and mortality.  Blood 
pressure, LDL-C, glucose, and excess body size may be important targets for improving vascular 
health and preventing clinical outcomes, particularly among African American women. 
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3.2 INTRODUCTION 
Arterial stiffening, as measured by aortic pulse-wave velocity (PWV), is an age-related 
process associated with clinical cardiovascular disease (CVD) events and mortality.77-80 
However, premature arterial stiffening may occur as a response to risk factors such as excess 
body weight, hypertension, type 2 diabetes mellitus, and the metabolic syndrome.  These risk 
factors may also predict the progression of aortic PWV over time.70, 75, 92, 93    
 
African American women have greater incidence of and mortality from clinical 
cardiovascular events,1 and appear to have higher PWV than do Caucasians.74, 133  In addition, 
African American women have a greater prevalence of CVD risk factors, including obesity, 
hypertension, and type 2 diabetes mellitus.1  This disproportionate CVD risk factor burden may 
contribute to higher PWV progression among African American women.   
 
The effect of certain CVD risk factors on arterial stiffness may also vary by ethnicity.  
Hypertensive African Americans have a cardiovascular mortality rate 3 to 5 times higher than 
that of hypertensive Caucasians,95 and hypertension is an especially robust predictor of coronary 
heart disease (CHD) among African American women.96   African Americans also develop 
higher systolic blood pressures (SBP) than do Caucasians beginning in early adulthood;134 
greater arterial stiffness among African Americans may reflect the greater cumulative lifetime 
exposure to high SBP and hypertension.  Several studies also suggest that African Americans 
may be particularly susceptible to vascular remodeling after exposure to hypertension, high mean 
arterial pressures, or to cytokines and growth factors related to atherosclerosis.97, 98, 135  
Therefore, it is conceivable that African American women with hypertension or atherogenic risk 
factors may develop more accelerated arterial stiffening than do Caucasian women with the same 
risk factors.  This question has not been assessed in relation to PWV progression, and may 
identify a potential pathway by which African American women develop more prevalent clinical 
disease.    
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 Identification and modification of risk factors that contribute to early arterial stiffening 
among women transitioning through the menopause may help to advance preventative care and 
improve clinical outcomes.  In this study of CHD-free, middle-aged women, we assessed: 1) the 
relationships of baseline levels of SBP, DBP, waist circumference, LDL-C, HDL-C, glucose, and 
triglycerides with PWV progression, and 2) whether associations between PWV progression and 
these individual CVD risk factors varied by ethnicity.  We hypothesized that risk factors related 
to blood pressure would be most strongly associated with accelerated PWV progression among 
African American women.   
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 3.3 METHODS 
3.3.1 Study Population 
The SWAN study examines the changing biological and psychological health of women 
across the menopause transition.  Descriptions of the study design and methods have been 
reported elsewhere. 136  Between 1996 and 1997, 3302 pre-menopausal or peri-menopausal 
women were recruited to one of seven research centers:  Detroit, MI; Boston, MA; Chicago, IL; 
Oakland, CA; Los Angeles, CA; Newark, NJ; and Pittsburgh, PA.  Eligibility criteria for the 
SWAN were as follows: aged 42-52 at enrollment, intact uterus and at least one ovary, menstrual 
bleeding within the prior three months, no current pregnancy or breast-feeding, no usage of 
reproductive hormones within the prior three months, and self-identification as a member of 1 of 
5 ethnic groups depending on the research site: Caucasian (all sites), African American (Boston, 
Chicago, Detroit, Pittsburgh), Chinese/Chinese American (Oakland), Hispanic (Newark) or 
Japanese/Japanese American (Los Angeles). 
 
SWAN Heart is an ancillary study designed to assess subclinical CVD in mid-life African 
American and Caucasian women.  SWAN participants from the Chicago and Pittsburgh sites 
(n=608) were recruited to the SWAN Heart cohort between 2001 and 2003 if they met the 
following criteria: no history of coronary heart disease, stroke, hysterectomy, or postmenopausal 
status, and no usage of diabetes medications or hormone therapy.    
 
Participants who met study criteria received their initial PWV measurements at SWAN 
Heart baseline (n=554).  Of the original cohort, 316 participants returned for a follow-up PWV 
measurement an average of 2.3 years later (range: 1.1 - 4.3 years).  Those who did not return 
were more likely to be African American, enrolled at the Chicago study site, and had marginally 
higher SBP, glucose levels, and waist circumferences.  HDL-C, DBP, LDL-C, age, triglycerides, 
35 
educational status, pulse rate, or smoking status did not differ significantly between those women 
who returned for follow-up and those who did not.  Additional participants were excluded from 
analysis for the following reasons: implausible or unreadable PWV scans at baseline or follow-
up (n=7), missing all plasma measurements (n=1), began usage of anti-hypertensive medications 
between the screening and baseline exams (n=5).  The final sample of 303 women with two 
PWV scans included 204 Caucasians and 99 African Americans. 
 
3.3.2 Measurement of Aortic Pulse Wave Velocity   
Arterial stiffness was assessed by the gold standard, carotid-femoral PWV.  In brief, 
arterial flow waves were simultaneously and non-invasively recorded at the carotid and femoral 
arteries of supine participants, using unidirectional transcutaneous Doppler flow probes (model 
810-a, 10 MHz, Parks Medical Electronics, Aloha, OR).  Aortic PWV is calculated as 
distance/transit time (cm/seconds).  The transit time of the pulse wave was calculated as the 
delay between the averaged carotid and femoral waveforms.  The distance traveled by the pulse 
waveform was estimated by measurement over the participant’s torso.  The distance from the 
carotid to aortic site was subtracted from the sum of the aortic to umbilicus and umbilicus to 
femoral site to adjust for the opposite direction of the blood flow in that arterial branch.  A 
higher PWV indicates a stiffer vessel.  This measure has been demonstrated to have good 
reproducibility, with an overall laboratory intraclass correlation of 0.77. 69  PWV values at 
follow-up were normally distributed.   
 
The following plasma, physical, and covariate measurements were taken at the SWAN 
visit coincident with or closest in time to each participant’s baseline SWAN Heart visit (SWAN 
years 4-7).   
  
36 
3.3.3 Plasma Measures 
Blood was drawn once, usually during days 2 to 5 of the follicular phase of the menstrual 
cycle and after a 12 hour fast.  Plasma samples were maintained at 4°C until separated, and then 
were frozen at –80°C and shipped on dry ice to the Medical Research Laboratories (Lexington, 
KY) which is certified by the National Heart Lung and Blood Institute, Centers for Disease 
Control Part III program.  Low-density lipoprotein cholesterol (LDL-C) and high-density 
lipoprotein cholesterol (HDL-C) were analyzed on EDTA-treated plasma.  HDL-C was isolated 
using heparin-2M Mn(II)Cl.  Triglycerides were analyzed by enzymatic methods via a Hitachi 
747 analyzer (Boehringer Mannheim Diagnostics, Indianapolis, IN, USA).  Glucose was 
quantified via a hexokinase-coupled reaction (Boehringer Mannheim Diagnostics). 
 
3.3.4 Physical Measures 
Resting blood pressure was measured three times after each participant had been seated 
for five minutes, and the average of the final two readings was recorded via a standard mercury 
sphygmomanometer.  Participants wore light, loose-fitting clothing for body size assessments.  
Height and weight were used to calculate BMI (kg/m2).  Waist circumference was measured at 
the natural waist, which is the narrowest aspect of the torso as seen from the anterior aspect.  If 
the natural waist was difficult to detect, waist circumference was measured at the smallest 
horizontal circumference between the lowest ribs and the iliac crest.   
 
3.3.5 Covariate Measures 
Following a 5-minute rest, pulse rate (beats per minute) was calculated by multiplying 
each participant’s pulse at 30 seconds by a factor of two.   
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Ethnicity, age, hypertensive medication usage (yes/no), educational attainment, smoking 
status, menopausal status, and study site (Chicago or Pittsburgh) were assessed via self-
administered or interview-administered questionnaires.  Education was originally coded as one 
of five options, but was collapsed to the following three categories due to low frequencies: high 
school education or less, some college (including associate’s degree and college degree), or 
postgraduate education.  Current smoking status (yes/no/unknown) was defined as intake of at 
least one cigarette per day between the previous SWAN visit and the SWAN Heart baseline year.  
Women with missing smoking data (n=26) were assigned as unknown smoking status.   
 
Menopause status was determined via self-reported menstrual patterns.  Pre-menopause 
was defined as menstrual bleeding within the prior 3 months without changes in regularity, early 
peri-menopause was defined as menstrual bleeding within the prior 3 months with change in 
regularity, late peri-menopause was defined as no menstrual bleeding within the prior 3 months 
but bleeding within the prior 12 months, and natural post-menopause was defined as no 
menstrual bleeding within the prior 12 months or longer.  Hysterectomy was defined as removal 
of the uterus and/or double oophorectomy.  Women who did not report menstrual bleeding 
patterns or who reported using exogenous estrogen within the past year were designated as 
unknown menopausal status.  Due to small counts, menopausal status was categorized as 
follows: premenopause or early peri-menopause (n=175), late peri- or postmenopause (n=103), 
and hysterectomy/unknown/hormone use (n=25). 
 
3.3.6 Data Analysis 
T-tests and Chi-Square tests were used to assess ethnic differences in CVD risk factors 
and covariates.  PWV progression was analyzed as follow-up PWV values adjusted 
simultaneously for both the continuous baseline PWV values and the time between SWAN Heart 
visits.  To these minimally-adjusted models, baseline levels of LDL-C, HDL-C, glucose, SBP, 
DBP, waist circumference, and triglycerides were added either separately or in combination to 
investigate the relationships of CVD risk factors with PWV progression.  Fully-adjusted models 
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predicting follow-up PWV included the following covariates: baseline PWV measurements, time 
between SWAN Hear visits, participant age, menopausal status, education, smoking status, and 
pulse rate.  BMI and waist circumference were highly correlated in this sample (r=0.90, 
p<0.0001).  To assess the effects of body size on arterial stiffness but to avoid collinearity, only 
waist circumference was included in the regression models.  Waist circumference explained 
more of the variance in PWV than did BMI, and overall was a strong predictor of PWV at 
follow-up in minimally- and fully-adjusted models. 
 
To formally test whether the effects of CVD risk factors on PWV progression were 
affected by ethnicity, interaction terms between ethnicity and each CVD risk factor were 
included in each minimally-adjusted linear regression models.  All models were two-tailed with 
alpha=0.05.  SAS version 9.1 software (SAS Institute, Cary, NC) was used for this analysis. 
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 3.4 RESULTS 
Participants were on average fifty years old, the majority had at least some college 
education and most were pre-or early peri-menopausal.  Participants had somewhat elevated 
BMI, LDL-C, SBP and waist circumferences.  Mean pulse rate, DBP, HDL-C, fasting glucose, 
and triglyceride levels were within normal ranges.  African American women had significantly 
higher SBP, DBP, BMI, and waist circumferences than did Caucasian women; Caucasian women 
had higher triglyceride and marginally higher HDL-C levels than did African American women.  
Baseline PWV did not significantly vary by ethnicity, although the mean baseline value among 
African Americans was 35.5 cm/s higher than among Caucasians.  Follow-up PWV was 
significantly higher among African American women (Table 1). 
 
Standardized regression coefficients of follow-up PWV on each CVD risk factor or 
ethnicity are presented in Table 2.  African American ethnicity, SBP, DBP, waist circumference 
were each positively associated with follow-up PWV in minimally-and fully-adjusted models.  
HDL-C was negatively and significantly related to higher follow-up PWV in minimally-adjusted 
models, but this association was not significant in the fully-adjusted models.   LDL-C was 
marginally associated with higher follow-up PWV both in minimally- and fully-adjusted models.  
Triglyceride and glucose levels appeared to be unrelated to follow-up PWV. 
 
CVD risk factors and ethnicity were entered simultaneously into a fully-adjusted model 
predicting follow-up PWV (Table 3).  SBP and waist circumference remained significantly 
associated with greater PWV progression.  African American ethnicity was not independently 
related to higher PWV after adjustment for SBP (African American ethnicity β(S.E.)= 35.4 
(22.9), p=0.12).  LDL-C, DBP, HDL-C, triglycerides, glucose, and the covariates were not 
related to follow-up PWV in this model.   
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To determine whether associations between each CVD risk factor and PWV progression 
varied by ethnicity, interaction terms between ethnicity and individual CVD risk factors were 
examined in minimally-adjusted models.  No interactions were observed between ethnicity and 
waist circumference, HDL-C, or triglycerides.  However, significant interaction terms were 
observed between ethnicity and the following covariates: SBP (p=0.03), DBP (p=0.0001), and 
LDL-C (p=0.01).  A marginally significant interaction term was observed between ethnicity and 
glucose (p=0.06).  LDL-C, SBP, DBP, and glucose were separately entered into minimally- and 
fully-adjusted models that were stratified by ethnicity.  Because waist circumference was highly 
related to PWV progression in earlier analyses, it was added as a covariate in the fully-adjusted 
models.  Table 4 presents the results of these analyses and the model variance in follow-up PWV 
explained by each CVD risk factor.   
 
SBP was associated with higher follow-up PWV among Caucasians and African 
Americans, although the relationship between SBP and PWV was stronger among African 
Americans than among Caucasians (Fig. 1).  SBP also explained more of the model variance in 
follow-up PWV among African Americans than among Caucasians (Table 4).  Among African-
Americans but not Caucasians, DBP and LDL-C were each associated with higher follow-up 
PWV values (Fig.’s 2, 3).  DBP and LDL-C also explained more of the model variance in 
follow-up PWV among African Americans in both the minimally- and fully-adjusted models 
(Table 4).  Glucose levels were associated with higher follow-up PWV only among African 
Americans, which was largely accounted for by waist circumference (β (S.E.) for glucose= 35.4 
(22.9), p=0.12 after adjustment for waist circumference) (Fig. 3, Table 4).   
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3.5 DISCUSSION 
In the current study of middle-aged women, baseline SBP and waist circumference 
measures were most strongly associated with higher two-year progression of aortic PWV after 
adjustments for age, cardiovascular, biological, and psychosocial risk factors.  Associations 
between CVD risk factors and PWV progression varied by ethnicity.  DBP and LDL-C levels 
were associated with greater PWV progression only among African American women.  To a 
lesser extent, glucose levels were associated with higher PWV progression among African 
Americans, but this difference was explained by waist circumference.  SBP was related to PWV 
progression among Caucasians, but this association was weaker than that observed among 
African Americans.  These relationships were not attributed to menopausal status, educational 
attainment, pulse rate, waist circumference, or smoking status.  To our knowledge, our findings 
are novel in a population of healthy women.   
 
A healthy artery must be sufficiently compliant, durable, and stable to withstand a range 
of hemodynamic forces.  Reduction of elasticity in the aorta normally occurs with age, and is 
accompanied by increases in collagen content and hypertrophy of vascular smooth muscle 
cells.91  Abnormally accelerated arterial stiffening may also occur in response to certain stimuli, 
including higher BMI, hypertension, type 2 diabetes mellitus, and the metabolic syndrome. 70, 75, 
92, 93   A stiffer artery is more susceptible to endothelial injury.13  Infiltration of lipids through the 
damaged endothelium may lead to atherosclerotic plaque formation in the vascular wall and 
culminate in clinical outcomes.  Arterial stiffening also results in increased blood pressure, 
which in turn leads to additional arterial damage and stiffening; this reinforcing feedback cycle is 
linked to clinical outcomes such as stroke and cerebrovascular disease.21 
 
An earlier study of adult males by Ferreira and colleagues observed that Afro-Brazilians 
presented with a greater SBP-dependent increase in cross-sectional PWV measurements than did 
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Caucasians, resulting in substantially higher PWV among Afro-Brazilians with hypertension as 
compared to Caucasians with hypertension.97  Our research supports this finding, and indicates 
that blood pressure measures are also strongly related to higher PWV among African American 
women.  Hyperlipidemia and hyperglycemia also appear to play important roles in the 
pathogenesis of arterial stiffening and ultimately, in clinical outcomes among African American 
women.   
 
Because higher PWV is associated with greater risk of clinical cardiovascular disease 
events,1, 77-80 part of the excess burden of clinical disease among African American women may 
be attributed to accelerated arterial stiffening in this group.  Results from the current study 
suggest that even African American women without hypertension, hyperlipidemia, and/or 
hyperglycemia may have higher risk of arterial stiffening-- and ultimately, adverse clinical 
outcomes—than do Caucasians with similar risk factors; excess systolic blood pressure among 
African Americans appears to be the cause of this association.  Therefore, additional exposure to 
CVD risk factors may be particularly detrimental to the vasculature of African American women.  
Given the disproportionate prevalence of obesity, hypertension, and type 2 diabetes mellitus 
among African American women, this area of research has considerable clinical implications.  
Our findings underscore the importance of aggressive and early clinical management of these 
risk factors in order to prevent clinical outcomes in this group.    
 
Few studies have examined structural or mechanical differences of the central arteries by 
ethnicity, and it remains unclear why the vasculature of African Americans may be more 
susceptible to adverse remodeling upon exposure to specific CVD risk factors.  Several related 
pathways have been proposed.  First, African Americans have been observed to experience 
excess dermatologic collagenization, or keloid synthesis, as an aberrant response to injury.  
Investigators have hypothesized that a similar process may occur in the vasculature in response 
to hypertension-related injuries or damage from cytokines related to atherosclerosis.135   
Increased intravascular collagen content could contribute to greater central arterial stiffness 
among African Americans.  Alternatively, recent work by the Bogalusa Study indicated that 
luminal enlargement associated with atherosclerosis was more strongly related to mean arterial 
pressures and vascular wall thickness among young African American adults than among 
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Caucasians.  This finding suggests that in a milieu of atherosclerotic or pressure-related risk 
factors, the vasculature of African Americans is more inclined to undergo compensatory 
remodeling.98  This mechanism may initially preserve perfusion, but the reserve capacity of the 
vessels is limited.  If exhausted, adverse responses to risk factors may contribute to increased 
arterial collagenization and stiffening.  Lastly, endothelial injury may enhance PWV progression 
by limiting the endogenous nitric oxide supply needed for normal vasodilation.  African 
Americans generally have less of a vasodilatory response to nitric oxide than do Caucasians, 99 
and damage to the endothelium from hypertension or through early plaque formation may 
disproportionately lead to accelerated PWV progression in this group. 
 
Further research is needed to clarify the mechanisms by which SBP, waist circumference, 
hyperlipidemia, and hyperglycemia contribute to accelerated arterial stiffness among all women.  
Hyperglycemia may stimulate aberrant protein cross-linking and increased collagen deposition in 
the vascular wall.18  Atherosclerosis, initiated by lipid infiltration into the vascular wall, may 
contribute to localized arterial stiffening.25  Diabetes mellitus, excess adiposity, and hypertension 
are also independently associated with an increased inflammatory milieu.  In one proposed 
pathway, inflammatory molecules may promote leukocyte infiltration into the arterial wall, 
leading to vascular smooth muscle cell infiltration, overproduction of dysfunctional collagen, 
disordered endothelial cells, broken elastin molecules, and a thicker arterial wall.15, 16  
Endothelial dysfunction may be a secondary effect of hypertension or inflammation, and result in 
reduced synthesis and/or release of nitric oxide.16, 17   Examining whether these pathways differ 
across various ethnic groups may help to further explain the differences in vascular remodeling 
observed in the current study.   
 
Low HDL-C and high triglyceride levels are considered important risk factors for clinical 
cardiovascular events, but were not associated with PWV progression in our analyses.  In this 
sample, mean HDL-C and triglyceride levels fell within normal ranges, and therefore may not 
have been as strongly associated with accelerated arterial stiffening as other CVD risk factors.  
Similarly, Caucasian women had marginally lower PWV progression than did African American 
women, and the extent of progression may have been insufficient to detect associations with 
CVD risk factors.  Future research is needed to identify CVD risk factors that contribute to PWV 
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progression among Caucasian women, particularly since clinical disease is also the leading cause 
of mortality in this group.   
 
Our study has several limitations.  Baseline levels of certain CVD risk factors appeared to 
exert measurable effects on arterial stiffness during a 2-year follow-up period.  However, it is 
possible that CVD risk factors measured at baseline changed during the follow-up period for 
some women. Wildman and colleagues examined associations of body size measures at baseline 
and over two years with respect to PWV progression.  Generally, baseline measures were most 
strongly associated with PWV progression, although some measures of body size changes were 
associated with PWV progression.93  Similarly, changes in CVD risk factors over time should 
also be assessed in future studies.  This may provide additional insight regarding how changes in 
CVD risk factors may exert either positive or negative effects on the progression of arterial 
stiffness.    
 
In conclusion, in this sample of healthy, middle-aged African American and Caucasian 
women, we found that SBP and waist circumference were associated with accelerated PWV 
progression.  SBP, DBP, LDL-C, and glucose levels were particularly robust predictors of PWV 
progression among African American women, and SBP was also associated with greater PWV 
progression among Caucasian women.  Early and aggressive management of these CVD risk 
factors may reduce the risk of adverse vascular stiffening and prevent clinical sequelae.  Future 
studies should consider whether the current clinical recommendations for acceptable risk factor 
levels—particularly with regard to LDL-C, glucose, SBP and DBP-- are adequate to prevent 
adverse clinical outcomes among African American women.137   
 
 
 
 
 
Table 3-1   Characteristics of the Total Sample and by Ethnicity 
 Total 
(n=303) 
Caucasian 
(n=204) 
African American 
(n=99) 
 
P value 
(Ethnicity) 
Age, years  50.1 (2.6) 50.3 (2.7) 49.7 (2.5) 0.068 
BMI, kg/m2  28.6 (6.3) 27.8 (5.7) 30.4 (7.0) 0.002 
SBP, mm Hg  117.5 (15.1) 114.0 (14.0) 124.8 (14.9) <0.0001 
DBP, mm Hg  74.8 (9.7) 72.6 (9.0) 79.2 (9.6) <0.0001 
Waist Circumference, cm  87.6 (13.7) 86.2 (13.3) 90.5 (14.1) 0.012 
LDL-C, mg/dL  119.6 (34.7) 119.3 (34.3) 120.3 (35.6) 0.82 
HDL-C, mg/dL  57.7 (14.1) 58.7 (14.3) 55.6 (13.4) 0.075 
Triglycerides, mg/dL  117.4 (88.4) 124.7 (100.0) 102.2 (55.8) 0.013 
Glucose mg/dL  90.8 (15.3) 90.3 (16.8) 91.8 (11.5) 0.35 
Baseline PWV, cm/s  800.1 (193.9) 788.6 (190.0) 824.1 (200.6) 0.14 
Follow-up PWV, cm/s  868.5 (195.5) 839.5 (179.1) 928.4 (214.5) 0.0005 
Pulse rate, beats/minute  70.8 (9.3) 70.4 (8.7) 71.7 (10.4) 0.31 
Menopausal Status % (N) 
Late Peri/Post-menopause 
Pre-/Early Peri-menopause 
Other or missing 
 
34.2 (104) 
57.6 (175) 
8.2 (25) 
 
34.1 (70) 
55.6 (114) 
10.2 (21) 
 
34.3 (34) 
61.6 (61) 
4.0 (4) 
 
0.28 
Educational Level  % (N) 
High School or less 
Any College 
Post-Graduate Education 
 
17.8 (52) 
51.5 (151) 
30.7 (90) 
 
17.6 (35) 
51.2 (102) 
31.2 (62) 
 
18.1 (17) 
52.1 (49) 
29.8 (28) 
 
0.99 
Mean (S.D.) unless indicated 
Missings: DBP (n=5), Waist Circumference (n=9), LDL-C (n=1), Educational Level (n=11) 
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Table 3-2   Individual Regression Coefficients of Follow-up PWV Scores on Each CVD Risk Factor or Ethnicity 
 
 Model 1 Adjustments 
 
Model 2 Adjustments 
 
 β (S.E.) P value P valueChange in 
Model R2 
 
β (S.E.)    Change in 
Model R2 
 
Ethnicity 
African American 
Caucasian 
 
79.9 (22.7) 
Referent 
 
0.0005 
 
0.038 
 
86.8 (24.2) 
Referent 
 
0.0004 
 
0.004 
SBP 4.56 (0.68) <0.0001 0.12 5.00 (0.76) <0.0001 0.12 
DBP 5.84 (1.08) <0.0001 0.088 6.42 (1.20) <0.0001 0.08 
Waist Circumference 4.58 (0.79) <0.0001 0.098 4.52 (0.83) <0.0001 0.08 
LDL-C 0.61 (0.32) 0.053 0.012 0.55 (0.33) 0.097 0.01 
HDL-C -1.70 (0.76) 0.027 0.018 -1.37 (0.81) 0.09 0.01 
Triglycerides 0.08 (0.12) 0.51 0.002 0.06 (0.13) 0.66 0 
Glucose 0.84 (0.72) 0.24 0.005 0.64 (0.76) 0.39 0 
 
β=Beta-coefficient, S.E.=Standard Error; Model 1 Adjustments: Baseline PWV and time between scans, Model R2 = 0.082;  Model 2 
Adjustments: Model 1 adjustments, age, pulse rate, study site, menopausal status, educational level, smoking status, Model R2= 0.11; 
Each risk factor or ethnicity was assessed individually with either Model 1 or Model 2 adjustments. 
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Table 3-3  Associations of CVD Risk Factors and Ethnicity on Follow-Up PWV Scores: Multivariable Linear Regression 
Models 
P value β (S.E.)  
Ethnicity 
African American 
Caucasian  
 
34.6 (24.9) 
Referent 
 
0.17 
SBP 3.46 (1.25) 0.006 
DBP 0.34 (1.87) 0.86 
Waist Circumference 2.92 (0.95) 0.0023 
LDL-C 0.32 (0.32) 0.32 
HDL-C -0.29 (0.88) 0.74 
Triglycerides -0.15 (0.20) 0.47 
Glucose -0.18 (0.76) 0.81 
Age 6.63 (4.57) 0.15 
Pulse Rate 1.63 (1.18) 0.17 
Study Site 
Pittsburgh 
Chicago 
 
-35.3 (24.8) 
Referent 
 
0.16 
Menopausal Status 
            Late 
Missing 
   Early 
 
-14.6 (26.3) 
3.48 (42.0) 
Referent 
 
0.58 
0.93 
 
Educational Level 
High School or Less 
       Any College 
Post-graduate 
 
16.7 (32.5) 
10.0 (24.4) 
Referent 
 
0.61 
0.68 
Smoking Status 
       Smoker 
    Missing 
Non-Smoker 
 
20.2 (32.4) 
-19.2 (55.7) 
Referent 
 
0.53 
0.73 
 
Model also adjusted for baseline PWV and time between scans; Model R2= 0.27 
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Table 3-4   Associations of Baseline LDL-C, SBP, DBP, or Glucose with Follow-Up PWV Scores Differ by Ethnicity 
 
  Caucasian  African American 
 
Model  No. 
 
Covariates β (S.E.) P value Model R2 Model R2P value β (S.E.)    
Model 1 SBP 3.01 (0.86) 0.0005 0.14  6.37 (1.31) <0.0001 0.24 
Model 2 SBP 2.66 (1.07) 0.014 0.22  6.10 (1.48) <0.0001 0.36 
         
Model 1 DBP 2.35 (1.36) 0.086 0.11  10.0 (1.98) <0.0001 0.26 
Model 2 DBP 1.58 (1.57) 0.32 0.20  9.21 (2.27) 0.0001 0.35 
         
Model 1 LDL-C 0.020 (0.36) 0.95 0.09  1.74 (0.58) 0.0035 0.14 
Model 2 LDL-C -0.27 (0.37) 0.47 0.20  1.44 (0.62) 0.024 0.27 
         
Model 1 Glucose 0.080 (0.73) 0.91 0.09  3.51 (1.86) 0.062 0.09 
Model 2 Glucose -1.22 (0.78) 0.12 0.20  3.00 (2.29) 0.19 0.23 
 
Model 1 Adjustments: Baseline PWV and time between scans, Model R2 = 0.082;  Model 2 Adjustments: Model 1 adjustments, age, 
pulse rate, study site, menopausal status, educational level, smoking status, Model R2= 0.11; Each risk factor was assessed 
individually with either Model 1 or Model 2 adjustments. 
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Figure 3-1    Relationship of SBP and PWV Progression by Ethnicity 
Model adjusted for baseline PWV and time between scans; p for interaction = 0.03 
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Figure 3-2   Relationship of DBP and PWV Progression by Ethnicity  
 
Model adjusted for baseline PWV and time between scans; p for interaction = 0.001 
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Figure 3-3   Relationship of LDL-C and PWV Progression by Ethnicity 
Model adjusted for baseline PWV and time between scans; p for interaction = 0.01 
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Figure 3-4   Relationship of Glucose and PWV Progression by Ethnicity  
 
Model adjusted for baseline PWV and time between scans; p for interaction = 0.06 
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 4.1 ABSTRACT 
The independent and combined effects of ethnicity and socioeconomic status (SES) on 
subclinical cardiovascular disease (CVD) are poorly understood.  Coronary artery (CAC) and 
aortic (AC) calcification, carotid artery intima-media thickness (IMT), and aortic pulse wave 
velocity (PWV) were measured in 536 middle-aged women (206 African American and 330 
Caucasian) participating in the Study of Women’s Health Across the Nation (SWAN) Heart 
cohort.   
 
Compared to Caucasian women, African American women had higher IMT and PWV, 
but similar CAC and AC scores. After adjustment for educational attainment or income, African 
American women had higher IMT and PWV, although further adjustments for systolic blood 
pressure (SBP) and anti-hypertensive medication usage reduced the association with PWV to 
non-significance.  After adjustment for ethnicity, low educational attainment and income were 
respectively associated with higher AC and PWV.  Lower income was associated with higher 
PWV among African American women only.  Both African American ethnicity and SES were 
related to indicators of subclinical CVD, although with variation across different SES and 
subclinical CVD measures.  
 
Future research should examine whether the relationships between ethnicity, SES, and 
subclinical CVD change or remain static during the life course. 
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4.2 INTRODUCTION 
The independent associations of African American ethnicity and low socioeconomic 
status (SES) with clinical cardiovascular disease (CVD) events in women are well-documented 
and striking.  Among African American women, mortality rates from coronary heart disease 
(CHD) are approximately 40% higher than among Caucasian women; clinical disease also 
presents at younger ages and with greater severity among African Americans. 1  Similarly, low 
SES, a broad-spectrum measure of material resources and social prestige, is associated with 
higher incidence of clinical cardiovascular events among women. 4, 103, 138, 139    
 
Although African American women carry a disproportionate burden of clinical disease, a 
surprising observation is that this group does not consistently show higher levels of subclinical 
CVD.  In a number of studies, African American women present with a lower prevalence 44, 45, 47, 
140 or similar prevalence or extent 49, 141 of coronary artery calcification (CAC) as compared to 
Caucasians.  Conversely, African American women present with greater mean or common 
carotid artery intima-media thickness (IMT) than Caucasians in several studies. 64, 66, 67  Early 
evidence suggests that African American women have greater arterial stiffness than do age-
matched Caucasians, although statistical controls for hypertension and other clinical 
characteristics reduce this difference. 142   
 
Some inconsistencies in the associations of African American ethnicity and subclinical 
CVD may result from variations in sample size and cardiovascular risk factor distributions across 
studies.  African American women are also more likely to be poorer, less-educated, and more 
disenfranchised from the health care system than are Caucasians. 90  Thus, some SES effects may 
actually be misclassified in extant literature as ethnic effects, and vice versa. 143    Low SES does 
appear to be independently associated with higher levels of subclinical CVD; for example, low 
educational attainment and income were related to greater prevalence and extent of CAC and 
aortic calcification (AC) in a study of middle-aged and older Caucasian women.114 
 
Only four studies to our knowledge have examined the combined associations of African 
American or Caucasian ethnicity and SES in analyses of subclinical disease.  The ARIC study 
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observed that higher income was associated with lower IMT progression in Caucasians, but 
higher IMT progression in African Americans; 68 a recent study of adolescents reported that low 
income was associated with higher PWV among African Americans but not among Caucasians, 
and that low neighborhood SES was related to higher IMT only among African Americans.133  
The CARDIA study reported that low educational attainment and Caucasian ethnicity were both 
associated with higher CAC,115 and MESA observed that low educational attainment was related 
to higher carotid plaque and IMT among Caucasians only.124  Cumulatively, these findings 
suggest that the role of SES may vary in the development of subclinical CVD among different 
ethnic groups. 
 
To the extent that differences exist between African American or Caucasian ethnicities 
and/or SES indicators with regard to subclinical CVD, it is also important to understand the 
pathways that account for these associations.  Population-based studies indicate that hypertension 
presents earlier and more severely among African Americans as compared to Caucasians, 1, 134 
which may partly explain why levels of some subclinical CVD measures are higher in this group.   
 
This paper investigates the independent and combined associations of African American 
and Caucasian ethnicities with education and income, in relation to subclinical CVD in a single 
cohort of healthy, middle-aged women.  Examining ethnic differences across multiple subclinical 
disease measures within a single cohort could help to clarify the correlations between these 
measures.  In addition, considering both the independent and combined relationships between 
SES and ethnicity may enhance our understanding of why the burden of subclinical CVD differs 
between some groups.   
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4.3 METHODS 
4.3.1 Study Population 
SWAN is a multi-site longitudinal study designed to examine the biological and 
psychological changes of women during the  menopause transition.  Between 1996 and 1997, 
participants (n=3302) received baseline clinical examinations through seven designated research 
centers: Detroit, MI; Boston, MA; Chicago, IL; Oakland, CA; Los Angeles, CA; Newark, NJ; 
and Pittsburgh, PA.  The SWAN protocol was approved by the institutional review board at each 
site, and all participants provided written informed consent.  Eligibility criteria for SWAN were 
as follows: age 42-52 at time of enrollment, intact uterus and at least one ovary, menstrual 
bleeding within the prior three months, no usage of reproductive hormones within the prior three 
months, and no pregnancy or breast-feeding.  To enroll, women also had to identify themselves 
as one of five racial/ethnic groups depending on site: non-Hispanic Caucasian (all sites), African 
American (Boston, Chicago, Detroit, Pittsburgh), Chinese/Chinese-American (Oakland), 
Hispanic (Newark), or Japanese/Japanese-American (Los Angeles).  Other recruitment details 
and enrollment procedures have previously been described. 136 
 
A sub-cohort of women (n=608) from the Chicago and Pittsburgh SWAN sites 
participated in the SWAN Heart Study, an ancillary study designed to assess subclinical CVD.  
Enrollment took place between 2001 and 2003, which was coincident with the 4th-7th annual 
SWAN visits for participants.  SWAN participants were eligible to join SWAN Heart if they had 
consented to a baseline subclinical atherosclerosis scan in conjunction with an earlier SWAN 
visit and did not have a history of coronary heart disease, hysterectomy or bilateral 
oophorectomy, and did not use diabetes medication or hormone therapy.  Participants were 
excluded from all analyses for the following reasons: between consent and the current subclinical 
CVD measurements, 32 participants began hormone therapy, 16 underwent 
hysterectomy/bilateral oophorectomy, 3 developed clinical CVD or diabetes, 3 did not answer 
any questions about hormone therapy or surgical menopause status, 15 did not keep their 
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appointment for subclinical CVD measurements, and 3 did not respond to questions about 
income or education. 
 
Additional participants were excluded from select analyses.  122 women were missing at 
least one subclinical CVD measure, and were excluded from models that used that measure as a 
dependent variable.  The 19 women who were missing educational attainment data did not vary 
from the rest of the sample by ethnicity, anti-hypertensive medication usage, age, BMI, or SBP.  
The 73 women who were missing income data were disproportionately African American 
(p=0.01) and had higher SBP (p=0.002).  The final sample of 536 women was comprised of 62% 
Caucasians (n=330) and 38% African Americans (n=206).  
 
4.3.2 Procedures  
Upon initial enrollment into SWAN and at each annual visit, participants answered self- 
and interviewer-administered questionnaires, and received laboratory, clinical, and 
anthropometric assessments.   Information on medical history, medication usage, educational 
attainment, and income were collected via questionnaires.  Ethnicity was self-reported at the 
baseline parent SWAN visit, and used in this assessment.  Information collected as part of the 
annual SWAN visit and coincident with or close in time to the SWAN Heart visit was also used 
in this analysis.    
 
4.3.3 Socioeconomic Status Measures 
Participants were asked at their baseline SWAN visit to indicate their annual total family 
income from 8 categories.  These were combined into three categories in this analysis due to 
small cell counts (<$50,000, $50,000-74,999, ≥ $75,000).  Participants were also asked at 
baseline to report years of completed education, which were categorized into high school or less, 
associate’s degree or some college without degree attainment, college degree, and post-graduate 
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education.  The Spearman correlation for income categories and educational attainment was 0.35 
(p < 0.0001) for African Americans and 0.31 (p < 0.0001) for Caucasians. 
 
4.3.4 Subclinical Disease Measures 
Coronary Artery and Aortic Calcification   CAC and AC were assessed using an Imatron 
C-150 electron-beam computed tomography (EBT) scanner.144  Briefly, 30 to 40 contiguous, 3-
mm thick transverse images were obtained from the level of the aortic root to the apex of the 
heart.  Calcium scores, calculated by the Agatston method, 145  had high reproducibility, with an 
intraclass correlation of 0.98 for AC scores and 0.99 for CAC scores. 146 
 
Carotid Artery Intima-Media Thickness  B-mode ultrasound was used to assess the 
thickness of the intima and media layers of the carotid arteries.  The available duplex scanners 
for the Chicago and Pittsburgh sites were comparable in image quality.  B-mode images were 
obtained from 8 locations: 4 locations each from the left and right carotid arteries.  Images were 
taken from the near and far walls of the distal common carotid artery (1-cm proximal to the 
carotid bulb), and the far walls of the carotid bulb (the point where the near and far walls of the 
common carotid are no longer parallel, extending to the flow divider) and the internal carotid 
artery (from the flow divider to 1-cm distal to this point).  IMT measures were performed by 
electronically tracing the lumen-intima interface and the media-adventitia interface across a 1-cm 
segment.  The mean of all average readings across the 8 locations comprises the average IMT.  
The mean of the maximum reading from each segment was calculated.  All readings were 
conducted at the University of Pittsburgh Ultrasound Research Laboratory.  An intraclass 
correlation of 0.98 was yielded upon replicate readings of 20 IMT scans.  
  
Aortic Pulse Wave Velocity  Arterial stiffness was assessed by the gold standard, carotid-
to-femoral PWV.  In brief, arterial flow waves were simultaneously and non-invasively recorded 
at the carotid and femoral arteries of supine participants, using unidirectional transcutaneous 
Doppler flow probes (model 810-a, 10 MHz, Parks Medical Electronics, Aloha, OR).  Aortic 
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PWV is calculated as distance/transit time (cm/seconds).  The transit time of the pulse wave was 
calculated as the foot-to-foot delay between the averaged carotid and femoral waveforms.  The 
distance traveled by the pulse waveform was estimated by measurement over the participant’s 
torso.  The distance from the carotid to aortic site was subtracted from the sum of the aortic to 
umbilicus and umbilicus to femoral site to adjust for the opposite direction of the blood flow in 
that arterial branch.  A higher PWV indicates a stiffer vessel.  This measure has been 
demonstrated to have good reproducibility, with an overall laboratory intraclass correlation of 
0.77 69.  
 
4.3.5 Covariate Measures   
Covariate measures were taken at the SWAN visit coincident with or closest in time to 
each participant’s SWAN Heart visit.  Body mass index (BMI) (kg/m2) was measured via weight 
and height calculations obtained at the annual SWAN visit (to the nearest 0.01 kg and nearest 
0.01 cm).  Age was self-reported via questionnaire.  Blood pressure was measured by trained 
personnel after the participant was seated for five minutes, and was averaged across two 
readings.   
 
4.3.6 Data Analysis  
Descriptive statistics for the study sample were determined by chi-square tests for 
categorical variables, and t-tests for continuous variables.  IMT and PWV measures were 
normally distributed across the sample. Many women had no observed CAC or AC (50% and 
29% of sample, respectively); to normalize these distributions, we added a constant to CAC and 
AC scores and log-transformed the sum scores. 
 
Spearman partial correlations were used to assess associations between continuous 
subclinical measures in the total sample and by ethnicity, with adjustments for age, BMI, and site 
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of data collection.  Linear regression was used to analyze the associations of SES and/or 
ethnicity measures with the continuous IMT, PWV, CAC and AC measures.  All regression 
models included age, BMI, and site of data collection.  Systolic blood pressure (SBP) and anti-
hypertensive medication usage were added to specific models to assess the role of blood pressure 
in subclinical disease.  To assess interactions between ethnicity and SES, linear regression 
models were created with each subclinical CVD measure as the outcome, and as predictors: 1) 
ethnicity and education or income, 2) the cross-product of ethnicity and education or income.  
Our sample provided 85% power to detect an interaction.  All models were two-tailed with 
alpha=0.05.  SAS 9.1 (Cary, NC) was used for all statistical analyses. 
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4.4 RESULTS 
Table 1 presents characteristics of the sample by ethnicity.  On average, study 
participants were 50 years old, overweight, and well-educated.  Compared to Caucasian women, 
African Americans had lower household incomes and educational degrees; African American 
women also had higher BMI, SBP, and reported greater usage of anti-hypertensive medications.  
Women did not differ in unadjusted mean CAC or AC levels by ethnicity.  African American 
women had significantly higher IMT and PWV levels than did Caucasian women. 
 
Correlations among subclinical CVD measures were assessed separately among African 
American and Caucasian women (Table 2), revealing a modest but positive association between 
CAC and AC measures among women of both ethnic groups.  No other correlations between 
subclinical CVD measures were observed.     
 
Table 3 presents linear regression analyses that modeled ethnicity, income, or education 
onto each of the four subclinical CVD outcomes, with adjustment for age, BMI, and study site.  
African American ethnicity was associated with higher IMT and PWV.  High school or less and 
some college education were associated with higher AC, and the high school education or less 
category was marginally associated with IMT.  Low income was associated with higher IMT and 
PWV, and marginally associated with AC; middle-income was also marginally associated with 
PWV.  To summarize briefly, African American ethnicity was associated with higher levels of 
IMT and PWV, and low SES was inversely associated with AC, IMT, and PWV.  No 
associations were observed between ethnicity, SES and CAC.   
  
Table 4 presents linear regression analyses that included both ethnicity and educational 
attainment as main effects.  In these models, African American ethnicity was associated with 
higher IMT and PWV (Table 4; model 1).  After further adjustment for SBP and hypertension 
medications, African American ethnicity remained associated with IMT, but the relationship 
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between African American ethnicity and PWV was reduced (p=0.053).  Women with a high 
school education or some college had higher AC scores than women with post-graduate 
education (Table 4; model 1).  This relationship remained significant after additional adjustments 
for blood pressure variables (Table 4; model 2).  No significant interactions between ethnicity 
and education were observed for any of the subclinical CVD outcomes.  
 
African American women had marginally higher IMT (p=0.07) and PWV (p=0.08), when 
income was included in lieu of education in linear regression models (Table 5; model 1).  With 
ethnicity in the models, the lowest income level was significantly associated with higher IMT 
and PWV, and marginally associated with AC.  Associations between African American 
ethnicity and both IMT and PWV were reduced to non-significance after adjustment for blood 
pressure variables.  The relationship between low income and PWV remained significant, and 
low income and AC remained marginally significant after adjustment for blood pressure 
variables (Table 5, model 2).  
 
Unadjusted mean PWV values indicated that low and middle-income African Americans 
had higher PWV than did Caucasians; this trend was reversed for higher-income African 
Americans, who had slightly lower PWV values than did Caucasians (Fig.1).  In linear 
regression models, a significant interaction term between ethnicity and low income for PWV was 
also observed (p=0.01).  When stratified by ethnicity and relative to high income women, low- 
and middle-income women had higher PWV among African Americans only [β (S.E.) for low 
income: 175.13 (43.5), p<0.0001; β (S.E.) for middle income: 150.94 (48.9), p=0.0024].  The 
variance in PWV explained by income was 11% among African Americans as compared to only 
0.7% for Caucasians.  After adjustments for age, BMI, study site, and blood pressure variables, 
the associations between PWV, and low and middle income as compared to high income 
remained significant for African Americans [β (S.E.) for low income: 149.2 (43.6), p=0.0008; β 
(S.E.) for middle income: 136.8 (47.6), p=0.005].  
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4.5 DISCUSSION 
In a cohort of CHD-free, middle-aged women, African American women had similar 
levels of CAC and AC, and higher levels of IMT and PWV, as compared to Caucasians.  As 
compared to women with higher SES, women with low educational attainment had higher AC 
and marginally higher IMT levels, and women with low incomes had higher IMT, PWV, and 
marginally higher AC levels.  These results were generally consistent with prior analyses of the 
independent associations of African American and Caucasian ethnicity or SES with subclinical 
CVD. 44, 45, 47, 49, 66, 67, 140, 142   
 
Our analysis of the combined associations of ethnicity and SES across four different 
subclinical CVD measures is novel, and reveals that African American ethnicity and low SES are 
not interchangeable in their associations across multiple subclinical CVD measures.  Compared 
to Caucasian women, African American women had higher IMT and PWV after adjustments for 
education, although ethnic differences in blood pressure partly explained associations for PWV.  
Low educational attainment was associated with AC before and after adjustments for blood 
pressure variables.  When income was used in lieu of education in the analyses, associations 
between lower incomes and higher IMT and PWV were observed; the relations between African 
American ethnicity and IMT or PWV were reduced.  Additional adjustments for blood pressure 
variables appeared to explain the relationship between low income and higher IMT.  Our 
findings suggest that lower incomes but not lower educational attainment may partly explain the 
associations between African American ethnicity and PWV.  The pathway by which low income 
and PWV are related was not explained by age, BMI, SBP, study site, or anti-hypertensive 
medication usage in our analyses; it is also unclear why low income and not low educational 
attainment is associated with higher PWV in this sample. 
 
Analysis of the interactions between ethnicity and SES further revealed that low- and 
middle-income African Americans had higher PWV than did high-income African Americans; 
these results were not observed among Caucasians.  Similar findings have been reported in the 
literature: Thurston and Matthews observed that among adolescents, low and medium-level 
household incomes were associated with higher PWV among African Americans, but not among 
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Caucasians.82  At higher income levels, ethnicity may become a less salient characteristic with 
respect to vascular functioning.  However, the synchronous impact of lower income with African 
American ethnicity may result in a “double jeopardy effect,” culminating in higher risk for 
arterial stiffness—and ultimately clinical outcomes-- beginning in early life and extending 
through middle age.  Further investigation of the interactions between African American 
ethnicity and SES with respect to PWV is needed to identify specific physiologic and 
psychosocial mediators that explain these associations. 
 
We observed little overlap in the subclinical CVD outcomes predicted by income and 
education.  Correlations between income and education were significant, but moderate in 
magnitude.  Formal education typically is completed in early adulthood and thereafter remains 
stable; income may change dramatically during an individual’s lifetime.  Therefore, studies that 
use only one measure of SES to examine relationships with subclinical CVD may be incomplete 
in their scope.   
 
To our knowledge, this is the first study that has examined the correlations between four 
subclinical CVD measures by ethnicity.  Significant correlations between CAC and IMT, 22 and 
CAC and PWV 24 have been previously assessed.  It was surprising, then, that only CAC and AC 
were significantly correlated.  Low overall levels of subclinical CVD in this study may have 
influenced this observation, and these results should be replicated in populations with greater 
extent of subclinical CVD. 
 
To the extent that ethnicity and SES differences exist in subclinical CVD, it is also 
important to identify pathways that account for these associations.  Among individuals over 50 
years old, SBP is a more important predictor of cardiovascular outcomes than is diastolic blood 
pressure or other blood pressure indicators.147  SBP has also been shown to strongly and 
positively influence arterial stiffness, 20, 70, 142 IMT, 148, 149 and calcification. 26, 150   In this 
sample, SBP levels and anti-hypertensive medication usage were higher among African 
American women than among Caucasian women.  The addition of SBP and anti-hypertensive 
medication usage to age, BMI and site-adjusted multivariable models attenuated some 
associations between African American ethnicity, SES and subclinical CVD.  This suggests that 
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higher SBP is a mediator in the sclerotic and atheromatous processes that contribute to 
subclinical CVD.  Aggressive clinical management of hypertension among African American 
and low-SES women may help to lower subclinical CVD in these populations-- particularly with 
regard to IMT and PWV—and may ultimately reduce clinical outcomes in these groups. 
   
Our study has several limitations.  In the interests of maximizing our statistical power and 
minimizing bias, we included women who had at least one recorded subclinical CVD measure.  
However, some participants did not receive all four measures, and some measures—namely 
PWV—were missing more values than others.  Therefore, the women in each subclinical CVD 
group assessed by this study are not identical.  Subgroup analysis showed that compared to the 
full sample, women missing any subclinical disease data did not significantly differ by age, BMI, 
or ethnicity.    
 
Another limitation of this study is its cross-sectional analytic design.  Whereas ethnicity 
is constant from birth, and educational attainment is fairly constant over adulthood, income is 
more dynamic.  A longitudinal study would be particularly informative in assessing the 
cumulative impact of income on subclinical CVD over the lifecourse.  This analysis represents 
an initial step in understanding the complex relationships between SES, ethnicity, and subclinical 
disease.  
 
In conclusion, our findings suggest that middle-aged African American and low SES 
women are at greater overall risk for subclinical CVD than are Caucasian or higher SES women.  
Unexpectedly, subclinical CVD measures were poorly correlated, and income and education 
showed little overlap in the prediction of subclinical CVD.  Important future directions should 
include a longitudinal assessment of atherosclerosis in this cohort to assess whether ethnicity and 
SES retain their predictive value.  Also important will be a thorough examination of 
psychosocial, environmental, and physiological factors that may mediate these associations.  
Identification of such factors provides a valuable opportunity to inform clinical decisions in the 
subclinical phase of disease, and to impair progression towards adverse clinical cardiovascular 
events.  
Table 4-1   Characteristics of the Total Study Population and by Ethnicity 
 
 Mean (SD) or % (No.) 
 Total 
(n=536) 
Caucasian 
(n= 330) 
African American 
(n= 206) 
P value 
(Ethnicity) 
 
Age, years 50.2 (2.9) 50.1 (2.9) 50.4 (2.9) 0.25 
BMI, kg/m2 29.4 (6.4) 28.3 (5.9) 32.0 (6.8) <0.001 
Annual household 
income 
   <$50K 
    $50K- <$75K 
     ≥$75K 
 
 
30 (141) 
25 (118) 
44 (207) 
 
 
23 (68) 
23 (69) 
54 (159) 
 
 
43 (73) 
29 (49) 
28 (48) 
 
 
<0.0001 
Educational Degrees 
    High School  
  Incomplete College 
   College 
   Post-graduate 
 
15 (78) 
30 (157) 
22 (115) 
33 (170) 
 
14 (44) 
26 (85) 
24 (76) 
36 (118) 
 
17 (34) 
37 (72) 
20 (39) 
26 (52) 
 
0.019 
SBP, mm Hg 120.0 (16.4) 115.9 (14.4) 126.3 (17.3) <0.0001 
BP Medications 4 (22) 3 (9) 6 (13) 0.042 
CAC units 12.8 (43.7) 12.8 (40.8) 12.7 (48.0) 0.97 
AC units 122 (342) 118 (324) 129 (370) 0.74 
IMT (mm) 0.67 (0.1) 0.66 (0.1) 0.69 (0.1) 0.0004 
PWV (cm/s) 796 (203) 774 (191) 835 (218) 0.002 
 
BMI= Body Mass Index, SBP=Systolic Blood Pressure, BP=Blood Pressure.   
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Table 4-2   Spearman Correlations Between Subclinical CVD Measures, By Ethnicity  
 
 CAC AC IMT PWV 
CAC 
 
- 0.29* 0.073 0.15 
AC 
 
0.25* - 0.067 0.086 
IMT 
 
0.026 0.084 - -0.021 
PWV 
 
0.064 0.12 0.064 - 
 
*p<0.05 
 
  Correlation coefficients above diagonal (shaded) are for African Americans, below diagonal are for Caucasians 
  Partial correlation coefficients were adjusted for age, BMI, and data collection site 
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Table 4-3 Minimally-Adjusted Associations Between Main Effects and Subclinical CVD Measures  
 
 β (S.E.) 
Measure CAC 
(n=514) 
AC 
(n=512) 
IMT 
(n=525) 
PWV 
(n=458) 
Ethnicity 
   African American  
   Caucasian  
 
-0.020 (0.11) 
Referent 
 
-0.078 (0.18) 
Referent 
 
0.025 (0.008)* 
Referent 
 
49.1 (19.2)* 
Referent 
     
Educational Attainment 
High School 
Incomplete College 
College 
Postgraduate 
 
0.28 (0.17) 
-0.013 (0.14) 
-0.013 (0.15) 
Referent 
 
0.81 (0.27)* 
0.44 (0.22)* 
0.36 (0.24) 
Referent 
 
0.024 (0.012) † 
0.013 (0.010) 
0.006 (0.011) 
Referent 
 
-8.82 (29.0) 
18.8 (23.7) 
-4.77 (26.0) 
Referent 
     
Income 
   Low 
   Middle  
   High 
 
0.06 (0.14) 
0.20 (0.14) 
Referent 
 
0.42 (0.23) † 
0.26 (0.24) 
Referent 
 
0.026 (0.001)* 
0.0036 (0.01) 
Referent 
 
78.4 (23.0)* 
45.9 (24.4)† 
Referent 
 
* p<0.05; † 0.05<p<0.10 
β=Beta-coefficient, S.E.=Standard Error 
All models adjusted for age, BMI, and data collection site 
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Table 4-4   Linear Regression Analysis Examining Education, Ethnicity and Subclinical CVD  
 
Model 1†       Model 2‡ 
 
 β (S.E.)§ β (S.E.) 
 CAC AC IMT PWV CAC AC IMT PWV 
African-
American║ 
-0.018 
(0.12) 
-0.19 
(0.18) 
0.024* 
(0.008) 
52.2* 
(19.8) 
-0.09 
(0.12) 
-0.22 
(0.19) 
0.018* 
(0.008) 
39.0† 
(20.1) 
Education ¶         
    High            
   School 
0.28 
(0.17) 
0.83* 
(0.27) 
0.020 
(0.01) 
-16.7 
(29.0) 
0.23 
(0.17) 
0.81* 
(0.27) 
0.016 
(0.012) 
-28.2 
(29.0) 
    Incomplete 
    College 
-0.010 
(0.14) 
0.47* 
(0.22) 
0.0093 
(0.01) 
13.1 
(23.7) 
-0.062 
(0.14) 
0.44* 
(0.22) 
0.0045 
(0.01) 
1.50 
(23.9) 
    College -0.012 
(0.15) 
0.37 
(0.24) 
0.0045 
(0.01) 
-6.48 
(25.8) 
-0.066 
(0.15) 
0.35 
(0.24) 
0.00021 
(0.01) 
-16.5 
(25.8) 
 
 
* p<.05; † 0.05<p<0.10 
† Model 1 adjusted for age, BMI, and data collection site  
‡ Model 2 adjusted for Model 1 adjustments, SBP, and anti-hypertensive medication usage 
§ Parameter estimates with corresponding standard errors are listed in table 
║Caucasian ethnicity was referent for African-American ethnicity  
¶ Post-graduate education was referent for education variables  
Note: Each subclinical disease measure considered in separate model
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Table 4-5   Linear Regression Analysis Examining Income, Ethnicity and Subclinical CVD 
           Model 1†       Model 2‡ 
                 
 β (S.E.)§  β (S.E.) 
 CAC AC IMT PWV  CAC AC IMT PWV 
African-
American║ 
-0.058 
(0.13) 
-0.14 
(0.21) 
0.016† 
(0.009) 
37.1† 
(21.4) 
 -0.13 
(0.13) 
-0.19 
(0.22) 
0.011 
(0.009) 
27.1 
(21.6) 
Inc  ome¶          
   <$50K 0.076 
(0.14) 
0.46† 
(0.24) 
0.021* 
(0.01) 
68.7* 
(24.4) 
 -0.0013 
(0.14) 
0.40† 
(0.24) 
0.016 
(0.01) 
60.0* 
(23.9) 
    $50- <$75K 0.20 
(0.15) 
0.28 
(0.24) 
0.001 
(0.01) 
42.2† 
(24.4) 
 0.20 
(0.14) 
0.28 
(0.24) 
0.0008 
(0.01) 
44.7† 
(24.4) 
 
 
* p<.05; † 0.05<p<0.10 
† Model 1 adjusted for age, BMI, and data collection site 
‡ Model 2 adjusted for Model 1 adjustments, SBP, and anti-hypertensive medication usage 
§ Parameter estimates with corresponding standard errors are listed in table 
║Caucasian ethnicity was referent for African American ethnicity 
¶ Annual income ≥ $75,000 was referent for the income variables   
Note: Each subclinical disease measure considered in a separate model  
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 Figure 4-1   Average Pulse Wave Velocity and Income Gradients by Ethnicity.   
Income Groups 
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Mean PWV score ± SE presented. 
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5.1 ABSTRACT 
While Caucasian ethnicity and low socioeconomic status (SES) are independently 
associated with higher cross-sectional measures of coronary artery calcification (CAC), little is 
known about the interrelationships of ethnicity, SES, and CAC progression in women.  Fewer 
studies have examined psychosocial mediators that may explain these relationships.   
 
A subgroup of 339 African American and Caucasian participants in the Study of 
Women’s Health Across the Nation (SWAN) Heart Study underwent electron-beam computed 
tomography scans to assess for the presence and extent of CAC.  Scans were conducted at 
SWAN Heart baseline and at a follow-up examination an average of 2.3 years later.  Data were 
also collected regarding ethnicity, education, income, candidate psychosocial mediators (anxiety, 
hostility and financial strain), and coronary heart disease (CHD) risk factors.  20% of the sample 
(n=68) progressed at least 10 CAC units over the follow-up period.  Women with high school or 
less education as compared to postgraduate education were 5.0 times more likely to have CAC 
progression of at least 10 units [95% CI: 1.75-14.3, p=0.003].  When stratified by ethnicity, low 
education was more strongly associated with higher CAC progression among Caucasians 
[OR=7.75, 95% CI: 1.97-30.4, p=0.003].  This observation was independent of anxiety, hostility, 
financial strain, baseline CAC scores, or CHD risk factors.   
 
Low educational attainment appears to have a striking and deleterious association with 
coronary atherosclerosis progression in middle-aged women, especially among Caucasians.  
Future studies should attempt to identify risk factors that explain this observation.  Additional 
research is also needed to identify risk factors that explain CAC progression among African 
American women.      
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5.2 INTRODUCTION 
Coronary artery calcification (CAC) is a measure of calcified atherosclerotic plaque in 
the coronary vessels.  Knowledge of the risk factors that contribute to CAC progression may 
clarify how early atherosclerotic disease develops into clinically-significant lesions.  Existing 
literature indicates that Caucasian ethnicity44, 45, 47, 49, 50, 140 and low socioeconomic status 
(SES)—assessed primarily by income or education114, 125, 151—are associated with higher CAC 
burden at a single timepoint.  No studies to our knowledge have examined the relationships of 
these risk factors with CAC progression.  Additionally, most cross-sectional studies examine the 
independent associations of ethnicity or SES with CAC, but do not examine their joint 
associations.  Some reported associations between low SES and CAC may be explained by 
African American ethnicity--or vice versa—as African Americans are more likely to be in lower 
socioeconomic positions than are Caucasians across multiple indicators of SES. 89     
 
The present study investigates the combined associations of ethnicity with education, and 
ethnicity with income, in relation to CAC progression among healthy, middle-aged African 
American and Caucasian women.  We also examine the roles of hostile attitudes, difficulty 
paying for basics (financial strain), and anxiety as mediators of the relationships between 
ethnicity, SES, and CAC progression.  Associations between hostility and certain measures of 
atherosclerosis have been identified in prior studies,65, 152 and hostility has also been associated 
with indicators of low SES.153  While financial strain is related to income, it has been 
prospectively linked to recurrent coronary events among women independent of income, and 
may better reflect real-time adequacy of resources.154  Several studies have hypothesized that 
anxiety reduces effective coping to adversity, which may be particularly detrimental to health 
outcomes among anxious, low-SES adults. 155, 156  Thus far, results have been inconclusive and 
no studies have assessed this hypothesis in early atherosclerotic disease or in atherosclerotic 
progression.   
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Based on findings from the cross-sectional CAC literature, we hypothesized that 
Caucasian ethnicity and low income or educational attainment would be associated with greater 
CAC progression over a two-year period.  We also hypothesized that the burdens of financial 
hardship, hostility or anxiety would partly explain any observed relationships. 
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 5.3 METHODS 
5.3.1 Study Population 
The SWAN study was designed to examine physiologic and psychological changes of 
women over the menopause transition.  Descriptions of the study design and methods have been 
reported elsewhere. 136  Briefly, 3302 pre-menopausal or peri-menopausal women were recruited 
between 1996 and 1997 to one of seven research centers:  Detroit, MI; Boston, MA; Chicago, IL; 
Oakland, CA; Los Angeles, CA; Newark, NJ; and Pittsburgh, PA.  Eligibility criteria for the 
SWAN were as follows: aged 42-52 at enrollment, intact uterus and at least one ovary, menstrual 
bleeding within the prior three months, no current pregnancy or breast-feeding, no usage of 
reproductive hormones within the prior three months, and self-identification as a member of 1 of 
5 ethnic groups depending on the research site: Caucasian (all sites), African American (Boston, 
Chicago, Detroit, Pittsburgh), Chinese/Chinese American (Oakland), Hispanic (Newark) or 
Japanese/Japanese American (Los Angeles). 
 
SWAN Heart is an ancillary study designed to assess subclinical cardiovascular disease 
(CVD) in mid-life African American and Caucasian women.  SWAN participants from the 
Chicago and Pittsburgh sites (n=608) were recruited to the SWAN Heart cohort between 2001 
and 2003 if they met the following criteria: no history of coronary heart disease, stroke, 
hysterectomy, or postmenopausal status, and no usage of diabetes medications or hormone 
therapy.    
 
SWAN Heart CAC measurements were assessed among 561 women at a baseline 
examination.  Of these participants, 401 returned for a follow-up examination an average of 2.3 
years later.  Participants who met SWAN Heart eligibility criteria at the time of the scans and 
had readable CAC scans at both SWAN Heart baseline and at follow-up were eligible for 
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inclusion in this analysis.  Baseline scans were missing for 27 women, who were excluded from 
further analysis.  Participants were also excluded if they, between initial SWAN Heart screening 
and baseline measurements, received hysterectomies (n=7), transitioned into menopause (n=19), 
had missing data on menopausal status (n=3), or had strokes (n=1).   Lastly, participants with 
unreadable EBCT scans at either baseline or at follow-up were excluded (n=5). Women who 
were excluded from our analysis had higher SBP and were six months older than women who 
were not excluded (p’s <0.05), but did not vary by BMI, ethnicity, study site, annual total 
household income, or educational attainment.  The final sample consisted of 339 participants; 
64.6% of the sample consisted of Caucasian women (n=219), and the remaining 35.4% consisted 
of African American women (n=120).   
  
5.3.2 Measurement of CAC  
CAC was measured at both study sites via an Imatron C-150 electron-beam computed 
tomography (EBCT) scanner.  We imaged at least 30 contiguous scan slices with 3-mm 
thickness from the level of the aortic root to the apex of the heart.  Images were taken during 
holds in respiration, so that each 100 millisecond exposure was obtained during the same phase 
of the cardiac cycle (80% of the ECG RR interval).  During a second pass, 6-mm contiguous 
images of the aorta were obtained from the aortic arch to the iliac bifurcation using a 300 
millisecond exposure time.  The Agatston method was used to calculate calcium scores, via a 
densitometric program available on the scanner.  Inter-observer agreement was high (r=0.98 for 
AC scores, r=0.99 for CAC scores).146   
 
5.3.3 Socioeconomic Status Measures 
Participants reported at their baseline SWAN visit their educational degree attainment. 
Education was combined into the following categories: high school/G.E.D. or less, associate’s 
degree or any college (with or without degree attainment), and post-graduate degree.  At their 
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baseline SWAN Heart visit, participants were asked to indicate their annual total household 
incomes from 8 categories.  Based on the sample distributions, we combined these into three 
categories (≤$50,000, $50,000-$75,000, ≥$75,000).   Participants who chose not to indicate 
completed degree level (n=11) or income (n=35) were excluded from analyses involving 
education or income, respectively.  Women with missing income information were more likely 
to be from Chicago, report African American ethnicity, and have higher SBP (p’s<0.05).  They 
did not differ from the remaining sample by age, BMI, smoking status or educational attainment.  
Women with missing educational information were more likely to be from Chicago (p<0.05), but 
did not vary from the remaining sample by ethnicity, age, BMI, SBP, smoking status, or income. 
 
5.3.4 Covariate Measures 
Covariate measures were taken at the SWAN visit coincident with or closest in time to 
each participant’s SWAN Heart visit.  Age and medication usage were assessed via 
questionnaire.  Height and weight, measured at the annual SWAN visit, were used to calculate 
BMI (kg/m2).  Resting blood pressure was measured three times after each participant had been 
seated for five minutes, and the average of the final two readings was recorded.  Current smoking 
status (yes/no/unknown) was defined as intake of at least one cigarette per day between the 
previous SWAN visit and the SWAN Heart baseline year.  Women with missing smoking data 
(n=26) were designated to the unknown smoking status category. 
 
5.3.5 Psychosocial Measurements for Mediational Analysis 
Measures of psychosocial traits thought to be associated with risk for CVD were selected 
for this analysis.  Cynical hostility was assessed using 13 items derived from the Cook-Medley 
Hostility scale, which evaluates cynical or hostile attitudes and behaviors.  Higher scores are 
indicative of greater hostility.  Cynical hostility was assessed only at the baseline SWAN visit (in 
1996-1997) because this personality characteristic is stable across middle and later ages.157, 158  
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Women were asked during SWAN visits coincident with SWAN Heart follow-up years, “How 
hard is it to pay for basics?”  Participants selected one of three options: Very hard, Somewhat 
hard, or Not at all hard; these data were later collapsed into two categories (Very hard or 
Somewhat hard versus Not at all hard) due to small cell sizes.  Trait anxiety was assessed via the 
Spielberger State-Trait Anxiety Inventory.159  Sum scores ranged from 10 to 40, and higher 
scores represented greater anxiety levels.  Complete anxiety scores were imputed from SWAN 
visits coincident with or close to the corresponding SWAN Heart visit.  Participants missing 
information on cynical hostility (n=10), difficulty paying for basics (n=28), or trait anxiety (n=8) 
were excluded from analyses involving that particular variable. 
 
5.3.6 Data Analysis 
We assessed CAC progression in two ways.  First, the arithmetic difference between 
baseline and follow-up CAC readings was calculated for each participant.  20% of the sample 
had CAC change scores ≥10 units; the rest of the sample had less or no detectable progression.  
This cutoff has been used previously to assess significant CAC progression in a sample of older 
women.68  Binomial logistic regression models were used to predict CAC progression outcomes 
of ≥10 units as compared to progression of <10 units.  Ethnicity and income, or ethnicity and 
education variables were added to each model with postgraduate education or high income as the 
referents, respectively.  Baseline CAC was assessed as a covariate in some models to assess the 
role of baseline CAC levels in the progression of CAC.  Ethnicity, income, education, study site, 
and smoking status were considered as categorical variables; age, SBP, BMI, and baseline CAC 
were assessed continuously.  Sensitivity analyses indicated that using an alternate cut point for 
CAC progression (≥ 5 versus < 5 units) did not alter the pattern of relationships between the 
main predictor variables, covariates and the outcome CAC measurements.  We choose to report 
the primary findings from the ≥10 cutoff because it is more clinically meaningful and has been 
linked to cardiovascular outcomes.36   
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The raw change in calcium was also evaluated as a continuous variable.  To normalize 
the distribution, we added a constant to each follow-up and baseline score, and took the natural 
log of each sum score.  Linear regression models were used to assess the relationships between 
the covariates and CAC scores at follow-up.  Ethnicity and income, or ethnicity and education 
variables were added to each model.  Regression models were simultaneously adjusted for 
continuous baseline CAC scores, study site, age, BMI, SBP and smoking status. 
 
To formally test whether the effects of ethnicity were altered by SES, interaction terms 
were created between ethnicity and education variables, and education and income variables, in 
separate models.  The interaction effect was tested in linear and logistic regression models.  To 
evaluate the role of hostility, anxiety and financial strain in observed relations between ethnicity, 
SES, and CAC progression, we assessed: 1) relations between SES or ethnicity and anxiety, 
hostility or financial strain, and 2) relations between anxiety, hostility or financial strain and 
CAC progression.  We next examined relations between ethnicity, SES and CAC progression 
after addition of anxiety, hostility or financial strain to the models. 
 
All logistic and linear regression models adjusted for time between CAC scans.  
Descriptive statistics for the sample were determined by chi-square tests for categorical variables, 
and t-tests for continuous variables.  Spearman correlations were used to assess relationships 
between categorical variables.  All models were two-tailed with α=0.05.  Analyses were 
performed using SAS v. 9.1 (Cary, NC).  
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5.4 RESULTS 
5.4.1 Sample Description 
In this sample, women were 50 years of age on average, and African American women as 
compared to Caucasian women had higher BMI, SBP, lower household incomes, higher cynical 
hostility scores, and greater difficulty paying for basics (Table 1). 
 
The mean CAC score and standard deviation assessed at baseline was 10.4 ± 34.8 and at 
follow-up was 18.2 ± 50.7.  CAC levels at baseline, follow-up, or change between baseline and 
follow-up did not vary by ethnicity.  Forty-one percent of the sample (n=139) did not have 
detectable CAC at baseline or at follow-up.  Twenty-percent of the sample (n=68) progressed at 
least 10 CAC units during the follow-up period.  Women in this higher progression group were 
older by an average of 8 months, and had higher BMI and SBP at baseline than did women with 
CAC progression less than 10 units.  The higher progression group also had greater difficulty 
paying for basics.  These women did not differ from the rest of the sample by ethnicity, hostility 
level, trait anxiety score, baseline smoking status, educational attainment or income.   
 
Table 2 lists Spearman correlations between the SES measures, anxiety, and financial 
strain, stratified by ethnicity.  Among both African American and Caucasian women, income 
was correlated with educational categories, and financial strain and anxiety were marginally 
correlated.  Among African Americans, educational categories were negatively correlated with 
hostility, and marginally but negatively correlated with anxiety.  Hostility was negatively 
correlated with income for Caucasians.   
 
5.4.2 Associations with CAC Progression as a Categorical Variable 
Table 3 displays results from binomial logistic regression models that assess ethnicity, 
educational attainment, and traditional CVD risk factors as predictors of higher versus lower 
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CAC progression levels.  Caucasians and women with high school education or less were more 
likely to exhibit CAC progression levels ≥ 10 units after adjustment for age, BMI, SBP, smoking 
status and study site (Table 3, Model 1).  After an additional adjustment for baseline CAC level, 
low educational attainment remained significantly associated with the higher CAC progression 
level (Table 3, Model 2).  Because baseline CAC was a strong, positive predictor of higher CAC 
change, it was retained as a covariate in all remaining multivariable models. 
 
The interaction term between ethnicity and high school education or less only approached 
conventional levels of significance (p=0.10).  However, we decided to stratify our analysis by 
ethnicity because this interaction term was significant using a lower cutoff of ≥5 units of CAC 
progression (p=0.02), which had a larger number of women in its high progression group (n=92).  
The results were consistent using either cutoff. 
 
Our findings indicate that high school education or less as compared to post-graduate 
education is strongly associated with ≥10 units of CAC progression only among Caucasian 
women, after adjustment for all physiologic covariates and baseline CAC scores (Table 4).  Low 
educational attainment was not associated with greater CAC progression among African 
American women [High school or less: OR= 2.53, 95% CI=0.41-15.8; Any College: OR=1.70, 
95% CI=0.45-6.2].   
 
5.4.3 Mediational Analysis with CAC Progression as a Categorical Variable 
We next tested the hypotheses that anxiety, difficulty paying for basics, or hostility 
explained the relationships between low education and higher CAC progression among 
Caucasian women.  Difficulty paying for basics was added to Table 4 covariates in a separate 
model. Although it was marginally associated with CAC progression among Caucasian women, 
it did not explain the associations between low education and higher CAC progression [OR= 
3.07, 95% CI: 0.92-10.3, p=0.068].  Hostility and anxiety were not associated with greater CAC 
progression among Caucasian women (not shown). 
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 While we did not observe a significant relationship between low education and CAC progression 
among African American women, for consistency, we tested whether anxiety, financial strain or 
hostility were related to higher CAC progression (not shown).  When added to Table 4 
covariates, difficulty paying for basics [OR=3.44, 95% CI: 0.90-13.2, p=0.071] was marginally 
associated with greater CAC progression among African American women.  Similar to 
Caucasian women, hostility and anxiety were not related to greater CAC progression among 
African American women (not shown).  
 
5.4.4 Associations with Continuous CAC Progression Scores in the Full Sample 
Linear regression models that assessed change in calcium  followed similar trends as the 
logistic regression models, although the interaction term between ethnicity and high school 
education or less was not significant (p=0.33).  Low education was significantly associated and 
Caucasian ethnicity was marginally associated with higher levels of follow-up CAC after 
adjusting for baseline CAC, age, BMI, SBP, smoking status, and study site (Table 5, Model 1).  
Difficulty paying for basics was associated with higher follow-up CAC when added to Model 1 
covariates, and appeared to partly explain the association between high school education and 
higher CAC (Table 5, Model 2).  Anxiety was marginally associated with higher follow-up CAC 
when added separately to Model 1 covariates (not shown, p=0.098).   Hostility was not 
associated with follow-up CAC (not shown).  In all models, baseline CAC was strongly and 
positively associated with higher follow-up CAC.    
 
When entered into logistic or linear regression models, income was not a significant 
predictor of CAC progression either independently or including the covariates used in the 
education analyses (not shown).     
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5.5 DISCUSSION 
In a cohort of middle-aged women initially free of stroke and CHD, women with high 
school degrees or less were more likely than those with postgraduate degrees to have higher 
CAC progression.  The inverse association between education and CAC progression appeared to 
be most pronounced among Caucasian women.  Age, BMI, SBP, smoking status, baseline CAC, 
anxiety, or hostility, did not account for the associations between low educational attainment and 
higher CAC progression.   
 
This investigation is the first to report an inverse relationship between education and 
CAC progression.  Previous work has been limited to cross-sectional associations between SES 
and CAC. 114, 125, 151  Cross-sectional studies of CAC reveal how lifetime exposure to risk factors 
contributes to atherosclerosis, but studies of progression may identify factors that accelerate 
short-term atherosclerotic changes.  Our findings indicate that low educational attainment is 
associated with adverse atherosclerotic progression over a two-year period. 
 
There was some suggestion that associations between educational attainment and CAC 
progression were more pronounced among Caucasian women.  These differences between 
African Americans and Caucasians should be interpreted with caution due to the marginal 
interaction between education and ethnicity, and the low frequency of African American women 
with low educational attainment in the sample.  To better explain the interaction between 
Caucasian ethnicity and SES towards coronary atherosclerosis, a critical next research step will 
involve the identification of such risk factors in a larger, multiethnic cohort.   
 
However, it is important to note that these findings do follow previously-reported trends.  
Education was inversely associated with cross-sectional measures of CAC in one study of 
middle-aged, predominately Caucasian women.114  Moreover, MESA noted that low education 
was associated with higher CAC among Caucasians, but not among African Americans.125  
Stronger educational gradients in risk factors such as BMI tend to be observed among Caucasian 
as compared to African American women, which may help to explain these differences.160  The 
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present findings underscore the importance of future work that examines ethnic differences with 
respect to SES and CAC progression. 
 
Education and income were highly correlated in this sample, but income was not 
associated with CAC progression in any models.  Annual household income reflects access to 
healthy lifestyles, material resources, and may contribute to perceptions of control and 
autonomy.102   Questions relating to financial strain may yield different information about an 
individual’s economic well-being as compared to objective reports of income.  Many middle-
aged women experience abrupt changes in economic conditions (e.g., retirement, care of elderly 
parents).  Financial strain is a subjective and dynamic measure, and may better reflect how 
changing finances and associated stresses contribute to greater atherosclerotic burden 
progression.  Our study found that difficulty paying for basics was not correlated with income 
among African Americans or Caucasian women; in this population, low income is not a proxy 
term for financial strain.   
 
The relationships between education, financial strain and higher CAC progression varied 
across the analyses.  In linear regression models that adjusted for education, financial strain 
appeared to explain the relationship between low educational attainment and high CAC at 
follow-up.  However, while financial strain was associated with higher CAC progression in 
logistic regression models, it did not explain the inverse association between education and CAC 
progression.  If CAC is indeed associated with financial strain, our sample may not have had 
enough economic hardship to consistently capture this relationship: at baseline, nearly 70% 
reported a household income over $50,000 and only 22% noted any difficulty paying for basics.  
This analysis should be replicated in a sample with a greater range of SES.   
 
Anxiety is associated with higher incidence of CHD in some studies.155, 161  The few 
studies that have examined relationships between anxiety and CAC are limited to cross-sectional 
analyses, and have found no associations between anxiety and CAC.162, 163    Anxiety did not 
account for the association between education and higher CAC progression in our analyses, but 
was marginally associated with higher CAC progression in linear regression models.  These 
results indicate that the role of anxiety in CAC progression may warrant further investigation.  
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Conversely, hostility was not associated with CAC progression in any models, and did not 
explain associations between education and CAC progression in the full sample or by ethnicity.  
 
CAC scores in our sample were comparable to those observed in other studies of CAC 
progression among women.146, 164  Consistent with extant literature, traditional CHD risk 
factors—namely age, smoking status, and SBP—were not reliably associated with higher CAC 
progression in this study.  Kronmal et al. reported that the predictive value of diabetes mellitus 
towards CAC progression was highest among African Americans, but was less related to 
progression among Hispanics, Caucasians and Asians.33  Several studies have observed that age, 
hypertension, and LDL cholesterol do not predict CAC progression. 164, 165  Cassidy et al. 
reported that higher BMI was associated with CAC progression, but only among adults at low 
CHD risk, similar to the findings observed here.166  Other physiologic and psychosocial risk 
factors may better explain why CAC progresses over time, and exploring candidate risk factors 
should be a goal of future research studies.   
 
Prior studies have found variation in the predictive value of baseline CAC towards CAC 
progression, while other studies caution that inclusion of baseline CAC in regression analyses 
may yield biased estimates.  Therefore, we elected to model our findings with and without 
adjustments for baseline CAC.  Our results were consistent across all analyses.  Moreover, CAC 
progression was considered as both a categorical and continuous variable, with results generally 
consistent across models.   
 
Our analysis has several limitations.  First, our sample was well-educated, and our low 
education categories were relatively small.  This limited our statistical power to assess 
differences in this group, particularly when we stratified our analyses by ethnicity.  Second, over 
forty percent of our sample did not present with any CAC at either baseline or follow-up 
examinations.  A longer period between examinations may have enabled more women to develop 
detectable CAC, which would have increased our statistical power to detect differences in CAC 
progression across SES categories. 
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In conclusion, we found that one in five CHD-and stroke-free, middle-aged women 
showed at least 10 units of CAC progression over a two-year period.  Lower educational 
attainment was predictive of higher CAC progression after adjustment for financial strain, 
hostility, anxiety, and a number of traditional CVD risk factors.  Caucasian women with low 
educational attainment appeared to have greater CAC progression than did African Americans 
with similar education.  However, this finding must be confirmed in a study with a larger cohort 
of African Americans with low educational attainment.  Additional research should examine 
specific factors that may play a role in the association between low educational attainment and 
higher atherosclerotic progression.  
Table 5-1   Clinical characteristics of the study population at baseline by ethnicity 
   
 Mean (SD) or % (No.) 
 Total Sample 
(n=339) 
Caucasian 
(n=219) 
African American 
(n=120) 
P value 
(for ethnicity) 
Age, years   50.1 (2.67) 50.2 (2.42) 50.0 (2.40) 0.48 
BMI, kg/m2   29.3 (6.46) 28.3 (5.43) 31.4 (6.13) <0.0001 
SBP, mm Hg   117.4 (15.2) 114.4 (13.5) 123.6 (16.7) <0.0001 
Annual household income 
<$50K 
$50K-<$75K 
≥$75K 
 
31.9 (97) 
23.0 (70) 
45.1 (137) 
 
25.4 (52) 
23.9 (49) 
50.7 (104) 
 
45.4 (45) 
21.2 (21) 
33.3 (33) 
 
0.0003 
Educational Degree 
≤High School 
Any College 
Post-graduate 
 
15.8 (52) 
52.7 (173) 
31.4 (103) 
 
15.5 (33) 
50.7 (108) 
33.8 (72) 
 
16.5 (19) 
56.5 (65) 
27.0 (31) 
 
0.44 
Cynical Hostility 3.61 (2.90) 3.00 (2.52) 4.83 (3.18) <0.0001 
Difficulty Paying for Basics 22.4 (68) 18.0 (37) 31.3 (31) 0.012 
Trait Anxiety 16.0 (4.6) 15.9 (4.2) 16.0 (5.0) 0.85 
 
N=Frequency, M=Mean, SD=Standard Deviation 
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Table 5-2   Spearman Correlations Between Measures of SES and Potential Mediators 
 
 Educational 
Attainment 
Income Difficulty Paying 
for Basics 
Cynical Hostility Trait Anxiety 
Educational Attainment - 
 
0.46 
p<0.0001 
-0.11 
p=0.28 
-0.26 
p=0.006 
-0.17 
p=0.064 
Income 
 
0.24 
p=0.0005 
- -0.034 
p=0.75 
0.0097 
p=0.92 
-0.11 
p=0.26 
Difficulty Paying for 
Basics 
-0.032 
p=0.65 
-0.091 
p=0.20 
- 0.14 
p=0.16 
0.19 
p=0.057 
Cynical Hostility 
 
-0.093 
p=0.18 
-0.15 
p=0.028 
0.061 
p=0.38 
- 0.090 
p=0.35 
Trait Anxiety 
 
0.10 
p=0.16 
-0.054 
p=0.44 
0.14 
p=0.050 
0.081 
p=0.24 
- 
 
* Shaded region indicates correlation coefficients for African Americans; unshaded region indicates correlation coefficients for 
Caucasians. 
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Table 5-3   Logistic Regression for Predictors of Coronary Artery Calcification Progression in Total Sample 
 
 Model 1  Model 2 
 
 Odds Ratio (95% CI)* P value P value Odds Ratio (95% CI)*    
  Ethnicity 
        Caucasian 
        African American 
 
 
2.29 (1.12-4.65) 
1.00 (Referent) 
 
0.023 
  
2.06 (0.96-4.41) 
1.00 (Referent) 
 
0.063 
    Education  
        High school or less 
        Any college  
        Post graduate  
 
3.42 (1.33-8.80) 
1.48 (0.69-3.2) 
1.00 (Referent) 
 
 
0.011 
0.31 
  
5.00 (1.75-14.3) 
1.72 (0.73-4.07) 
1.00 (Referent) 
 
0.0027 
0.22 
     Age 1.09 (0.97-1.22) 0.14  1.07 (0.94-1.22) 0.28 
     BMI 1.10 (1.04-1.16) 0.0004  1.06 (1.002-1.12) 0.04 
     SBP 1.03 (1.003-1.05) 0.028  1.02 (0.99-1.05) 0.10 
     Baseline CAC - -  1.05 (1.02-1.07) <0.0001 
 
*=95% Confidence Interval; Covariates in models include time between scans, smoking status and study site 
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Table 5-4   Logistic Regression for Predictors of Coronary Artery Calcification Progression among Caucasian Women 
 
P value Odds Ratio (95% CI)*  
    Education  
     High school or less 
     Any college  
     Post graduate  
 
7.75 (1.97-30.4) 
1.53 (0.48-4.88) 
1.00 (Referent) 
 
 
0.003 
0.47 
     Age 1.10 (0.92-1.31) 0.29 
     BMI 1.12 (1.02-1.22) 0.013 
     SBP 1.05 (1.005-1.09) 0.027 
     Baseline CAC 1.05 (1.02-1.08) 0.0009 
 
*=95% Confidence Interval; Covariates in model also include time between scans, smoking status and study site 
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Table 5-5   Linear Regression for Predictors of Coronary Artery Calcification Progression in Total Sample 
 
 CAC Progression* 
 
 Model 1  Model 2 
 
 β (S.E.) † P value  β (S.E.) † P value 
     Ethnicity 
        Caucasian 
        African 
American 
 
 
0.21 (0.12) 
Referent 
 
0.083 
  
0.30 (0.13) 
Referent 
 
0.017 
     Education 
      High school or less 
       Any college  
       Post graduate  
 
0.35 (0.17) 
0.15 (0.12) 
Referent 
 
 
0.040 
0.22 
  
0.28 (0.17) 
0.11 (0.13) 
Referent 
 
 
0.10 
0.41 
     Age 0.008 (0.020) 0.71  0.004 (0.021) 0.84 
     BMI 0.013 (0.011) 0.24  0.014 (0.011) 0.23 
     SBP 0.005 (0.004) 0.23  0.006 (0.004) 0.15 
     Baseline CAC 0.86 (0.05) <0.0001  0.84 (0.05) <0.0001 
Difficulty Paying for 
Basics 
- -  0.34 (0.13) 0.012 
 
*Log-transformed CAC scores; †= β=Beta-coefficient, S.E.=Standard Error; Covariates in model include time between scans, 
smoking status, and study site 
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7.0  GENERAL DISCUSSION 
7.1 SUMMARY OF FINDINGS 
This dissertation project investigated the independent and combined associations of 
cardiovascular risk factors, socioeconomic status (SES), and psychosocial factors with 
subclinical CVD in middle-aged women.  Our sample included CHD- and stroke-free African 
American and Caucasian participants from the Study of Women’s Health Across the Nation 
(SWAN) Heart Study.  Coronary artery calcification (CAC), aortic calcification (AC), carotid 
artery intima-media thickness (IMT), and aortic pulse wave velocity (PWV) were measured 
among participants at a baseline examination and at a follow-up examination an average of 2.3 
years later.   
 
Overall, our analyses suggest that African American women are at greater risk of 
developing subclinical disease measures related to arteriosclerosis.  We observed that IMT and 
PWV were higher among African American women than among Caucasian women.  The excess 
of CVD risk factors among African American women may have increased the risk for 
developing measures of arteriosclerosis; consistent with the general population, 95 African 
American women in our study had higher BMI, waist circumference, SBP and DBP levels than 
did Caucasian women.  In addition, SBP, DBP, LDL-C, and glucose appeared to have a stronger 
impact on PWV progression among African American women than among Caucasian women, 
which may have contributed to the accelerated arteriosclerosis observed in this group.   
 
Conversely, our results indicated that CAC progression was higher in a low-SES 
subgroup of Caucasian women.  This finding is consistent with earlier angiography and autopsy 
studies, which have reported a greater extent of coronary vessel disease among Caucasian 
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women as compared to African American women.86  Caucasian women—particularly those with 
low educational attainment-- may be more prone to developing calcified atherosclerotic plaques 
in their coronary arteries.   
 
Blood pressure variables explained several of the relationships between African 
American ethnicity, low income, and cross-sectional subclinical measures that were observed in 
Research Articles 2 and 3; this emphasizes the role of blood pressure in subclinical CVD 
development.  Blood pressure also related to PWV progression in this sample, particularly 
among African American participants.  Collectively, these findings underscore the importance of 
early blood pressure management in order to prevent the development of subclinical CVD 
among middle-aged women. 
 
Our findings in Research Articles 2 and 3 indicated that low SES is independently and 
robustly associated with certain subclinical CVD measures. These associations were not 
completely explained by ethnicity or by modifiable risk factors, such as BMI.  The specific 
mechanisms by which low SES exerts detrimental effects on the vasculature of this group of 
women remain unclear.  However, our findings are consistent with other research studies of 
subclinical and clinical CVD, and confirm that low SES is an important predictor of subclinical 
CVD.68, 82, 114-119, 151, 167   
 
With regard to SES, it is important to note that our analyses included an understudied 
population in the subclinical CVD literature—African American women with relatively high 
SES.  Several large community-based studies of subclinical CVD report a wider range of SES in 
their samples than did SWAN Heart, but African Americans in their studies also tend to report 
substantially lower indicators of SES than observed in our study.  In the ARIC study, only 17.6% 
of African American women had annual household incomes greater than $35,000 as compared to 
51.2% of Caucasian women.168  Similarly, 30.0% of African Americans in the MESA study had 
high school degrees or less as compared to 21.3% of Caucasians, and 11.0% of African 
Americans had annual household incomes less than $12,000 as compared to 4.0% of 
Caucasians.169  The well-educated sample of African American women in the SWAN Heart 
Study is fairly unique as compared to other large, multi-ethnic studies of subclinical CVD.   
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 Indeed, women recruited to the SWAN Heart Study generally reported relatively high 
indicators of SES; more than half of the sample in any one of our analyses had college 
educations or higher.  While this may have limited our ability to detect the relationships between 
subclinical CVD and severe economic deprivation or hardship, our results likely indicate how 
variations in social status affect subclinical CVD.  We did observe gradations in the extent of 
subclinical CVD between relatively low SES and higher SES participants.  For example, even 
our “low income” group- which, in this sample, consisted of some women who had an annual 
household income close to $50,000 per year—had higher IMT and PWV levels.   
 
Recruitment into the SWAN Heart Study was community-based, and involved the 
Chicago and Pittsburgh member study sites involved in the parent SWAN study.  Community-
based studies may limit selection biases observed in physician referral studies for the evaluation 
of subclinical CVD.  In addition, both of the SWAN Heart sites recruited Caucasian and African 
American women; the Chicago site enrolled women from two different facilities in order to 
increase representation of African Americans. This recruitment strategy enabled us to enroll 
enough African American women to assess certain ethnic differences in subclinical CVD 
measures.   
 
The SWAN Heart Study recruited healthy women who were CHD-free at the onset of the 
study.  For this reason, the overall extent of subclinical CVD in this population was fairly low.  It 
will be important to revisit the analyses of this dissertation project as the participants continue to 
age.  The associations between ethnicity, SES, cardiovascular risk factors, and subclinical CVD 
progression that were observed in our analyses may remain robust or may become attenuated 
with time.  Other risk factors may become increasingly important in predicting the course of 
subclinical CVD progression as these women transition through the menopause and into older 
age.  
 
Examining our hypotheses early in the cardiovascular disease process and prior to clinical 
events is important.  First, learning what factors contribute to subclinical CVD may help to 
identify targets early in the course of cardiovascular disease that ultimately can prevent clinical 
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outcomes.  Furthermore, recall bias may be a factor in studies that require patients with clinical 
CVD to remember what their CVD risk factor levels were prior to their clinical event.  
Additionally, individuals who undergo clinical treatment for symptomatic CVD may have 
artificially-reduced risk factor levels that confound the relationships between risk factors and 
clinical disease.   
 
Our general analytic strategy across the three research articles had several limitations.  
Only two ethnic groups were recruited to the SWAN Heart Study, and we recommend that our 
analyses be applied to cohorts that include women of other ethnicities.  Indeed, subclinical CVD 
among Hispanic American and Asian American women is relatively understudied, although 
cardiovascular outcomes are major causes of mortality among women in these groups.  In 
addition, not every woman in our study sample participated in each of the different subclinical 
CVD scans or received scans at both baseline and follow-up.  In order to maximize statistical 
power, we retained those women who had at least one subclinical CVD measurement in the 
cross-sectional analysis, and those women with a baseline and a follow-up PWV or CAC 
measurement for the progression analyses.  For this reason, the samples differ slightly between 
the three analyses.  Lastly, we attempted to match cardiovascular and psychosocial risk factors 
assessed at annual SWAN visits to each participant’s corresponding SWAN Heart baseline or 
follow-up year.  However, because some women missed at least one SWAN visit, we had to 
impute covariate data from the closest SWAN year to our analyses.  This was a consideration for 
a minority of women, but should still be noted as a limitation as their risk factors may have 
changed in the intervening time between their SWAN and SWAN Heart visits. 
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7.2 PUBLIC HEALTH SIGNIFICANCE  
Clinical CVD is the leading cause of mortality among American women.  The direct and 
indirect costs of CVD in the U.S. are estimated to be $475.3 billion dollars in 2009 alone.170  
Early risk factor management and preventive care could profoundly impact the overall health of 
the public, reduce the economic burden of CVD, and curtail morbidity and mortality from 
cardiovascular causes.   
 
Investigating the interrelationships between risk factors that contribute to higher 
subclinical CVD may help to identify targets that prevent progression into clinical outcomes.  In 
our analyses, we observed that blood pressure variables were important risk factors for the 
development of subclinical CVD—particularly for IMT and PWV.  A recent meta-analysis 
suggests that usage of anti-hypertensive medications, including angiotensin-converting enzyme 
inhibitors and β-blockers, reduces IMT progression in populations with diabetes or CHD.100  
Treatment of pre-hypertension and hypertension in otherwise healthy women may also help to 
prevent the early cardiovascular changes that culminate in clinical outcomes.   
 
Our findings indicated that the effects of SBP, DBP, and LDL-C may be stronger among 
African Americans than among Caucasians in relation to PWV progression, a measure of 
arteriosclerosis that is related to adverse clinical outcomes.  Waist circumference and glucose 
also were related to PWV progression among the African American women in our sample.  
Differences in the magnitude of the effects of CVD risk factors on PWV progression in addition 
to an excess of CVD risk factors may contribute to the disproportionately high prevalence of 
adverse clinical outcomes among African American women.  Even in our generally healthy, 
relatively high-SES sample of African American women, participants had marginally high SBP 
and lipid levels, and did not report that they were receiving treatment for these conditions at 
study baseline.  Clinicians may need to manage these risk factors earlier and more aggressively 
in order to prevent clinical outcomes in this group.  As reported by the International Society on 
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Hypertension in Blacks, “Undiagnosed, untreated, and inadequately treated hypertension results 
in an enormous burden of disease for African Americans… a key obstacle is the failure of 
medical providers to treat high blood pressure early and to continue treating it persistently to 
reach and maintain an appropriate target blood pressure.”171  This statement may also be valid for 
the treatment of hyperlipidemia, diabetes mellitus or pre-diabetes, and other conditions related to 
cardiovascular risk.  Currently, treatment recommendations do not vary by ethnicity.  However, 
our data suggest that even borderline levels of risk factors are associated with arterial stiffening 
over a two-year period.  It is possible that clinicians are not treating these risk factors sufficiently 
or early enough in the pathogenesis of CVD to prevent clinical events.  It is also possible that 
current clinical thresholds for CVD risk factors are insufficient to prevent clinical disease among 
African Americans.  Suggested future work includes a reassessment of current clinical guidelines 
for healthy SBP, DBP and LDL-C targets among African Americans, in order to establish 
adequate levels for successfully managing hypertension and hyperlipidemia in this population.   
 
It is more challenging to modify and “treat” socioeconomic status.  Our findings indicate 
that lower SES is associated with certain measures of subclinical CVD, which may in part be 
explained by excess cardiovascular risk factors in this group.  Although we did not examine this 
question directly, low-SES individuals are more likely to engage in “cigarette smoking, physical 
inactivity, poor diet, and substance abuse” than are high-SES individuals.104  Certainly, these 
lifestyle factors are important targets for reducing subclinical CVD in this group.  In addition, 
public policy efforts that facilitate upward mobility, improve the quality of education for all 
children, and encourage successful college degree completion among low-SES adolescents may 
diminish the psychological and health-related burdens associated with poverty in the United 
States. 
 
We observed that psychosocial factors such as anxiety and financial strain were weakly 
but consistently related to greater CAC progression among Caucasian women with low 
educational attainment.  Modifying certain psychosocial factors among low-SES women may 
lead to the prevention of cardiovascular outcomes.  Improving the accessibility of services that 
assist individuals and families with low SES and enhance overall health would be one strategy; 
efforts could include providing credits for healthy foods or for activities that promote physical 
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health, or could include reducing costs and availability of medical and dental care in low-income 
neighborhoods.  Another strategy is to improve the availability of mental health services to 
women of low SES.  If women utilize effective coping strategies that ameliorate feelings of 
anxiety and strain, some prevention of clinical outcomes may ultimately be achieved.  
Encouraging accredited medical schools to teach better interviewing skills to students could be 
an additional approach.  Special emphases could include improving cultural competency and 
eliciting information about the lifestyle concerns, needs, and coping strategies of low-SES 
patients.  Asking these questions may reveal patients who may benefit from mental health 
services or psychotropic medications.  While these types of questions should be considered 
standard for any patient-provider interview, they may be particularly important for identifying 
vulnerable low-SES women, and ultimately, improving cardiovascular outcomes in this group.  It 
is important to note that the costs to the public for improved mental health services may 
ultimately be less than the costs for treating eventual clinical cardiovascular diseases and stroke. 
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7.3 FUTURE RESEARCH 
In this dissertation project, we observed that blood pressure, and to a lesser extent, 
financial strain, were important mediators of the associations between ethnicity, low SES and 
subclinical CVD change.  Additional research is needed to clarify the relationships between 
ethnicity, SES, and cross-sectional and longitudinal measures of subclinical CVD progression.  
Special attention to the CVD and psychosocial risk factors that may explain these associations 
may generate new or improved targets for clinical management.  There is still much to learn 
about why certain women develop clinical outcomes.  If we are better able to understand how 
and why the vasculature changes prior to these clinical outcomes, better interventions may be 
developed for preventing clinical disease.   
 
Certainly, atherosclerosis and arteriosclerosis are cumulative, progressive diseases with 
extensive latent phases.  To better characterize the roles of biological and psychosocial risk 
factors on the natural history of these diseases, it is important to examine them throughout the 
lifecourse.  Our analyses investigated the associations of subclinical CVD with current or recent 
cardiovascular risk factors and SES indicators.  However, we recommend future work to 
examine how changes in risk factors over time affect the progression of subclinical CVD.  For 
example, studies that examine the effects of cumulative lifetime SES on subclinical CVD 
outcomes may be more informative for understanding how, why, and when SES begins to affect 
vascular health and functioning.  Some of this work has been assessed in studies such as 
CARDIA, which has been pioneering in its longitudinal investigation of subclinical CVD 
beginning in young adulthood.  A limitation of these studies is under-enrollment of diverse 
ethnic groups.  CVD is a leading cause of mortality among Asian and Hispanic Americans as 
well.  We also recommend that longitudinal assessments of atherosclerosis and arteriosclerosis in 
these populations should be examined in future work.   
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Future research should focus on the prevention of subclinical CVD progression.  A meta-
analysis by Wang and colleagues concluded that antihypertensive medication usage prevents 
progression of IMT among individuals with diabetes or symptomatic coronary heart disease.172  
However, no study has yet examined whether anti-hypertensive medications can be used to 
prevent subclinical CVD progression in relatively healthy populations with borderline or clinical 
hypertension.  While SBP and DBP were observed to be some of the most potent risk factors for 
PWV progression in our CHD-free sample, the average SBP of our participants was only in the 
pre-hypertensive range, and DBP was in the normal range.  We recommend that future clinical 
trials examine whether the following interventions are effective in reducing subclinical CVD 
progression in healthy populations with borderline hypertension: 1) lifestyle and behavioral 
interventions that reduce dietary sodium intake and tobacco usage, and increase physical activity, 
2) pharmacologic treatment of marginally elevated blood pressure.  Improved blood pressure 
control in the earliest stages of hypertension may be important in preventing adverse vascular 
remodeling over time. 
 
As noted earlier, the effects of blood pressure on PWV progression were particularly 
robust among African American women.  According to the JNC 7 on the Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure, the current recommendation for blood 
pressure targets is 130/80 or less for individuals with non-diabetic renal disease or type 2 
diabetes;147 however, the optimal blood pressure target for preventing end-organ damage is now 
considered less than 120/80.171  Thus far, no research studies have established whether these 
targets are adequate for preventing clinical outcomes among African American women.147  
Clinical trials are needed to examine which blood pressure targets—130/80, 120/80, or even 
lower—are most effective for preventing clinical outcomes among African Americans.   
 
Our work suggests that even African American women with borderline hypertension may 
be at risk for accelerated arterial stiffening.  A preventive strategy that should be examined in 
future research studies would include beginning African-American women on anti-hypertensive 
medication regiments if they are either pre-hypertensive or normotensive and have at least one 
additional cardiovascular risk factor (e.g., obesity or a family history of CHD).  Currently, there 
are no differences in clinical guidelines across different ethnic groups for treating hypertension 
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or pre-hypertension.147  However, given the strong associations between blood pressure and 
subclinical disease and clinical cardiovascular outcomes among African Americans, this 
approach should be considered.  It is important to note that certain pharmacologic treatments 
have well-characterized side effects, or are considered to be less effective for controlling blood 
pressure in African Americans (e.g., ACE inhibitors);171  therefore, analysis of the risks and 
benefits of starting early and aggressive blood pressure treatment in this population would be 
most safely considered in the setting of clinical trials.  
 
It remains unclear why blood pressure, hyperlipidemia, and hyperglycemia rendered 
African American women in our study more vulnerable to PWV progression.  It does appear that 
this susceptibility to adverse cardiovascular profiles begins early in life.  The Pathobiologic 
Determinants of Atherosclerosis in Youth autopsy study observed that young African Americans 
had more extensive fatty streaks on autopsy in their coronary arteries and aortas than did young 
Caucasians.173  Earlier findings also indicate that young African Americans have greater sodium 
sensitivity than do young Caucasians,174 which may contribute to excessive salt and water 
retention, and ultimately, higher blood pressures beginning in childhood.  Genetic studies may be 
important in elucidating what particular factors contribute to hypertension and hyperlipidemia 
among African Americans, and we encourage future research in this area. 
 
Anxiety and psychological risk factors are associated with higher levels of subclinical 
CVD.  In our study, high baseline anxiety levels were marginally related to higher CAC 
progression.  Some researchers speculate that stress elicits an adrenergic response that 
cumulatively may contribute to hyperglycemia, hypercortisolemia, and autonomic dysregulation; 
this eventually may lead to clinical events.175  Understanding the relationships between 
emotional and cognitive stimuli, biological and physiologic responses, and CVD is important.  
Future studies could investigate the efficacy of various mental health interventions in reducing 
negative affect and emotions, and examine whether these interventions are effective in reducing 
progression of subclinical CVD measures.  Mental health interventions may be an efficacious 
component of preventive care.  
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7.4 CONCLUSION   
Cardiovascular disease is a major cause of morbidity and mortality among American women, 
and particularly among African American women.  In these analyses, we studied the associations 
of early subclinical cardiovascular changes with ethnicity, SES, and cardiovascular disease risk 
factors in a biracial sample of CHD-free, middle-aged women. We found cross-sectional and 
longitudinal associations between ethnicity and subclinical CVD measures.  We observed that 
SBP, DBP, LDL-C, and glucose were stronger predictors of PWV progression among African 
American women than among Caucasian women.  Generally, African American ethnicity was 
more strongly associated with higher levels of measures that relate to arteriosclerosis, including 
IMT and PWV; SBP appeared to partly explain higher PWV among African Americans.  
Women of low SES and Caucasian ethnicity also appeared to have greater progression of 
atherosclerotic coronary plaque.  In addition, we observed that low SES was predictive of higher 
levels of AC, IMT, and PWV, independent of ethnicity.  We also evaluated the associations of 
SES and progression of CAC, and found that Caucasian women with low educational attainment 
were more likely to develop higher CAC progression over the follow-up period.  This association 
was partly explained by financial strain, and anxiety appeared to play a role in CAC progression 
in this group.  In sum, our findings provide evidence for independent and combined associations 
between ethnicity, SES, and subclinical CVD.  Our findings also suggest that psychosocial 
factors such as financial strain may mediate some of these relationships.  We recommend that 
future work should examine the progression of subclinical CVD in this group of women, and 
attempt to identify other psychosocial and biological variables that explain these associations.   
APPENDIX: SUMMARY OF EPIDEMIOLOGIC STUDIES ON SUBCLINICAL 
CVD MEASURES AND CVD OUTCOMES, AND ETHNIC DIFFERENCES IN 
SUBCLINICAL CVD MEASURES 
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 Table A-1. Coronary Artery Calcification and Cardiovascular Events 
Authors Design Study Sample Results Conclusion/Comments 
Budoff MJ, Shaw, LJ, et 
al., 2007.  J Am Coll 
Cardiol. 
Prospective, average 
6.8-year follow-up.  All-
cause mortality 
endpoint. 
Multi-site, UCLA 
investigators.   
n=25,253 physician-
referred, consecutive 
asymptomatic adults.  
Mean age 56 yrs, 50% 
male 
1. 510 deaths.  CAC predicted 
mortality.   
2. Presence of CAC was 
associated with 2.2 increased 
risk, after adjustment for CVD 
risk factors. 
1.  The greater the amount 
of CAC, the greater the risk 
of death 
2.  Did not consistently 
adjust for other CVD risk 
factors, likely an 
overestimation of risk. 
 
Church TS, Levine, BD, 
et al., 2007.  
Atherosclerosis. 
Prospective, average 
follow-up of 3.5 years. 
Physician- or self-
referred 
population. 
n=10,746 men and 
women. 
1. 81 CHD death or non-fatal 
MI.   
2. Low event rate for people 
with no CAC; CAC ≥100 
associated with increased 
CHD risk (RR: 6.4-8.4) as 
compared to <100 units CAC 
(RR: 0.4-2.4), depending on 
number of CHC risk factors. 
 
1.  Physician-referred 
population. 
2.  EBCT method was 
slightly different, used 
Agatston method but 
different CT slice thickness 
than standard method. 
Detrano R, Guerci AD, 
et al., 2008.  NEJM. 
Prospective, average 
follow-up of 3.8 years. 
Multi-Ethnic Study 
of Atherosclerosis 
(MESA) cohort. 
n=6722 African 
American, Chinese, 
Hispanic, Caucasians, 
aged 45-84 at baseline 
1. 162 coronary events.  
2. Compared to 0 CAC, CAC 
1-300 (HR: 7.73, p<0.001), 
CAC>300 (HR: 9.67, 
p<0.001) associated with any 
coronary event 
 
1.  No differences in 
predictive value of CAC by 
ethnicity. 
Detrano R, Wong ND, et 
al., 1999. Circulation. 
Prospective, average 
f0ollow-up of 41 
months. 
South Bay Heart 
Watch. 
n=1196 asymptomatic, 
high CHD-risk adults.  
Mean age 66. 
1. 68% had CAC>0.  17 
coronary deaths, 29 nonfatal 
MIs.   
2. CAC did not change ROC 
area significantly when added 
to Framingham risk model 
variables. 
1.  CAC may not add 
incremental value to CHD 
risk assessment in high-risk 
groups 
2.  Very few CVD events, 
may have limited ability to 
see associations. 
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Table A-1 (Continued) 
 
Folsom AR, Kronmal 
RA, et al., 2008.  Arch 
Intern Med. 
Prospective, average 5.3 
years of follow-up.   
MESA cohort.  
Comparison of 
predictive value of 
CAC and IMT 
towards CVD. 
n=6698 African 
American, Chinese, 
Hispanic, Caucasians, 
aged 45-84 at baseline 
1. 222 CVD events.   
2. Each 1-SD increase in CAC 
associated with 2.1x increased 
risk of CVD.  Adjustment for 
CVD risk factors (RFs).   
3. For each 1-SD increase in 
IMT, 1.3x increased risk of 
CVD. 
 
1.  CAC was more related 
than IMT with risk of CVD. 
2.  Ethnicity-adjusted.  No 
data present risks by ethnic 
group. 
Lakoski SG, Greenland 
P, et al., 2007.  Arch 
Intern Med. 
Prospective, average 
follow-up of 3.75 years. 
MESA cohort. 
Women-only. CAC 
scores and risk for 
cardiovascular 
events in women 
classified as “low 
risk” based on 
Framingham Risk 
Scores.   
n=3601 women aged 
45-84 at baseline.  90% 
of these women were 
classified as low risk 
based on FRS.   
1. 58 CVD events. Prevalence 
of CAC was 32% (n=870, 
CAC>0) 
2. Low-risk women with CAC 
were at significantly increased 
risk for CHD (HR: 6.5) and 
CVD events (HR: 5.2).  The 
HRs remained significant and 
similar after exclusions of 
statin users and anti-
hypertensive med users. 
3.  Advanced CAC (CAC 
score ≥ 300) was highly 
predictive of future CHD and 
CVD events over a 3.75-yr f/u 
period.  Women who had 
CAC scores ≥ 300 were older, 
had higher LDL levels, and 
higher SBPs.   
4. No ethnicity x CAC 
interaction in prediction of 
CHD/CVD events.   
 
1.  95% of US women 
younger than 70 YO are 
judged to be at low risk for 
CHD based on FRS 
standards (NHANES III), so 
the FRS alone is not a good 
predictor for future 
CHD/CVD in women.  This 
may enhance the importance 
of subclinical measures in 
this subgroup. 
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Table A-1 (Continued) 
LaMonte MJ, Fitzgerald 
SJ, et al., 2005.  Am 
Journal of Epidemiology. 
Prospective, average 
follow-up of 3.5 yrs.   
CAC score and 
CHD events in 
asymptomatic men 
and women.  
EBCT used.  
3619 participants. Ages 
22-96 YO.  20% were 
40 YO.  Mean age = 
53.8 +/- 9.9 yrs.  64% 
men, >97% White.  
Participants received 
scanning as part of a 
preventative health 
exam or physician/self-
referral.  Aerobics 
Center Longitudinal 
Study. 
1. Primary endpoint = CHD 
events (nonfatal MI or death 
from cardiac causes).  
Secondary endpoint = all CHD 
events (hard events + PTCA 
and CABG).   
2. 287 CHD events in time pd 
(19 deaths, 62 nonfatal MIs, 
206 revascularizations).   
3. Zero CAC was seen among 
20.4% of women with these 
events and  71.7% of women 
without these events 
 
1. Questionnaire asked 
about CVD risk factors 
before CHD event; recall 
bias from questionnaire is 
likely. 
2.  More women than men 
had CHD deaths or nonfatal 
MIs 
3. No CHD events were 
seen in younger group, but 
there were some young 
people with CAC.  Authors 
suggest these types of 
people may benefit from 
EBCT screening. 
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 Table A-2  Aortic Calcification and Cardiovascular Events 
Authors Design Study Measurements Results Conclusion/Comments 
Walsch CR, Cupples 
LA, et al., 2002.  Am 
Heart Journal. 
Prospective, 
22-year follow-
up. 
Framingham Study, 
n=2467 total, 1437 
females. Free of CHD 
at study onset 
 
Participants received 
AAC measurements at 
year 10 (1966-1970) 
Abdominal AC (AAC), 
lateral lumbar 
radiograph. 
1. 141 cases of CHD among men, 
169 among women.  AAC was 
categorized into tertiles. 2. Among 
women, CHF risk was increased 
for the second (HR 1.8, 95% CI 
1.1-2.9) and third (HR 3.2, 95% CI 
2.0-5.1) tertiles compared with the 
lowest tertile of AAC. 
 
1.  Authors adjusted for 
existing CHD, because of 
the relationship between 
CHD and CHF. 
2.  Differences in prognostic 
value of AAC by ethnicity 
were not reported. 
Wilson PWF, Kauppila 
LI, et al., 2001.  
Circulation. 
Prospective.  
28-year follow-
up. 
Framingham Heart 
Study, 1049 men and 
1466 women, mean age 
61 years. 
AAC on lateral lumbar 
radiograph. Adjustment 
for a number of risk 
factors. 
1. 454 CHD cases, 709 CVD cases, 
365 CVD deaths.   
2. 2 highest tertiles of AC were 
significantly associated with 
greater CHD and CVD mortality 
among women (RR: 1.25, 95% CI: 
0.95-1.65), (RR: 1.78, 95% CI: 
1.33-2.38), respectively. 
 
1. Differences in prognostic 
value of AAC by ethnicity 
were not reported. 
2.  It is unclear whether 
calcification in thoracic wall 
and abdomen are 
interchangeable. 
Witteman JC, Kannel 
WB, et al., 1990.  Am J 
Cardiol. 
Prospective, 
12-year follow-
up. 
Framingham Study, 
n=5209.  
Thoracic AC, chest X-
ray 
1.  Extent of AC approximately 
doubled in each decade of life  
2.  Presence of AC was associated 
with doubled CVD risk over 
follow-up 
3.  Presence of AC was associated 
with doubled risk of CHD and 
claudication among women, less so 
among men 
 
1.  The prognostic value of 
AC was decreased with 
increasing age 
2.  Framingham Heart Study 
is not ethnically-diverse, 
unclear what associations 
are for Blacks 
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 Table A-3  Carotid Artery Intima-Media Thickness and Cardiovascular Events 
Authors Design Study Measurements Results Conclusion/Comments 
Bots ML, Hoes 
AW, et al., 1999.  
J Int Med. 
Prospective, 
10-12 year 
follow-up. 
Rotterdam, 
Netherlands.  1683 
men and women, 
mean age 70. 
Common-carotid artery IMT 
(CCA-IMT).  Stroke, CHD, 
and death were endpoints.  
CCA-IMT divided into 
quintiles. Low versus high 
CCA-IMT values were 
reported.  Fairly high CCA-
IMT levels among women in 
sample (0.79±0.16 mm) 
1.  10-year risk of stroke: 4.8% (95% 
CI: 3.8-5.8) for lowest quintile of 
CCA-IMT versus 16.1% (12.3-21.9) 
for subjects in highest quintile.  
2.  10-year risk of CHD: 13.1% (95% 
CI: 12.0-14.2) to 23.4% (95% CI: 
21.4-25.4) 
3.  Risk of death in 11.5 yrs: 15.0% 
(95% CI: 12.8-17.4) versus 46.0% 
(42.8-49.3%) 
 
1.  Sample is not ethnically-
diverse and is elderly. 
2.  Risk of death was very 
high in this sample, much 
moreso than other studies 
3.  No adjustments of RFs 
for CVD risk factors—a 
limitation for interpretation 
4.  Average SBP values 
were marginally 
hypertensive for women 
 
Chambless LE, 
Folsom AR et al., 
2003.  Journal of 
Clinical 
Epidemiology 
Prospective, 
median 10.2 
year follow-
up. 
Atherosclerosis Risk 
in Communities 
Study (ARIC).  
Coronary heart 
disease risk 
prediction in ARIC. 
Used nontraditional 
(non-Framingham;  
total cholesterol, 
HDL, current 
smoking, diabetes, 
BP) risk factors to 
explore individual 
risk of incident CHD.  
15972 men and women in 4 
US communities.  Assessed 
BMI, WHR, sport activity 
index, FEV, plasma 
fibrinogen, Factor 8, VWF, 
LP, pack years, IMT.  
Longitudinal (baseline visit: 
1987-1989, subsequent f/u 
exams in 1990-2, 1993-5, 
1996-8).  Blacks and Whites. 
 
1.  Black women had higher incident 
CHD rates than White women 
(p<.05) and Black men had lower 
rates than White men (p<.05). 
2.  For ARIC Black women, hazard 
rate ratios (HRR) were higher for 
hypertension and current smoking 
than Framingham women.  For ARIC 
white women, HRRs were higher for 
diabetes and current smoking. 
3.  IMT did not bring a significant 
increase in the CHD prediction 
model when added to covariates, 
although it did add to the area under 
the ROC curve of at least 0.005 for 
women of each ethnicity. 
 
 
1.  IMT does not 
independently predict CHD 
incident events but does add 
to individual risk 
(probability that a person 
who had an incident event 
within the 10-yr time pd had 
a higher risk score than a 
person who did not have an 
event by that time).  
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Table A-3 (Continued) 
Lorenz MW, 
Markus HS, et al., 
2007.  Circulation. 
Meta-analysis. Examined 8 relevant 
studies, including 
ARIC, Rotterdam, 
CHS, and CAPS. 
 
Pooled age- and sex-adjusted 
ORs over the studies.   
1.  Per 1-SD CCA-IMT difference, 
relative risk of MI was 1.26 (95% CI: 
1.21-1.30) 
2.  Per 1-SD CCA-IMT difference, 
relative risk of stroke was 1.32 (95% 
CI: 1.27-1.38) 
3.  Per 0.10-mm increase in CCA-
IMT, relative risk of MI was 1.15 
(95% CI: 1.12-1.17) 
4.  Per 0.10-mm increase in CCA-
IMT, relative risk of stroke was 1.18 
(95% CI: 1.16-1.21)  
 
1.  Important meta-analysis 
2.  Data not reported by 
gender or ethnicity 
3.  Graded increase in 
cardiovascular risk for each 
category  increase in IMT 
O’Leary DH, 
Polak JF, et al., 
1999. NEJM 
Carotid IMT 
thickness as a 
risk factor for 
new-onset MI 
and stroke in 
older adults. 
N=5858, subjects ≥ 
65 YO.  Mean age= 
72.5. 
 
Black and White men 
and women with no 
prior history of CVD.  
 
Examined 
prospectively for 
median 6-7 yrs. 
 
Cardiovascular 
Health Study. 
Incidence of CVD events 
correlated with IMT. 
Relative risk of MI or stroke 
increased with IMT. 
 
 
1. RR of MI/stroke (adjustment for 
age and sex) for highest thickness 
quintile as compared to lowest 
quintile was 3.87. 
 
2. After adjustment for traditional 
risk factors, association between CV 
events and IMT was significant.  
RFs: age, sex, DBP, SBP, pack years 
of smoking, LDL/HDL, diabetes, 
atrial fibrillation. 
 
1.  Common carotid IMT and 
combined IMT were better 
predictors of stroke than 
internal carotid IMT; 
combined was overall better 
for predicting events. 
2.  IMT is a strong predictor 
of new CVD events. 
3. An increase of 1 SD in 
combined IMT thickness was 
associated with a RR of 1.36 
for combined end point of MI 
or stroke after adjustment for 
age, sex, and other risk 
factors
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Rosvall M, Janzon 
L, et al., 2005.  
Atherosclerosis. 
Prospective, 7-
year follow-
up. 
Malmo Study, 
Sweden.  5163 men 
and women.  Mean 
age= 57.5 yrs. 
Common carotid IMT.   
22.6% current smokers, 25.1% 
had low activity, normal waist 
circumferences. 
1. 86 incident cases of stroke (41 for 
men, 45 for women).   
2. Age- and gender-adjusted carotid 
IMT were related to future stroke 
(p<0.05).  Graded increase between 
IMT and stroke risk. 
1.  Population of Europeans, 
not ethnically-diverse 
2.  Highest categories of IMT 
were most strongly and 
significantly related to stroke.  
HRRs in these groups ranged 
from 3.20-2.84. 
3.  CVD endpoints were not 
gender-stratified, and CVD 
risk factors and IMT levels 
were not reported by gender. 
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 Table A-4 Aortic (Carotid-Femoral) Pulse Wave Velocity and Cardiovascular Events 
Authors Design Study Measurements Results Comments/Conclusions 
Meaume A, Benetos A, 
et al., 2001.  
Arterioscler. Thromb. 
Vasc. Biol. 
Prospective, mean 
follow-up 30 
months.  
182 consecutive patients 
into 3 Paris hospitals.  141 
consented and had readable 
scans.  Mean age 87.1 years. 
Complior device was 
used for aortic PWV 
measurements. 
1. 56 patients died, 27 from 
CV events.  Age (p=0.005) 
and loss of autonomy 
(p=0.01) were best 
predictors of mortality. 
2. Aortic PWV was major 
risk predictor (OR: 1.19, 
95% CI: 1.03-1.37;  
p=0.016) 
3. Mean blood pressure, 
SBP, prior history of CV 
were associated with higher 
CV mortality. 
 
1.  Antihypertensive drug 
treatment and blood pressure 
had no additive role on CV 
risk, but this could be partly 
due to age of the patients and 
comorbidities 
2.  Plasma glucose, age, 
plasma albumin, and CRP 
were not related to CV 
events. 
3.  French sample of men and 
women, sex-adjusted ORs 
 
Boutouyrie P, Tropeano 
AI, et al., 2002.  
Hypertension. 
Prospective, mean 
follow-up 5.7 yrs. 
1045 hypertensives. Mean 
age 51 YO, n=674 men, 
n=371 women. 
Asymptomatic for CV.  
France. 
Carotid-femoral 
PWV, Framingham 
risk score. 
1. 53 coronary events, 97 
CV events.   
2. RR for CHD events: 1.42 
per 3.5 m/s PWV (p<0.01).  
For all CVD events, RR: 
1.41 (p<0.001). 
3. Framingham risk score 
(FRS) predicted CHD and 
CVD in population 
(p<0.001 and p<0.0001, 
respectively). 
4. After adjustment for 
FRS, PWV was still 
associated with coronary 
events (RR: 1.34, p=0.039). 
 
 
 
 
 
1.  This is one of the first 
studies to show an association 
between aortic stiffness and 
CHD and CVD 
2.  French sample of men and 
women, sex-adjusted RRs 
3.  Participants had already 
been treated for hypertension; 
while mean SBP was high 
(150 mm Hg), treatment 
might confound results 
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Sutton-Tyrrell K, Najjar 
SS, et al., 2005.  
Circulation. 
 
Prospective, mean 
follow-up 4.6 years 
2488 participants in Health, 
Aging, Body Composition 
(ABC) Study.  Ages: 70-79, 
40% Black, 48% male. 
Carotid-femoral 
PWV. 
1. 265 deaths.  111 were 
from CVD.  341 CHD, 94 
strokes, 181 CHF events. 
2. Average PWV: 810 cm/s 
(641-1052) 
3. Higher PWV associated 
with higher total mortality 
(p=0.019 between lowest 
and highest PWV quartiles), 
CV mortality (p=0.004 
between lowest and highest 
PWV quartiles) after 
adjustments for age, gender, 
race, SBP, known CV 
disease. 
4. High PWV quartiles 
associated with CHD 
(p=0.007) and stroke 
(p=0.001) 
 
1.  Older sample, relatively 
well-functioning, PWV values 
are low for this age.   
2. PWV was not associated 
with CHF 
 
Mattace-Raso F, van der 
Cammem T, et al., 
2006.  Circulation. 
Prospective, mean 
follow-up for stroke 
(3.2 yrs), mean 
follow-up for CHD 
(4.1 yrs) 
2835 subjects in Rotterdam 
study.  Mean age: 71.7 yrs, 
39.2% men. 
Carotid-femoral 
PWV. 
1. 101 subjects developed 
CHD, 63 developed stroke, 
352 subjects died. 
2. Average IMT: 0.86±0.14 
mm.  Average PWV: 
1330±290 m/s.   
3. HR for CHD in the 2nd 
and 3rd tertiles of PWV: 
1.72 (0.91-3.24), 2.45 
(1.29-4.66), after 
adjustment for age, gender, 
MAP, and HR. 
4. HR for stroke in the 2nd 
and 3rd tertiles of PWV: 
1.22 (0.55-2.70) and 2.28 
(1.05-4.96). 
1.  PWV was adjusted for IMT 
in some models, which did not 
explain the association 
between PWV and CV events 
2. Aortic PWV had additive 
predictive value above 
traditional CVD risk factors 
and IMT 
3.  Low numbers of stroke 
could have reduced the ORs 
for these associations 
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 Table A-5. Ethnic Differences in Coronary Artery and Aortic Calcification  
Authors Study Sample Measurements Results Comments/Conclusions 
Bild DE, Detrano R, et 
al.  2005.  Vascular 
Medicine. 
 
Cross-sectional MESA study.  6814 
White, Black, Hispanic, 
Chinese men and 
women ages 45-84 YO. 
Mean age = 62-63 
among all age groups.   
 
Blacks had highest SBP 
and DBP, lowest total 
cholesterol and 
triglyceride levels, highest 
rate of current smoking 
(18%), and high levels of 
diabetes (21%).    
1. After adjustments for CV 
risk factors, relative risks 
for coronary CAC were 0.78 
in Blacks, 0.85 in Hispanics, 
0.92 in Chinese.   
2. Amount of CAC was 
greatest among Whites, 
followed by Chinese (77% 
that of Whites), Hispanics 
(74% that of Whites), and 
Blacks (69% that of 
Whites). 
3. White men had the 
highest prevalence of CAC 
of all groups (70.4%); of 
women, Whites had the 
highest prevalence (44.6%). 
 
1. Increased BMD associated 
with lower vascular CAC. 
2. Blacks have lowest RR of 
CAC and lowest prevalence of 
CAC. 
3. CAC may not be a good 
prognostic index for 
Blacks/Hispanics, or a lower 
limit should be considered. 
4. BMI associated with CAC 
in Whites only 
Bild DE, Folsom AR, 
et al.  Arterioscler 
Thromb Vasc Biol.  
2001. 
Cross-sectional Coronary Artery Risk 
Development in Young 
Adults (CARDIA).  443 
men and women, ages 
28-40.   Volunteers 
from the larger 
CARDIA sample.   
EBCT scans for this 
study were done at year 
10.  Mean age-35 YO 
across groups.   
No participants had a 
history of CVD.   
 
Presence of CAC was 
positively associated with 
age, male sex, BMI, 
weight, SBP, and total + 
LDL cholesterol at 
baseline and year 10.   
 
 
1. Presence of CAC was 
seen in 16.1% of Black 
men, 11.8% of Black 
women, 17.1% of White 
men, and 4.6% of White 
women (p=0.04).    
 
1. White men had the most 
CAC, White women had the 
least CAC. 
2.  A longitudinal analysis of 
CAC progression over the 10-
year period would have been 
interesting for assessing long-
term effects of CV risk factors 
on CAC progression 
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Table A-5 (Continued) 
Budoff MJ, Yang TP, 
et al., 2002. Coronary 
Artery Disease.  
Cross-sectional 
 
782 patients undergoing 
coronary angiography 
due to evidence of CVD 
(angina most common). 
White (mean age= 58 
YO, 75% men), Blacks 
(55 YO, 53% men), 
Hispanics (55 YO, 64% 
men), Asians (58 YO, 
73% men).   
 
EBCT. 
 
UCLA medical center. 
 
 
Asians and Blacks had 
highest hypertension 
levels (65 and 66% 
respectively) compared to 
Whites and Hispanics 
(44% and 66%).   
 
Statistical controls for 
age, gender, and risk 
factors (hypertension, 
tobacco, diabetes, age, 
gender, family history, 
hypercholesteremia, statin 
usage). 
  
1. In Whites, 84% 
prevalence of CAC and 
significant obstruction on 
angiogram was 71%.   
2. Blacks had a lower 
prevalence of CAC (62%, 
p<.001) and angiographic 
disease (49%, p<.01).   
3. Hispanics had a lower 
prevalence of CAC (p<.001) 
and angiographic 
obstruction (p<.01).   
4. Asians were not 
significantly different to 
Whites with regard to CAC 
or angiographic stenosis.   
 
1. Blacks and Hispanics have 
less CAC and obstructive 
coronary disease. 
2. Whites and Asians have 
comparable levels of CAC and 
obstructive coronary disease 
Budoff MJ, Nasir K, et 
al., 2006.  
Atherosclerosis. 
Cross-sectional UCLA physician-
referred population. 
 
16560 asymptomatic 
patients with high 
CHD-risk.  70% males, 
average age 52.  
Whites, Blacks, Asians, 
Hispanics. 
  
Whites had more 
dyslipidemia, but Blacks 
and Hispanics had more 
hypertension, smoking, 
and diabetes. 
Relative risks for men 
having CAC compared to 
Caucasians were 0.64 for 
Blacks, 0.88 for Hispanics, 
0.66 for Asians.  For 
women, compared to 
Caucasians, risks were 1.58 
for Blacks, 0.84 for 
Hispanics, 0.71 for Asians. 
 
 
1.  Black women had more 
CAC than did any other ethnic 
group, but also had more RFs. 
2.  Physician-referred 
population. 
3.  Presents data by gender. 
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Diez Roux AV, 
Detrano R, et al., 
Circulation. 2005. 
Cross-sectional MESA.  6814 White, 
Black, Hispanic, 
Chinese men and 
women ages 45-84 YO 
(median ages across 
ethnic/gender groups: 
61.3-62.4) 
Median sex distributions 
and ages were similar 
(~61-62) across ethnic 
groups.    
 
Prevalence of 
calcification was higher in 
white non-Hispanics. 
 
CAC differences were 
controlled in analyses by 
smoking, BMI, LDL, 
HDL, hypertension, and 
diabetes. 
 
 
1.  Prevalence of CAC 
highest among Whites 
2.  Low education 
associated higher prevalence 
of CAC among Whites (RP: 
< high school vs. college, 
1.17; 95% CI: 1.05 to 1.32) 
but with lower prevalence of 
calcification in Hispanics 
(RP: 0.91; 95% CI, 0.77 to 
1.09) (p for 
interaction=0.02)? 
Hispanic paradox 
1. Not being born in the US 
was associated with a lower 
prevalence of CAC in Blacks 
and Hispanics after adjustment 
for age, sex, income, and 
education.   
2. Years in US were positively 
associated with prevalence of 
CAC in non-US born Chinese 
and non-US born Blacks.  
3. Income was inversely 
associated with CAC (Blacks in 
lowest income categories had 
12% higher probability of 
calcification than those in 
highest category). 
 
 
Doherty TM, Tang W, 
et al., 1999.  J Am Coll 
Cardiol. 
Cross-sectional South Heart Bay 
Watch.  1375 high-risk 
but asymptomatic 
adults (n=93 Blacks, 
1282 Whites). 
Similar Framingham risk 
scores.    
1. Prevalent CAC in 59.9% 
of Whites, 35.5% of Blacks 
(p=0.0001).   
2. After 70 months of 
follow-up, 23.7% of Blacks 
vs. 14.8% of Whites 
(p=0.04) had either CHD 
death, MI, angina, or 
revascularization.   
3. Blacks were 2.16 times 
more likely to have at least 
one event than were Whites, 
after adjustment for age, 
gender, and risk factors. 
1.  Small number of Blacks, not 
enough to stratify results by 
gender 
2.  Despite lower prevalence of 
CAC, Blacks had more CHD 
events than did Whites 
3.  High-risk population.  Only 
one measure of subclinical 
CVD was assessed.   
4.  Authors suggest that 
differences in Ca2+ 
metabolism, differing 
importance of risk factors, and 
greater left ventricle mass 
among Blacks may explain 
ethnic differences in CVD 
outcomes. 
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Jain T, Peshock R, et 
al., 2004.  J Am Coll 
Cardiol. 
Cross-sectional Dallas Heart Study  528 
Whites (242 women, 
286 men) and 761 
Blacks (380 women, 
381 men).  Women 
were apprx. 54 YO (+/- 
5 yrs), men were apprx. 
51 yrs old.   
Assessed clinical 
characteristics of black 
and white participants by 
gender.  Threshold status 
for CAC was≥10 vs. < 10 
units.  ORs to assess 
differences. 
. 
 
1. No sig. differences were 
found in the prevalence of 
CAC between the two 
ethnic groups. 
2. For Black and White 
men, prevalence of CAC: 
37% v 41% (p=0.35), for 
Black and White women, 
prevalence of CAC: 29% v. 
23% (p=0.21) 
 
1. No SES adjustments 
2. Sig. predictors of CAC were 
smoking, SBP, DBP, BMI, and 
plasma cholesterol, HDL, 
triglycerides, and glucose.  
3. No difference in CAC ORs 
between blacks and whites 
were seen after adjusting for 
age and gender 
Khurana C, 
Rosenbaum CG, et al., 
2003.  Am Heart 
Journal. 
Cross-sectional Women’s Health 
Initiative-Observation 
Study (WHI-OS) 
 
128 Black women, 733 
White women.  
Postmenopausal, CAD-
free. 
 
CAC in black and white 
women. 
Framingham algorithm 
used to assess 10-year risk 
of CVD.   
1. Black women had higher 
dietary fat consumption, 
higher BMI, and greater 
prevalence of hypertension, 
diabetes, and smoking than 
did White women. 
2. DM and not exercising 3x 
per week were 
independently associated 
with higher CAC in Whites 
only. 
3. Educational level, BMI, 
dietary fat consumption, 
family history of premature 
CAD, hypertension, and 
smoking were not 
associated with CAC in 
Blacks, Whites, or the 
combined cohort. 
4. Black and White women 
had similar CAC scores 
despite higher RFs among 
Blacks. 
 
 
1. Consistent with SWAN 
Heart in that educational level 
is not associated with CAC in 
Blacks and Whites 
2.  Inconsistent in that 
educational level, BMI, and 
hypertension are not associated 
with CAC in Blacks and Whites 
3.  Black and White women 
were both well-educated 
 in this sample 
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Lee TC, O’Malley PG, 
et al., 2003.  J Am Coll 
Cardiol.  
Cross-sectional 1000 adults, 
asymptomatic, active-
duty personnel.  
Prospective Army 
Coronary Calcium 
(PACC) Project.  Mean 
age 42. 
EBCT, plasma and 
biologic, physiologic 
measurements.   
1. Blacks had more RFs, 3x 
the hypertension, LDL-C, 
inflammation, but had less 
waist circumference.  After 
adjustments for RFs, 
2. CAC was prevalent 
among 19.2% of Whites and 
10.3% of Blacks (p=0.004).  
3. After adjustment for 
CVD risk factors and SES, 
Blacks were 39% as likely 
to have any CAC present 
(p=0.007). 
 
1.  Blacks had less CAC than 
did Whites, but low SES and 
high CVD risk explain some 
CAC in Blacks 
2.  Regardless of excess CVD 
risk factors among Blacks, 
Whites had more prevalent 
CAC 
3.  Data were not presented by 
gender. 
 
Lewis TT, Everson-
Rose SA, et al., 2009.  
Psychosomatic 
Medicine. 
 
Cross-sectional SWAN Heart Study. 
508 African American 
and Caucasian women, 
38% African American. 
EBCT, CES-D depression 
scale. 
 
CAC and AC 
1. CAC was present among 
76.8% of Black women and 
64.0% of White women 
(p=0.002).   
2. 23.7% and 21.3% of 
Black and White women, 
respectively, had AC above 
100 units. 
3. 58.8% of Blacks and 
41.4% of Whites had CAC 
(p=0.0001). 
 
 
 
 
 
 
 
 
 
 
 
1.  Blacks had higher CAC and 
AC prevalence than did 
Caucasian women 
2.  No ethnic differences in the 
women who had high levels of 
AC 
3.  Black women with 
depressive symptoms had 
higher AC, but there was no 
association between depression 
and AC among Whites. 
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Newman A, Naydeck 
BL et al., 2002.  
Arterioscler. Thromb. 
Vasc. Biol. 
Cross-sectional 614 elderly adults.  
Cardiovascular Health 
Study study, Pittsburgh 
site.  59% women, 23% 
Black.  Ages 67-99. 
EBCT 1. Median CAC scores. 
2. For Black v. White 
women, 134 units versus 
233 units of CAC, 
respectively (p=0.02). 
3. After adjustment for age, 
CVD, and CVD risk factors 
(although association was 
significant after adjustment 
only for men).   
4. Hypertension was related 
to higher CAC among 
White men only.  Diabetes 
was not related to CAC 
score.  Significant ethnicity 
x gender interaction was 
observed: CAC association 
was stronger for White men. 
5. Blacks had lower odds of 
having a CAC score after 
adjustment for age and 
clinical CVD.  
 
1. Blacks showed less CAC 
than Whites, even after control 
for CVD risk factors and CVD.  
More pronounced among men. 
2. Older Blacks may exist with 
CAC for longer than Whites 
(survival effect). 
3. Should examine the 
associations between CAC and 
risk factors within each ethnic 
group and within each 
gender/ethnicity designation. 
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 Table A-6.  Ethnic Differences in Carotid Artery IMT 
Authors Design Study Measurements Results Comments/Conclusions 
D’Agostino RB, 
Burke G, et al., 1996  
Stroke. 
 
 
 
Cross-sectional Insulin Resistance 
Atherosclerosis Study 
(IRAS).  
 
Blacks (n=281), Whites 
(n=329), Hispanics 
(n=410). Ages 40-69 
YO.  Non-diabetics. 
CCA-IMT and internal 
carotid artery (ICA) IMT 
 
Unadjusted CCA means: 
Blacks : 855.3 (SE=13.1)  μm 
Hispanics: 736.9 (8.7)  μm 
Whites: 814.5(12.7)  μm at 
one study site, 785.0 (14.5)  
μm at second site 
 
Unadjusted ICA means:  
Blacks: 909.7 (22.6)  μm 
Hispanics: 736.9 (8.7)  μm 
Whites: 887.3 (27.8) at one 
study site, 798.8 (25.9)  μm at 
second site 
1. 4 adjustments: 1) 
demographics (age, sex, 
center), 2) demographics 
+ HDL, LDL, smoking 
status and hypertension,  
3) model 2 + insulin 
sensitivity 
4) model 3 + fasting 
glucose 
2. Blacks had higher  
CCA-IMT than Whites 
after all 4 adjustments  
3. Hispanics had less 
CCA-IMT than Whites 
after all 4 adjustments 
4. No sig. differences in 
ICA-IMT between 
ethnic groups 
1.  Ethnic differences seen in 
CCA but not in ICA. 
2. Men and women were 
pooled together (women = 
50% of study)—possible 
limitation 
3. Blacks and Hispanics not 
directly compared 
Everson-Rose SA, 
Lewis TT, et al., 
2006.  Am Heart J 
 
  
Cross-sectional SWAN Heart study, 
women-only 
 
Blacks (n=213), Whites 
(n=376).  Avg. 
age=50.3. 
Mean and max IMT 
 
Unadjusted  Mean IMT: 
Blacks: 0.689 (0.10) 
Whites: 0.656 (0.09) 
 
Unadjusted Max IMT: 
Blacks: 0.896 (0.13) 
Whites: 0.854 (0.12) 
 
Blacks had higher mean and 
max IMT than Ws 
(p’s<.0001) 
 
1. Black ethnicity 
entered into models with 
Whites as referent group. 
2. Controlling for 
cynical hostility, age, 
ethnicity, and education, 
ethnicity was sig. 
predictor of mean and 
max IMT (p’s<0.01) 
3. Additional controls 
for BMI, SBP, and 
smoking make ethnicity 
NS 
1. Women only 
2. Association with increased 
IMT among Blacks 
disappears with adjustments 
for CVD risk factors  
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Howard G, Sharrett 
R, et al., 1993.  
Stroke. 
 
Cross-sectional ARIC. 
 
Black Females 
(n=2219), Black Males 
(n=1391), White 
Females (n=5377), 
White Males (n=4837).  
 
Ages: 45-64 YO 
CCA, BIF (Bifurcation IMT), 
ICA IMT 
 
Incomplete data for all carotid 
segments.  CCA had highest 
number of complete data 
points, ICA had lowest 
 
Unadjusted estimates of mean 
wall thickness over 3 age 
categories (45-54, 55-64, 
65+): 
Black Females: 0.58-0.75  
White Females F: 0.55-0.73 
Black Males: 0.64-0.86 
White Males: 0.62-0.80 
 
1. 1-year, age-related 
progression rates were 
estimated: 
2. BIF: 0.015 mm/y in 
women, 0.018 mm/y in 
men  
3. ICA: 0.010 mm/y for 
women, 0.014 for men 
4. CCA: 0.010 mm/y in 
both sexes 
 
1. BIF-IMT>CCA-IMT, ICA 
more variable 
2. Black females and White 
males had a flattening of 
higher percentiles at left BIF: 
cannot be explained by the 
cross-sectional design 
 
Kalra L, Rambaran 
C, et al., 2005.  
Arterioscler Thromb 
Vasc Biol. 
 
Cross-sectional n=78 Afro-Caribbeans 
and n=82 age-and-sex-
matched Whites  
 
Ages: 35-75 YO 
 
Carotid IMT (CIMT) = mean 
of differences between 
blood/intima borderline and 
media/adventitia borderline 
 
Mean CIMT of Blacks greater 
than Whites:  
0.81 mm v. 0.75 mm (p=0.02) 
 
1. Black ethnicity sig. 
associated with CIMT 
(p=0.04) after 
adjustments for age (per 
5-yr category), Waist-
Hip-Ratio (WHR), SBP 
(per 5mmHg increase), 
current smoker, White 
ethnicity 
 
 
 
1. Blacks had higher BMI and 
DBP but comparable 
abdominal girth, SBP, 
Glucose, HDL, and 
triglycerides 
2.  Blacks  had higher TNF-α, 
IL-6, and fasting insulin. 
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Kieltyka L, Urbina 
EM, et al., 2003.  
Atherosclerosis. 
 
 
Cross-sectional Bogalusa Heart Study  
 
Black Females (n=87), 
White Females 
(n=226), Black Males 
(n=63), White Males 
(n=141) 
 
Ages: 20-37 YO 
 
CCA-IMT, Bulb-IMT, ICA-
IMT 
 
Unadjusted CCA-IMT: 
Black Females: 0.69±0.09 
White Females:  0.65±0.08 
ethnicity p=0.001 
 
Unadjusted Bulb-IMT: 
Black Females: 0.89±0.16 
White Females:0.65±0.08 
Black Males: 0.89±0.18 
White Males: 0.89±0.17 
ethnicity (BF/WF) p=0.001 
sex (WM/WF) p=0.001 
 
Unadjusted ICA-IMT: 
Black Females: 0.69±0.11 
White Females: 0.66±0.14 
ethnicity p=ns 
 
1. Black ethnicity sig. 
associated with CCA-
IMT after adjustments 
for FRS, log 
triglycerides, log BMI. 
2. Black ethnicity sig. 
associated with Bulb-
IMT after adjustments 
for FRS. 
3. ICA-IMT not 
associated with ethnicity 
1.  FRS was not sig. different 
by ethnicity 
2.  FRS explained more of the 
variance of Bulb-IMT (9%) 
than the CCA (5%) or ICA 
(3%) 
 
 
 
 
Manolio TA, Burke 
GL, et al., 1994.  J 
Clin Epidemiol. 
Cross-sectional Cardiovascular Health 
Study (CHS), aged ≥65 
YO 
 
n=4926 Whites, n=244 
Blacks 
 
Mean ages: 72.3-73.3 
YO across ethnic and 
gender groups (NS) 
 
Blacks had generally higher 
CVD risk factors than Whites 
except for hyperlipidemia 
 
Unadjusted CCA-IMT 
Black Females: 1.03 mm 
White Females: 0.97 mm 
Black Males: 1.12 mm 
White males 1.05 mm 
 
Unadjusted ICA-IMT 
Black Females: 1.36 mm 
White Females: 1.40 mm 
Black Males: 1.56 mm 
White males 1.67 mm 
1. Regression results 
adjusted for age, SES, 
risk factors, and 
prevalent CHD: 
For women: 
Max IMT: 0.04 (95%CI: 
0.01-0.08) 
ICA-IMT: -0.12 (-0.24-
0.01) 
 
 
1.  High IMT levels in sample 
2.  Black women had 
approximately 0.05 mm-
thicker IMT than White 
women, which remained 
unchanged across analyses 
(p<0.001) 
3.  Black women had slightly 
lower ICA-IMT than did 
White women 
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Ranjit N, Diez-Roux 
AV, et al., 2006.  
Arterioscler Thromb 
Vasc Biol 
 
 
Cross-sectional 
and prospective 
  
 
 
ARIC, 12085 adults, 
CHD-free. 
Mean age: 
approximately 53, 2-3 
observations 
5-9 years 
 
Mean CCA baseline (μm) 
(adjusted for age/site): 
White Males: 641.1 (2.17) 
Black Males: 690.0 (7.0) 
White Women: 582.0 (1.57) 
Black Women: 640.2 (5.04) 
 
5-yr change (μm): 
White Men: 45.8 (1.77) 
Black Men: 35.8 (3.44) 
White Women: 46.8 (1.35) 
Black Women: 37.3 (2.37) 
 
SES at Baseline: 
Highest v. lowest income: 
Whites: -6.3 (3.7) μm 
(p=0.05); Blacks: -19.6 (7.7) 
μm  (p=0.009) 
 
Highest v. Lowest Education: 
Whites: -27.2 (4.4) μm 
(p<0.0001); Blacks: -26.7 
(6.9) μm (p=0.0001) *p’s are 
for trend 
 
SES and Progression: 
Highest v. lowest income: 
Whites: 11.5 (3.0) μm 
(p<0.005); Blacks: -11.1 (5.7) 
(p=0.039); Low v. high 
education NS 
 
Mean IMT diff. per unit 
decrease in combined SES 
score: Whites: -0.9 (NS) 
Blacks: 2.1 (0.8) (p=0.007) 
1.  Study examined SES 
and ethnicity interactions 
with respect to cross-
sectional/longitudinal 
IMT 
 
2.  SES was inversely 
associated with cross-
sectional IMT among 
both Blacks and Whites 
 
3.  Low SES was 
associated with higher 
IMT progression among 
Whites, but high SES 
was associated with 
higher IMT progression 
among Blacks 
1.  Unclear why high-SES 
Blacks had higher IMT 
progression than did low-SES 
Blacks 
2.  Authors refute a “ceiling 
effect” in IMT among Blacks 
3.  Authors are not able to 
explain this observation, and 
it remains robust after 
adjustments for multiple CV 
risk factors 
4.  Suggests that high-SES 
Blacks have a greater risk of 
arteriosclerotic/atherosclerotic 
progression with time, but the 
risk factor mediating that 
observation is not known 
5.  Authors did not examine 
candidate psychological 
mediators in this population 
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Sutton-Tyrrell K, 
Zeigler-Johnson C, 
et al., 1998.  CVD 
Prevention. 
 
 
 
Cross-sectional 3 female cohorts 
(HOPE, WHLP, HWS) 
were pooled; all in 
Pittsburgh 
 
n=382 premenopausal 
(n=90 Blacks; n=292 
Whites), n=253 
postmenopausal (n=53 
Blacks, n=200 Whites) 
 
 
Carotid plaque, median 
IMT, max IMT 
Median IMT of whole group: 
0.71 mm 
(range: 0.51-1.51) 
 
Higher IMT among 
postmenopausal women than 
premenopausal: 0.75 vs. 0.70 
mm 
 
Unadjusted median IMT 
levels were higher among B 
than W: 
0.79 mm vs. 0.70 mm. 
 
Significant Spearman 
correlations with IMT: older 
age, higher IMT, SBP, LDL, 
cholesterol, and glucose. 
 
Premenopausal women: 
ethnicity was not associated 
with CCA-IMT (p=0.992) but 
was associated with ICA-IMT 
(p<0.001).  Association 
disappeared with adjustment 
for hysterectomy. 
 
Postmenopausal women: 
ethnicity was associated with 
CCA-IMT (p=0.004) but not 
ICA (p=0.162).   
 
After adjustments for 
smoking, age, BMI, 
SBP, DBP, PP, 
cholesterol, LDL, and 
triglycerides: ethnicity 
was not associated with 
focal plaque. 
 
Independent associations 
with IMT: Black 
ethnicity, older age, 
smoking and higher 
LDL, SBP, and BMI  
 
 
1.  Women only 
2.  Black ethnicity was 
associated with IMT in pre- 
and post-menopausal women. 
3.  Different RF distribution: 
premenopausal Black women 
had higher BMI and BP, 
postmenopausal Black 
women were younger, had 
higher BMI, lipid and glucose 
levels.  Fewer Black women 
took HRT than Whites.   
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 Table A-7.  Ethnic Differences in Aortic Pulse Wave Velocity  
Authors Design Study Measurements Results Comments/Conclusions
Chaturvedi N, Bulpitt 
CJ, et al., 2004.  J of 
Hypertension. 
Cross-
sectional 
103 Europeans, 99 Afro-
Caribbeans, ages 40-65, 
England.  Sample was 
recruited from a family 
medicine registry in 
London, and individuals 
were invited to participate 
Carotid-femoral, 
carotid-radial, 
femoral -dorsalis 
PWV, 
interventricular 
septal thickness 
(IVST) 
1.  PWV was higher among 
Blacks than Whites (12.7 vs. 
11.2 m/s, p<0.0001). 
2.  Afro-Caribbeans had higher 
IVST than did Whites (9.6 vs. 
9.1 mm, p=0.0005) 
3.  No ethnicity x IVST 
differences, no ethnicity x SBP 
differences with regard to PWV  
4. No carotid-radial differences 
between Blacks and Whites 
5. Femoral-dorsalis pedis PWV 
was higher among Blacks, and 
entirely explained by higher 
blood pressures 
 
1.  Blacks had higher cf-PWV 
(central aortic stiffness) than 
did Whites 
2.  Blood pressure measures 
or waist-hip-ratio did not 
explain association between 
Black ethnicity and cf-PWV 
3.  Blood pressure fully 
explained femoral-dorsalis 
PWV difference between 
Blacks and Whites 
4.  Extent of  clinical disease 
in population was unclear 
5. Selection bias may be a 
limitation of this study 
 
Ferreira AV, Viana 
MC, et al., 1999.  J of 
Hypertension. 
Cross-
sectional 
82 White (49 untreated 
hypertensive and 33 
normotensive) and 38 
Black (24 normotensive 
and 14 untreated 
hypertensive) male 
volunteers. 
Mean ages: 23-29 across 
ethnic and hypertensive 
categories.  Brazil. 
 
PWV via Complior 1.  PWV was correlated with 
age, weight, BMI, SBP, and 
DBP, not glycemia, cholesterol, 
height, or heart rate. 
2.  In the normotensive group, 
Whites had higher PWV than did 
Blacks.  In the hypertensive 
group, Blacks had higher PWV 
than did Whites. 
3. Among hypertensives, Whites 
had lower PWV than did Blacks 
4.  Interaction between race and 
blood pressure status 
determining PWV (p<0.001). 
 
1.  Important article: the 
magnitude of the effect of 
elevated blood pressure may 
confer greater arterial 
stiffness among Blacks than 
among Whites 
2.  The small frequencies in 
this study may limit the 
ability to detect some 
differences 
3.   The sample consisted of 
Black and White police 
soldiers who were of similar 
socioeconomic status (SES) 
4.  Age, then SBP, were the 
strongest predictors of PWV 
in the sample 
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Strain WD, Chaturvedi 
N, et al., 2006.  Am J 
Hypertens. 
Cross-
sectional 
Europeans (49 with diabetes, 
100 without) and Afro-
Caribbeans (66 with diabetes, 
88 without) 
 
 Sample was recruited from a 
family medicine registry in 
London, and individuals were 
invited to participate. 
 
Carotid-
femoral, 
carotid-radial, 
femoral -
dorsalis PWV, 
interventricular 
septal thickness 
(IVST) 
1.  Cf-PWV was highest among 
diabetics and among Blacks 
2. Blacks with diabetes had 
significantly higher cf-PWV 
than those who did not; no 
similar association between 
whites (interaction between 
diabetes and ethnicity) 
3.  Blacks with diabetes had 
higher femoral-dorsalis PWV 
than did Whites with diabetes 
(p=0.008); no ethnic differences 
in femoral-dorsalis pedis among 
non-diabetics 
 
1. Diabetes has a 
disproportionate impact on 
cf-PWV among Blacks as 
compared to Whites 
2.  Black ethnicity seems 
most strongly related to 
higher cf-PWV segment, not 
related to carotid-radial 
 
Thurston RC, 
Matthews, KA  2009.  
Social Sci and Med. 
Cross-
sectional 
214 Black (n=81) and 
Caucasian adolescents (n=78), 
ages 12-14  
PWV, IMT, and 
socioeconomic 
status measures 
1. Blacks had significantly 
higher PWV (571.4 vs. 525.3 
cm/s, p=0.01) and similar IMT 
levels (0.54 vs. 0.53, p=0.05) 
compared to Whites, after 
controlling for age, gender, BMI, 
and SBP 
2. Low or medium family 
income and lower neighborhood 
SES were also associated with 
higher PWV, after controls for 
age, gender, BMI, and SBP; low 
family assets were associated 
with higher IMT after same 
adjustments 
3.  Lower neighborhood SES 
was associated with higher IMT 
among Blacks only, low and 
medium family incomes were 
associated with higher PWV 
among Blacks only 
1.  No White ethnicity x SES 
interactions were observed 
for PWV or IMT, but low 
counts in the low SES 
categories could have 
explained that 
 
2.  Even in adolescence, 
Blacks have higher PWV and 
marginally higher IMT 
 
3.  SBP and DBP were in 
normal ranges, but both 
Black and White adolescents 
were slightly overweight on 
average; no significant 
difference in BMI across 
ethnic groups 
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Wildman RP, Farhat 
GN, et al., 2005.  
Hypertension. 
 
Prospective, 
2 years (1.3-
3.7) 
152 Whites and Blacks 
Aged 20-40 (mean=30.4) 
45% male, 44% Black 
 
Carotid-femoral 
PWV, waist 
girth, body 
weight, BMI, 
annual weight 
gain 
 
1. Range in PWV change: 
-141.1 cm/s-194.2 cm/s 
2. Blacks had higher PWV 
increases than Whites, even after 
adjustments for baseline PWV 
(Beta co-efficient: 21.8, 
p<0.0001) 
3. After adjustments for weight 
and weight change, Blacks had 
15 cm/s larger annual increase in 
PWV than Whites (p=0.024) 
4. Waist girth, body weight, and 
BMI were all related to PWV 
progression 
5.  4.5 kg- weight loss or more 
was associated with PWV 
change of -29.9 cm/s, and 18.2 
cm/s gain for those with 4.5-kg 
weight gain 
 
 
1.  Weight change was related 
with decreased PWV 
2.  No significant ethnicity x 
weight interactions with 
regard to PWV progression, 
although it appeared that for a 
5-lb weight gain, the effect on 
PWV progression was greater 
for Blacks than for Whites 
(6.1 cm/s per year vs. 3.7 
cm/s/per year, respectively) 
3. Effect of weight change on 
the vasculature may be 
stronger among Blacks than 
among Whites, but the 
sample is likely too small to 
assess significant differences  
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